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 I 
Abstract 
Drug discovery requires prompt decision-making to identify which new chemical 
entities constitute viable new drug candidates and have a high likelihood of market success. 
Conventional in vitro cell-based screens sometimes provide misleading data that may not 
represent in vivo responses. We developed an array of microcellular platforms to provide a 
uniform environment for single-cell suspension, mimic in vivo functions, and demonstrate the 
biological effects of a drug on the chemistry of a single cell at the molecular level. 
Dopaminergic mesoporous inorganic-organic hybrid resin (HR4-DOPA) was used to coat the 
wells of 200-microwell plates fabricated for these experiments. The biocompatibility of HR4-
DOPA was demonstrated by cell adhesion and viability assays. HeLa cell adhesion to the 
HR4-DOPA film was comparable to the controls: mesoporous inorganic-organic hybrid resin 
(HR4), ECM proteins (fibronectin and collagen IV), and glass. HeLa cell viability on HR4-
DOPA was 86.1%, indicating insignificant growth inhibition. We also investigated the 
optimal microwell depth and cell concentration for HeLa single-cell occupancy: 25-µm-deep 
microwells at 1.0 × 10
6
 cells/ml demonstrated 67.5% single-cell occupancy while providing 
sufficient cell-adhesive surface area for long-term cell culture (≥ 3000 µm2). We obtained 
singly occupied microwells with only 5.9% array-to-array variation, thus providing adequate 
throughput for accurate quantification in advanced single-cell analyses. Arrays of HR4-
DOPA-coated microwells can be used for high-throughput single-cell-based assays for drug 
discovery as a “bio-cell processor.” Given that the microwell arrays are integrated in a 
microfluidic biochip, they can mimic the in vivo microenvironment; we can thus predict in 
vivo responses through high-throughput, isolated single-cell analysis to assess cellular 
chemistry at the molecular level. 
Keywords: drug discovery, high-throughput screening, single-cell-based assay, dopaminergic 
mesoporous inorganic-organic hybrid resin (HR4-DOPA), HeLa cells, microwell, single-cell 
occupancy   
 II 
Zusammenfassung 
In der Medikamentenforschung ist eine schnelle Entscheidungsfindung erforderlich, um 
neue chemische Stoffe aus einem Kandidaten-Pool möglicher neuer Medikamente zu finden, 
die eine Chance auf Markteinführung haben. Konventionelle, in vitro, zell-basierte Methoden 
liefern oft irreführende Ergebnisse, die nicht der in vivo Antwort entsprechen. Wir haben ein 
Einzelzell Array in einer mikrofluidischen Platform entwickelt, das ein gleichförmiges 
Millieu für die Zellen bereit stellt, in vivo Funktionalität imitieren kann und biologische 
Effekte eines Medikaments auf die Chemie einer einzelnen Zelle auf molekularer Ebene 
demonstrieren kann. Ein dopaminerges, mesopores, inorganisches/organisches Harz (HR4-
DOPA) wurde benutzt um die Microwells einer 200-Microwell-Platte zu beschichten. Die 
Biokompatibilität dieses Harzes wurde durch Zell-Adhäsions- und Viabilitäts-Experimente 
nachgewiesen. Die Anlagerung von HeLa Zellen an HR4-DOPA war vergleichbar mit der an 
den Vergleichssubstanzen: mit HR4 (Hybrides, mesoporöses, inorganisches/organisches 
Harz), mit Proteinen der extrazellulären Matrix (Fibronectin, Collagen IV) und mit 
biologischem Glas. Die Viabilität der HeLa Zellen auf HR4-DOPA lag dabei bei 86,1%, was 
auf eine geringe Wachstumshemmung hindeutet. Die optimale Tiefe der Wells und die 
optimal Anzahl der Zellen wurden ebenfalls untersucht, wobei eine Zellzahl von 1,0 × 10
6
 
Zellen/ml und eine Tiefe der Microwells von 25 µm die besten Ergebnisse lieferten mit einer 
Einzel-Zell Belegung der Wells von 67,5% und eine genügend große Fläche (≥ 3000 µm2) für 
die Zellanlagerung und Langzeit-Kultivierung bereit stellt. Die Reproduzierbarkeit der 
Ergebnisse war dabei hoch, lediglich 5,9% Abweichung wurde festgestellt. Somit liefert 
dieser Ansatz eine geeignete Methode für die exakte Bestimmung und Quantifizierung 
verschiedener zellulärer Prozesse bei der state-of-the-art Einzel-Zell Analyse. Anordnungen 
von HR4-DOPA beschichteten Microwells können für Hochdurchsatz Untersuchungen in der 
Medikamentenforschung als „Bio-Zell Prozessor“ verwendet werden. Vorausgesetzt die 
Microwells sind integriert in einen mikrofluidischen Biochip, können diese eine in vivo 
ähnliche Mikroumgebung bereit stellen für weiterführende Versuche. Somit wird es möglich, 
in vivo Reaktionen akkurat und in einem Hochdurchsatz Verfahren voraus zu sagen und 
zelluläre Reaktionen auf der molekularen Ebene zu testen.  
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 Introduction Chapter 1. 
 New Drug Application 1.1.
 Aim of a new drug application 1.1.1
The pharmaceutical industry has expanded the development of new drug therapies in 
response to increasing healthcare demands from the global population. The mission of 
pharmaceutical research companies is to understand a prevalent or an emerging disease, to 
research and develop new therapies, and to bring a safe and effective new treatment to 
patients. The most recent trend in pharmaceutical research is to pursue drug development for 
the treatment of chronic diseases, for example, the 3 leading causes of death, that is, 
cardiovascular disease (CVD), cancer, and stroke. Among these 3 chronic conditions, CVD is 
the biggest killer [1]. According to an estimate by the Centers for Disease Control and 
Prevention (CDC, USA), in the United States alone, the cost of treating CVD was US $444 
billion in 2010, and more than 1 in 3 (83 million) American adults have some form of CVD. 
 Process of a new drug application 1.1.2
The process of new drug application (NDA) demands time and major investments of 
financial, human and technological resources. A new medicine must conform to strict 
regulations regarding testing and manufacturing standards. In most cases, it takes 
approximately 10–15 years to develop one new drug from the time of discovery to the time it 
is available for treating patients. The average cost for research and development for each 
successful medicine is estimated to be between US $0.8 billion and 1 billion, which includes 
the cost of thousands of failed attempts . Out of approximately 5,000–10,000 candidate drugs, 
ultimately only one single drug will receive approval through the NDA process, as shown in 
Figure 1.1. During the NDA process, researchers work to 
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- validate drug targets identified from basic causes of disease at the level of genes, 
proteins, and cells, 
- discover the correct molecule (potential drug) to interact with the chosen target, 
- examine the new compound in both the laboratory and clinical settings for safety and 
efficacy, 
- gain approval and market the new drug for use in the general population [1, 3-5]. 
 
Figure 1.1: New drug application (NDA). 
(a) Overview of the NDA process and timeline, including the estimated number of drug 
candidates in preclinical trials and the number of volunteers needed during each phase of 
clinical trials for a single new drug [2]. 
(b) Trend in capitalized preclinical, clinical, and total costs per approved drug, in terms of 
millions of US dollars (year 2009) [3]; IND: Investigational New Drug, FDA: Food and 
Drug Administration, LG-scale MFG: Large-scale manufacturing. 
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 Importance of cell-based screening assays during preclinical trials in an new 1.1.3
drug application 
A new bottleneck emerges at the point of drug discovery in the early phases of an NDA 
[6]. Drug discovery obviously requires prompt decision-making to identify from an enormous 
number of potential compounds, which kind of new chemical entities (NCEs) would 
constitute viable new drug candidates and have a high probability of becoming marketable [1, 
6]. To reduce the risk to pharmaceutical firms, promising screening approaches have included 
a series of toxicity and in vitro cell-based assays that are performed at an intermediate stage 
after gene- or protein-based studies but before early in vivo animal testing [1, 6-8]. 
 Microelectromechanical systems 1.2.
Microelectromechanical systems (MEMS) constitute a technology that can be used to 
miniaturize mechanical and electromechanical elements (i.e., devices and structures) in the 
analytical sciences. Commonly, miniaturized elements are fabricated using silicon, glass, or, 
more recently, different polymer types. Over the last several decades, MEMS researchers 
have developed an extremely large number of microsensors for chemical species, inertial 
forces, temperature, pressure, magnetic or electric fields, etc [9]. Many of these 
micromachined sensors have shown better performance than their macroscale counterparts 
[10]. Miniaturized sensors and actuators with microelectronic integrated circuits are added to 
develop complete systems-on-a-chip and to increase the numerous commercial market 
opportunities [11]. Among various MEMS applications, biochips or “lab-on-a-chip” have 
been widely adopted in the fields of analytical chemistry and the biomedical sciences, with 
integration of nano- or microfluidics, photonics, electronics, and chemistry for biomedical 
research [12-14]. With the help of these biochips, biological matter can be manipulated to 
analyze and measure its activity in a chip. Today, microbiochips are being extensively used in 
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the drug discovery process because of their capability for rapid high-throughput multiplexed 
analysis using low volumes of sample and reagent as well as a convenient and cost-effective 
approach for various analytical processes in biomedical research [15-17]. 
 Single-cell Analysis for drug discovery 1.3.
 Misleading results from conventional in vitro cell-based screening 1.3.1
Cell models in conventional in vitro cell-based screening continue to provide misleading 
data that are not necessarily representative of in vivo responses. Widely divergent phenotypes 
can arise even within the same cells in a short time scale because of slightly different cellular 
environments in the assay, such as temperature gradients or different chemical compound 
densities [8, 18-21]. Therefore, cell population analysis does not demonstrate a consistent 
response distribution, even when the same experiment is performed multiple times [22]. This 
behavior makes repetitive experiments and statistical analyses yielding average values and 
standard error of the mean (SEM) mandatory for the development of mathematical 
descriptions of cellular behavior [23]. To increase the reliability of an analysis of cellular 
responses and to benefit from economies of scale, uniform environmental conditions are 
required for cells in the early discovery process [8, 19]. 
In additional, multiplex and complicated cell-to-cell contact and communications within 
a single population of cells can conceal direct and accurate correlations between cells and 
stimuli [24]. Several types of cell-to-cell communication exist, including neurotransmitters 
recognized in the synapse, antigens that trigger antibody responses, and target cells that 
respond to specific hormones [25]. 
 Need for a single-cell isolation system for drug discovery 1.3.2
In order to overcome the disadvantages associated with cell population analysis, a new 
technology that can not only provide uniform cellular environments during drug screening 
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but can also allow analysis of the direct effects of a drug on a single isolated cell is required 
in clinical diagnostics [26, 27]. In addition, because each cell can express a phenotype more 
or less different from other cells, even within the same cell type, an array of isolated single 
cells is required to produce regular cellular responses from individual cells in a quantitative 
manner [27, 28]. 
To allow highly accurate measurement of cellular response to a drug, researchers have 
used microfabrication techniques to create cell culture models [4, 8, 27]. These microcellular 
platforms can provide a uniform cellular environment and can mimic in vivo functions [19, 
29, 30]. Moreover, an array of individual living cells can contribute to the elucidation of the 
biological effects of a drug on a single cell and can provide remarkable information regarding 
cellular chemistry at the molecular level [20, 27]. 
 Single-cell isolation system 1.4.
 Single-cell isolation techniques 1.4.1
Single-cell isolation systems have been developed to provide various aspects of 
environmental control, measurements on fast timescales, image processing, and isolation of 
secreted biomolecules. Single-cell isolation methods have been developed in two ways: (1) 
microfluidic techniques and (2) array-based techniques [27, 31]. 
Microfluidic systems provide dynamic control of cells as well as reagents via fluid 
perfusion and pressure gradients. Hydrodynamic systems trap single cells by using (1) 
microfluidic ports, (2) semipermeable microstructure, or (3) microfluidic pipette-like 
channels that are smaller than the diameter of the cell. Continuous flow is required to 
maintain the cell in the correct position. Single-cell encapsulation systems are prevalent 
because an enclosed chamber surrounding individual cells can biologically and physically 
isolate a single cell from the environment. This system has high-throughput potential because 
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many cells can be encapsulated if a microfluidic droplet generator is used [32, 33]. 
Other methods such as array-based techniques have been developed to isolate single 
cells in uniform environments without integration into a microfluidic platform. Common 
methods for creating arrays are based on (1) physical trapping, (2) chemical modification, (3) 
physical modification, (4) holographic optical tweezers, or (5) dielectrophoretic techniques. 
 Limitations of previous single-cell isolation system 1.4.2
Polydimethylsiloxane (PDMS) is commonly used in hydrodynamic systems designed to 
trap single cells. PDMS enables numerous replications at both micro- or nanometer scales 
with high-precision from a micro- or nanofabicated mold. However, the inherent properties of 
PDMS do not allow for cellular adhesion, which, due to the absence of supporting cells, an 
extracellular matrix and growth factors, could affect the natural behavior of anchor-dependent 
cells that can survive only when they adhere to substrates. 
Almost all micro single-cell arrays are developed in 2D culture systems using planar 
patterns of a cell adhesive, although conventional 2D cultures usually suffer from contact 
inhibition and a loss of native cell morphology and functionality [34, 35]. Compared to 2D 
cultures, 3D in vitro cell models provide a more realistic cellular environment and can 
reproduce in vivo cellular metabolism and function, including morphogenesis, gene 
expression, and differentiation [36, 37]. However, a 3D cell culture array must be 
multilayered, which makes it difficult to fabricate the array and to use it in high-throughput 
toxicological tests. The native 3D cellular morphology of the microwells on the plate is 
maintained, thereby providing a novel approach for 3D in vitro cell models that are suited for 
population statistics analysis from individual cell measurements. In addition, the cell 
adhesive surface of a microwell can support native cellular functionality by supporting cells, 
extracellular matrices, or growth factors [38]. 
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 Research objective 1.5.
The main objective of this study is to introduce single-cell arrays for 3D in vitro cell 
models into high-throughput drug discovery and screening by developing a platform with an 
array of microwells coated with cell adhesive material to control the 3D shape of cells and to 
maintain native cell morphology and functionality. 
 Scope of this work 1.6.
A potential application for this research, illustrated in Figure 1.2, is a bio-cell processor 
that can be used for drug discovery and can be integrated with novel platforms such as 
microfluidic chips and biochips. Microfluidic chips are designed for the introduction of 
nutrient cell media and drugs by using microvalves and mixers. Biochips are designed for 
immobilizing single cells, for mimicking the in vivo microenvironment, and for application to 
high-throughput drug screening with cellular analysis. A single-cell array is essential with 
regard to the bio-cell processor in order to maintain the native morphology and functionality 
of experimental cells and to provide results that better predict in vivo responses during the 
drug discovery process. 
 HeLa cells for microengineering (Chapter 3) 1.6.1
Depending on the type of cell, cellular behaviors differ widely. Surface treatment 
techniques using chemical or physical methods were determined to optimize cellular 
immobilization. The cell line used for experiments should be carefully chosen with respect to 
significance for clinical diagnosis and application to a microplatform for single cell analysis. 
HeLa, a cervical cancer cell line, was used in this study on the basis of previous literature, 
because of its biological value for cancer treatment and good adherent behavior on 
hydrophilic surfaces [39-42]. Despite many different descriptions of the biological 
characteristics of HeLa cells, few physical properties of HeLa cells have been reported. 
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Therefore, this study included collection and reanalysis of the physical properties of HeLa 
cells as well as measurement of cell diameter to provide technical specifications for the 
physical dimensions of the microwells intended for cells from the HeLa cell line. 
 
Figure 1.2: Schematic drawing of a bio-cell processor for drug discovery.  
The bio-cell processor was composed of microfluidic chips and biochips. Microfluidic chips are 
designed for introducing both nutrient cell media and drugs by using microvalves and mixers. 
Biochips are designed for immobilizing single cells and mimicking the in vivo 
microenvironment and for application to high-throughput drug screening with cellular analysis. 
 
 Dopaminergic mesoporous inorganic-organic hybrid resin (Chapter 4) 1.6.2
New biological materials and novel technologies for surface engineering have been 
developed for a wide range of biological studies and applications, including medicine, 
pharmacology, and bioengineering [43-45]. An ideal biological material should be amenable 
to molecular design for a biologic purpose and easily synthesized [44]. Moreover, for 
application in microfabrication, a new biologic material should enable easy fabrication to 
exacting specifications and should be highly stable against water and organic solvents. 
Dopaminergic mesoporous inorganic-organic hybrid resin (HR-DOPA), one of the various 
materials available for promotion of cell adhesion, was used in this study. It was modified 
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from mesoporous inorganic-organic hybrid resin (HR) by substituting dopamine for catechol 
salt. HR films have demonstrated good adhesion strength to various substrates, high stability 
against organic solvents, and good biocompatibility [46, 47]. However, HR films were only 
stable for short periods because of silane coupling agents. The stability of HR films is 
guaranteed for only 3 weeks after synthesis, and HR films can therefore not be used after this 
period. 
 HeLa cell adhesion assay and viability on HR-DOPA (Chapter 5) 1.6.3
Analysis of cell adhesion is an essential part of cell biology. Cell adhesion is the first 
step in a cascade of events, including cell survival by proliferation and migration and cell 
communication through cell-cell or cell-matrix interactions, which are dominated by the 
chemical or physical properties of substrates and media [48-50]. Cell adhesion assays 
commonly quantify cell adhesion by manually counting adherent cells per unit area [49, 51]. 
Moreover, biocompatibility of a new material should be proven by cell adhesion assays [52, 
53]. Therefore, HeLa cell adhesion assay and viability experiments were performed to verify 
the biologic functions of HR-DOPA for microcellular applications. 
 Micro single-cell array coated with HR-DOPA (Chapter 6) 1.6.4
The native cellular morphology and function of microwells coated with a cell adhesive 
surface are maintained, thereby providing a novel approach to 3D in vitro cell models that is 
suited for population statistics analysis from individual cell measurements [34-37]. In this 
study, microwells for micro single-cell arrays were (1) designed according to the physical 
dimensions of HeLa cells, (2) fabricated by soft lithography and microcontact printing, and (3) 
examined for HeLa cell occupancy of microwells after staining living cells. 
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 State of The Art Chapter 2. 
 Introduction 2.1.
Single mammalian cells are fragile and small and therefore strictly require a particular 
microenvironment, such as one with moderate cell density, oxygen level, temperature, and 
nutrition level, to keep them viable and healthy [54]. Much of the research effort underway in 
the field of microtechnology pertains to miniaturizing biochips and mimicking the natural 
properties of single cells with in vivo functions, which involves provision of appropriate and 
uniform microenvironmental conditions for the cells [26, 27]. 
The use of microtechniques for analyzing isolated single cells, otherwise referred to as 
“single cells on chip,” has increased over the last decade because these methods can be used 
to clearly elucidate the effects of a specific stimulus on a single cell. In particular, these 
techniques can help elucidate cellular chemistry at the molecular level while minimizing cell-
cell communications, stochastic biological noise, temperature gradients, and non-uniform 
densities of chemical compounds [8, 18-21, 24, 54]. In order to achieve significant results for 
cell reactions to external stimuli, a large number of single cells must be investigated to 
acquire adequate sets of data, which can be used to reasonably determine the distribution of 
responses and thereby to safely draw conclusions taking into consideration cellular 
heterogeneity [23, 27, 28]. Conventionally, 10,000 cells are considered the standard number 
for single-cell analysis [54]. However, some single-cell analysis techniques have assessed 
1,000 single cells to provide adequate sets of data [55]. In general, analytical single-cell 
techniques are developed with the aims of being time-efficient and accurate, as well as the 
considerations of instrument compatibility, cell accessibility/manipulation, gentle cell 
handling, stable and robust cell tracking, continuous cell monitoring, and mimicking of in 
vivo conditions [27]. 
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In this chapter, single-cell isolation techniques for microplatforms have been classified 
and explained in terms of their features and applications, and a detailed review of some 
representative papers is given. Furthermore, the significance of previous studies involving an 
array of microwells has been interpreted by comparing the geometry of microwells (size and 
shape), their material, the cell conditions, and the integration of microfluidics or sensors in 
these studies. 
 Single cell isolation techniques 2.2.
Single-cell isolation systems have been developed by the combined use of 
microengineering, chemistry, physics, and microfluidic techniques. Therefore, designing and 
constructing an analytical microplatform for isolated single cells requires comprehensive 
knowledge of several disciplines: (1) microengineering, for fabricating and integrating the 
device; (2) chemistry, for modifying the device’s surface and analyzing its chemical 
characteristics; (3) physics, for analyzing phenomena at the nano- or microscale and for 
detecting and manipulating cell behaviors; and (4) fluidics, for controlling the flow and 
carrying cells; as well as (5) biology, for identifying and testing hypotheses concerning cell 
behavior. 
The methods for single-cell isolation are largely categorized as microfluidic techniques 
or array-based techniques. Microfluidic techniques are used for perfusion cell cultures, where 
nutrient solutions are continuously fed to the bioreactor and the spent medium is constantly 
removed. Array-based techniques for static cell culture are used for conventional static cell 
culture. 
 Microfluidic techniques 2.3.
When designing microfluidic systems, it is important to recognize some unique physical 
principles at the micrometer scale, as well as general physical principles at the macro scale. 
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Generally, microfluidic channels with low Reynolds numbers (1 or below) assure laminar 
flow conditions, and mass transport of reagents and cells is highly controlled by fluid 
diffusion and pressure gradients [56]. 
Hydrodynamic systems designed to trap single cells are mainly divided into (1) 
semipermeable microstructures for changing flow direction by altering the shape of the 
microstructures after trapping cells, (2) microfluidic ports using pressure drops between 2 
microfluidic channels with different length and/or size, (3) microfluidic pipette-like channels 
trapping single cells by negative pressure, and (4) droplet-based microfluidic systems 
encapsulating a single cell in an aqueous droplet within the oil phase. 
 Semipermeable microstructures 2.3.1
An array of semipermeable microstructures is used in microfluidic chips with the aim of 
constructing large-scale perfusion systems that recirculate media. This can be used for large 
quantities of reagents and enables analysis of large groups of individual cells in a uniform 
microenvironment [57].  
 
Figure 2.1: Semipermeable microstructures for capturing or paring cells. 
(a) The mechanism of cell trapping using flow-through arrayed suspended obstacles [57]. The 
cup-shaped PDMS trapping sites allow a fraction of fluid streamlines to enter the traps. 
After a cell is trapped, the fraction of streamlines through the barred trap decreases, leading 
to the self-sealing quality of the traps and a high quantity of single-cell isolates. 
(b) Three-step cell-loading protocol [58]. [A] Cells are first loaded ‘up’ toward the smaller 
back-side capture cup. [B] The direction of the flow is reversed, and the cells are transferred 
‘down’ into the larger front-side capture cup two rows below. [C] The second cell type is 
loaded in from the top, and cells are captured in front of the first cell type. 
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Semipermeable microstructures are shaped like a pocket and are alternately arrayed such 
that intact cells can be easily transported into the micropockets [57-59]. Once a single cell 
enters a micropocket, the shape of the micropocket changes. The changed shape of the 
microstructure results in a diversion of flow direction and therefore the subsequent cells are 
transferred to the vacant pockets. Using this technique, most cells are loaded in an array in a 
short period (e.g., < 30 s) [57]. 
 Microfluidic ports 2.3.2
In a hydrodynamic single-cell array of microfluidic ports using differential fluidic 
resistance, individual single cells are sequentially confined in a trapping site composed of a 
short channel and a narrow channel [60-62].  
 
Figure 2.2: Cell trapping mechanism by changing flow conditions using microfluidic ports. 
(a) Schematic diagram of the fluidic cell trap [61]. [A] When the trap is empty, flow resistance 
along the straight channel is lower than that of the loop channel, and the main stream carries 
a cell into the trap if it is empty (trapping mode). [B] Cells will be carried along the loop 
channel if the trap is filled, bypassing the occupied trap (bypassing mode). 
(b) Hydrodynamic homotypic and heterotypic single cell co-culturing array [62]. [A] Loading of 
a spherical single cell (purple) reverses the fluidic resistance ratio, acting to divert 
subsequent cells (R1’ > R2) for sequential (R2 > R1) single cell arraying. [B] Viable cells 
adhere and flatten, restoring the Q1 > Q2 condition (i.e., R2 > R1). [C] Flow reversal is used 
for introducing a second spherical cell type and sequential single cell coupling (R1’’ > R2; R2 
> R1). 
 
Pressure force used to trap individual cells is generated by the different lengths [60] and 
sizes [61, 62] of the trapping and bypassing channels. To create the required pressure drops in 
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the microchannels varying with respect to the trapping state and the bypassing state, fluidic 
simulations and calculations are strongly required. 
 Pipette-like microfluidic systems 2.3.3
Pipette-like microfluidic systems use negative pressure driven by an exterior micropump 
to trap single cells, while the pressure required for trapping cells in microfluidic ports is 
spontaneously generated by differential pressure drops, as previously described [60-62]. 
Large groups of individual cells have been arrayed at a high density by using array-based 
single-cell isolation systems for static cell culture, but in a relatively short period with the 
help of the lower pressure. By using a micropump instead of complicated schemes of 
pressure drop generation, designing single-cell isolation systems using pipette-like 
microfluidics is easier than using microfluidic ports. 
 
Figure 2.3: Pipette-like microfluidic devices to entrap single cells in an array. 
(a) High-density microcavity array for cell entrapment [63], (b) A pipette-like microfluidic 
device to visualize intercellular events of trapped single cell by space- and time-resolution [64]. 
 
 Droplet-based microfluidic systems for single cell encapsulation 2.3.4
Recently, ultrahigh-throughput screening platforms using drop-based microfluidics have 
been rapidly developed because of their ability to overcome the scale and speed limitations of 
conventional robotic screening systems [65]. Aqueous droplets of picoliter volume dispersed 
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in oil are amenable to ultrahigh-throughput screening speeds (thousands of reactions per 
second) for biochemical analysis. Compared to conventional robotic screening systems, 
microfluidic droplets can be used for screening with a ~1000-fold increase in speed and a ~1-
million-fold reduction in cost (Table 2.1) [65]. Microfluidic systems to sequentially generate 
droplets, for encapsulating and isolating single cells from the nozzle, at upstream of the 
microchannels symmetrically joining of two oil phase channels and an aqueous phase channel 
(Figure 2.4) [66-68].  
 
Figure 2.4: Microfluidic droplet-generation devices for isolating single cells 
(a) A microfluidic droplet-generation device to produce hydrogel beads containing single living 
cells [66]. (b) Ordered single cell encapsulation in aqueous droplets [67]. 
 
Table 2.1: Comparison of time and costs for the complete screen using traditional robot system 
and in microfluidic emulsions [65]. 
 Robot Microfluidic droplets 
Total reactions 5  107 5  107 
Reaction volume 100 µl 6 pl 
Total volume 5,000 l 150 µl 
Reactions per day 73,000 1  108 
Total time ~2 years ~7 h 
Number of plates or devices 260,000 2 
Cost of tips $ 520,000 $ 1.00 
Amortized cost of instruments $ 10 million $ 0.30 
Substrate $ 4.75 million $ 0.25 
Total cost $ 15.81 million $ 2.50 
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General materials of aqueous droplet were cross-linked hydrogel constraining cell 
motility and making the encapsulated cells incubated in suspension [66, 67]. However, 
microdroplets are only useful for anchorage-independent cells because the anchorage-
dependent cells in suspension are induced to undergo apoptosis by losing their natural 
morphology and functions [69]. 
 Array-based single cell isolation techniques 2.4.
Array-based single-cell isolation systems are fabricated for static cell cultures. They rely 
on specific chemical or physical properties of the surface to promote cell adhesion and im-
mobilization. Array-based single-cell isolation systems are categorized into (1) two-
dimensional cell adhesive patterns created chemically or physically, (2) dielectrophoretic 
electrodes, (3) magnetophoresis for immobilizing cells bound to magnetic particles coated 
with immunochemical molecules, (4) optical tweezers forcing cells to be trapped by the 
highest light intensity, and (5) microwells into which cells settle by gravity or flow via micro-
channels. 
 Two-dimensional cell adhesive patterns 2.4.1
The chemical and physical properties of cell-repellent and cell-adhesive biocompatible 
materials have been developed and analyzed with a focus on the interaction between cells and 
the surface. A surface treatment that promotes or prevents cell adhesion is applicable to the 
specification of other single-cell isolation techniques [8, 62, 70, 71]. Recently, surface 
chemistry analysis of biomaterials has assisted in the development of planar single or 
multiple cell-patterning methods using microtechnology.  
The size of micropatterned cell-adhesive islands strongly regulates cell behavior such as 
cell growth, migration, proliferation, and viability (Table 2.2) [45, 72]. When the cell 
attaches on the surface with small cell-material contact area, the cell usually cannot survive 
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shaping round without formation of focal contacts and spreading. At middle-sized adhesion 
area, the cells are most active in proliferation and migration. If the contact area is very large 
with well-developed focal adhesion sites, the cells tend to be in differentiation phase rather 
than proliferation and migration [45]. Chen et al. [72] showed that apoptosis of single human 
or bovine endothelial cells adhering to a cell-adhesive pattern progressively declined as the 
island size was increased from 75 to 3000 µm
2
. Cell-adhesive patterns covering an area larger 
than 3,000 µm
2
 were suggested for long-term cell culture (see Figure 2.5). Micro single-cell 
arrays are commonly developed in 2D culture systems by using planar cell-adhesive patterns. 
However, conventional 2D cultures may often be subject to contact inhibition and exhibit loss 
of native cell morphological features and functionality [34, 35]. 
Table 2.2: Correlation between the extent of cell adhesion and the subsequent cell behavior [45]. 
Cell spread viability migration proliferation differentiation 
small ↓ ↓ ↓ ↓ 
medium ↑ ↑ ↑ ↓ 
high ↑ ↓ ↓ ↑ 
     
Figure 2.5: Effect of spreading on cell growth and apoptosis [72]. 
(a) Nomarski images of the final shapes of bovine adrenal capillary endothelial cells adherent to 
the fabricated substrate.  
(b) Apoptotic index (percentage of cells exhibiting positive TUNEL staining) and DNA 
synthesis index (percentage of nuclei labeled with 5-bromodeoxyuridine) after 24 h, plotted 
as a function of the projected cell area. Data were obtained only from islands that contained 
single adherent cells; similar results were obtained with circular or square islands and with 
human or bovine endothelial cells. 
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 Self-assembled monolayers  2.4.1.1
The interactions of cells with polymers are very difficult to measure because polymers 
have various chemical functional groups [51]. Therefore, self-assembled monolayers (SAMs) 
have been used as a surface chemical model to interpret the interactions of proteins and cells 
with artificial surfaces. SAMs are composed of a head group, tail, and functional group. The 
substrate materials depend on head groups. Alkanethiols, which contain an S–H head group, 
are the most commonly used molecules for attachment of noble metals such as gold (Au) and 
platinum (Pt). Silanes (SinH2n+2 or SiR3) are generally used on nonmetallic oxide surfaces 
such as glass and silicon dioxide. Phosphonic acids (–PO(OH)2) are used on surfaces coated 
with metal oxides such as Al2O3, Ta2O5, NbO5, ZrO2, and TiO2 [73, 74].  
Table 2.3: Comparison of well-defined terminal functional groups such as hydroxyl (OH), 
carboxyl (COOH), amine (NH2) and methyl (CH3) referring to water contact angle and surface 
charge related to cell adhesion and protein adsorption. 
Functional 
Group 
hydroxyl 
(OH) 
carboxyl 
(COOH) 
amine 
(NH2) 
methyl 
(CH3) 
Chemical 
Structure 
    
Water contact 
angle [75] 
29.0 ± 0.6° 
(hydrophilic) 
22.7 ± 0.9° 
(hydrophilic) 
52.9 ± 2.3° 
(hydrophilic) 
108.6 ± 0.3° 
(hydrophobic) 
Chemical 
Structure 
in medium 
(pH=7.4)     
Surface charge 
in culture 
medium 
neutral 
 
negative 
carboxylate anion 
positive 
ammonium cation 
neutral 
 
Effect on cells 
[76] 
increase osteoblast 
differentiation 
increase osteoblast 
attachment 
promotes myoblast 
and endothelial 
proliferation and 
osteoblast differ-
entiation 
promotes in-
creased leukocyte 
adhesion and 
phagocyte migra-
tion 
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The well-defined terminal functional groups in SAMs are the hydroxyl (OH), 
carboxyl (COOH), amine (NH2), and methyl (CH3) groups [77]. The strength of cell adhesion 
to SAMs decreases in the following order: OH > COOH = NH2 > CH3 [78]. Four different 
functional groups of SAMs are involved in the surface charge and wettability of polymers 
related with cell adhesion as well as protein adsorption. Table 2.3 shows the characteristics 
of the main functional groups of SAMs, focusing on water contact angle and surface charge 
in cell culture medium (pH = 7.4). The planar cell-adhesive micropatterns of SAMs were 
generally fabricated by photolithography or micro-contact printing (µCP) [79-81]. 
 Surface charge 2.4.1.2
Nearly all cells (except for some bacteria) are covered with negatively charged 
functional groups at a neutral pH [82]. Therefore, the surface charge needed to immobilize 
cells is typically positive and is created by coating chemical components (i.e., amine 
functional groups) [83], by changing chemical composition and exposer to light [84], or by 
applying DC electrical fields to the electrodes for temporarily capturing cells (electrophoresis 
[EP]) [85]. Negatively charged surfaces are also utilized to immobilize cells on the surface; 
oxygen plasma treatment of polymers or hydrogels has been commonly used to increase 
negative charge by adding carbonyl groups or ester groups, thereby generating moderate 
wettability for cell adhesion [86, 87]. 
 Surface hydrophilicity/hydrophobicity 2.4.1.3
Wettability has been commonly assessed to determine cell adhesion onto polymers, 
copolymers, and polymers treated by plasma, corona, or surface graft polymerization [51]. 
Measurement of the water contact angle is very simple and clearly indicates the 
comprehensive result from various chemical molecules and physical properties of the surface. 
Moderate wettability for cell adhesion is in the range of 40–70° of the water contact angle [51, 
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88]. Extreme hydrophobicity or hydrophilicity of the surface inhibits cell adhesion [89-91] as 
shown in Figure 2.6. A super-hydrophobic surface randomly binds to nonspecific proteins 
such as albumin, preventing cell adhesion. The albumin adsorbs onto hydrophobic surfaces 
10–100 times more effectively than fibronectin and vitronectin (which promote cell adhesion), 
and thus the albumin layer interferes with cell-to-surface interactions [90]. Water molecules 
are strongly attached on super-hydrophilic surfaces. Cell-adhesive ECM molecules such as 
fibronectin and vitronectin bind too weakly to detach water molecules on super-hydrophilic 
surfaces and are not subsequently adsorbed onto the surface. Therefore, cells are poorly 
attached to super-hydrophilic surfaces [91, 92]. Micropatterns for cell adhesion as well as 
protein adsorption in terms of wettability have been fabricated by coating the mixed SMAs 
with different well-defined functional groups [51] or by chemically modifying the surface 
using plasma treatment [93]. 
 
Figure 2.6: A conceptual model of the behavior of fibronectin and albumin adsorbed to surfaces 
with different wettability [90-92]. 
(a) On superhydrophilic substrates, water molecules are strongly attached, preventing any cell-
adhesive ECM molecule such as fibronectin (Fn) or vitronectin (Vn).  
(b) On moderately wettable substrates (water contact angle: 40–70°) Fn and Vn are adsorbed on 
the surface and help cell adhesion.  
(c) A superhydrophobic surface is randomly bound to non-specific proteins such as albumin 
without cell binding domains. The albumin adsorbs on hydrophobic surfaces 10–100-fold 
higher than Fn and Vn. 
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 Surface roughness 2.4.1.4
Mechanistic investigations indicate that substrate microtopography can alter the 
establishment and organization of cell membrane-based focal adhesion complexes and can 
therefore invoke specific signaling pathways that may regulate cellular phenotypes and 
functions [94, 95]. Although microtopography affects cell behavior, cells exist in interfaces 
with topography closer to the nanometer scale [96]. Ranucci and Moghe [95] reported a 
cellular focal adhesion mechanism for substrate topographic regulation of cellular motility on 
ligand-modified polymer substrates, as shown in Figure 2.7.  
 
Figure 2.7: Proposed mechanisms for substrate topographic regulation of cellular motility on 
ligand-modified substrates [95]. 
(a) In the absence of binding ligands and substrate microtexture. (b) The incorporation of 
substrate microtexture in the form of micropores. (c) Increased cellular adhesion to the 
untextured substrate by adsorbing adhesive ligands to the polymer. (d) Distinct mechanical and 
biochemical modes of cellular adhesion during the formation of focal adhesion complexes. 
 
 Holographic optical tweezers 2.4.2
Holographic optical tweezers are considered essential tools for manipulating single cells 
and for performing sophisticated biophysical/biomechanical characterizations. The trapping 
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forces depend on the intensity of laser power, the size and shape of the trapped particles, and 
on the index of refraction of the trapped particles relative to the surrounding medium. Optical 
tweezers can be used to transport foreign materials into single cells, to deliver cells to specific 
locations, and to sort cells in microfluidic systems [97]. For single-cell trapping, optical 
tweezers are used to apply non-contact force to cells, using well-defined geometries with 
accurate force resolution and amenability to liquid medium environments. The cellular 
microarray by using an optical tweezer enables to separate and immobilize single cells with 
the precise control of the cell number and density within the measurement region [98, 99]. 
However, cells can be damaged by high-intensity light and elevated temperatures [97]. 
 
Figure 2.8: Holographic optical tweezers for single cell isolation.  
(a) Principle of optical tweezer [97]. The scattering (Fscat) and gradient (Fgrad) components of 
optical forces on a dielectric sphere due to a Gaussian laser beam (light intensity increases 
from b to a). 
(b) Cellular microarray in microfluidic chip combined with optical tweezers enabling precise 
control of the cell density [98]. 
(c) Controlled tilt-angle of rod-shaped E. coli by adjusting torque by varying the amplitude of 
the highly focused linear polarized Gaussian beam [100]. 
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 Magnetophoretic techniques 2.4.3
The migration of a particle under a magnetic field is termed magnetophoresis. Magnetic 
separation of ferromagnetic nanoparticles in microfluidic devices is widely utilized in 
chemical and/or biological analyses [101-103]. Magnetophoresis using immunobinding and 
electromagnets is applicable to a wide range of single-cell analyses owing to the potential for 
specific sorting/immobilization of target cells in a short time and to the reversibility of 
immobilization/release of target cells by an on-and-off magnetic force [104, 105]. However, 
the range of the effective magnetic force is limited because the magnetic force dramatically  
decreases with the distance between the magnet and the beads.  
 
Figure 2.9: Magnetophoretic single cell isolation techniques. 
(a) Permalloy based magnetic single cell micro array (MSCMA) [104]. Yellow regions show the 
gold substrate and blue regions are the electroplated permalloy. 
(b) A reversible assembly of immunomagnetically labeled single cells in an array by CCCs 
creating a template periodically attracting and repelling zones [105]. 
 
 Dielectrophoretic techniques 2.4.4
Dielectrophoresis (DEP) is a common approach for performing cellular manipulations 
by using the interactions of the dipole of particles or cells and the spatial gradient of the 
electric field. Typically, AC fields are used for DEP in order to minimize physiological 
impact on the cells and any electrochemical reactions at the electrodes. The dipolar rate of 
cells polarized by applied electric fields is predominantly due to the cell wall, cell membrane, 
and/or cytoplasmic electrical properties. The DEP force on particles or cells is strongly 
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dependent on the dipole constitution and magnitude. Free-charge dipoles of particles or cells 
dominate at low frequencies whereas polarization-charge dipoles dominate at high 
frequencies. Dielectrophoretic microarrays simultaneously and actively trap thousands of 
single mammalian cells in alignment with a planar or microstructured microelectrode array 
[106-109]. However, known undesired effects of electric fields on cells are induced thermal 
heat caused by electric currents and the electric fields imposed within the cell membrane or 
the cytoplasm [82]. 
 
Figure 2.10: Dielectrophoretic single cell isolation techniques. 
(a) Addressable positive dielectrophoretic (p-DEP) trapping array with a passive, scalable 
architecture (“ring-dot” geometry) [106]. 
(b) A dielectrophoretic microarray to simultaneously and actively trap thousands of single 
mammalian cells [107]. 
 
 Microwells 2.5.
Micro single-cell arrays are generally developed using planar cell adhesive patterns, 
although conventional 2D cultures are often subject to loss of native cell morphology and 
functionality [34, 35]. Compared to 2D cultures, 3D in vitro cell models provide a more 
realistic cellular environment and can reproduce in vivo cellular metabolism and function, 
 ２６ 
including morphogenesis, gene expression, and differentiation [36, 37]. However, a 3D cell 
culture array must be multilayered, which makes it difficult to fabricate the array and to use it 
in a high-throughput toxicological test. The native 3D cellular morphology of the microwells 
on the plate is maintained, thereby providing a novel approach for 3D in vitro cell models 
that are suitable for population statistics analysis from individual cell measurements. In 
addition, the cell adhesive surface of a microwell can support native cellular functionality by 
supporting cells, extracellular matrix, or growth factors [38]. 
By spatially arranging isolated cells in an array, a sufficient number of single cells can 
be quantitatively analyzed to draw valid conclusions, rather than interpreting individual cell 
variation as noise due to cell population heterogeneity [23, 27, 28, 54, 55]. Larger microwells 
generally facilitate long-term culture (days and weeks) while smaller microwells are designed 
for instant analysis (hours and days) because of the correlation between cell behavior and the 
size of the cell-adhesive area [45, 55, 72]. Nevertheless, there is a strong interest in using 
smaller microwells than larger ones for single cell analysis because the shorter distances and 
diffusion times of molecules and cells are more suitable for time-efficient and accurate 
analysis, especially in high-throughput applications [27, 55]. 
Rettig and Folch at the University of Washington, USA [38], reported an optimization 
study of microwell dimensions and cell-seeding parameters for mouse fibroblast cells 
(NIH3T3) and rat basophilic leukemia cells (RBL-1) as models of anchorage-dependent and 
anchorage-independent cells, respectively (Figure 2.11). Circular microwells of PDMS of 
different diameters (15, 20, 25, 30, 35, and 40 µm) and depths (16, 21, and 27 µm) were 
fabricated using soft lithography and were arrayed with 10-µm-thick walls as a hexagonal 
honeycomb. An optimal ratio of depth to diameter for obtaining maximum single-cellular 
occupancy was ~1 for both cell types. The maximum single-cell occupancy of NIH3T3 cells 
was 84.5% ± 0.2% in microwells with a depth of 27 µm and a diameter of 25 µm, whereas it 
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was 92.2% ± 2.2% in microwells with a depth of 21 µm and a diameter of 20 µm for RBL-1 
cells after 40 min of settle time. Single-cell occupancy did not increase as the depth increased 
beyond the optimal diameter for both cells. 
 
Figure 2.11: Optimization study of PDMS microwell dimensions and cell seeding parameters 
for NIH3T3 and RBL-1 [38].  
(a) Schematics of the fabrication and seeding procedure.  
(b) Nine representative pictures of RBL-1 cells in microwells for all the combinations of 3 
different diameters with range of 20–40 µm and three different depths with range of 16–
27 µm. Scale bar is 100 µm.  
(c) Cellular occupancy as a function of microwell dimensions. Each vertical bar depicts the 
percentage of microwells occupied by a single cell (black segment), 2 cells (dark gray), 
more than 2 cells (light gray), or no cells (white). 
 
Deutsch and co-workers at Bar Ilan University, Israel [110], fabricated adjacent rough 
cone-shaped cell retainers (CR) used for high-content correlative multi-parametric 
measurements of living individual anchorage-independent cells within a population (Figure 
2.12). The CRs made of glass were wet-etched by hydrofluoric acid (HF, 48%) with a 
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densely packed 2D arrangement of ~8-µm-deep hexagonal picoliter wells (PWs) with a 20-
µm-pitched honeycomb-like pattern. Cellular occupancy, retention, and apoptosis were 
investigated using 4 different human acute T lymphoblastic leukemia cell lines: MOLT-4, 
U937, Jurkat, and K-562. The percentage of occupied PWs was 81% ± 4.2% from 7,000 
loaded cells, and the single-cell occupancy rate was 93% ± 2.8% of all the cells located in the 
PWs. 
 
Figure 2.12: Adjacent rough cone-shaped cell retainers (CRs) [110].  
(a) SEM micrograph of the CR structure. Scale bar is 10 µm.  
(b) Post-fixation observations of Jurkat T cells by SEM image. Scale bar: 20 µm.  
(c) Highly dense loading of K-562 myelogenous leukemia cells in CRs. 
 
Ochsner and co-workers at the Swiss Federal Institute of Technology (ETH), Zurich, 
Switzerland, [111] fabricated arrays of microwells with different geometries (circle, square, 
triangle, rectangle, or spindle) and a depth of 10 µm to control the 3D shape of single cells 
(Figure 2.13). Adherence of HUVECs was limited to the inside of microwells by passivation 
of the microwell plateau by using inverted microcontact printing. The cell-repellent polymer 
on the plateau was PLL-g-PEG, and the surface of the microwell was air-plasma-treated 
PDMS coated with specific adhesive proteins (fibronectin) or lipid bilayers (1,2-dioleoyl-sn-
glycero-3-phosphocholine [DOPC]). Adequately controlled 3D shape of the cells was seen in 
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fluorescent confocal images of cell nuclei and actin cytoskeletal networks, stained by 
ethidium homodimer (blue) and Alexa 488-phalloidin (green), respectively (Figure 2.13). 
 
Figure 2.13: Arrays of microwells with different geometries (circle, square, triangle, rectangle 
and spindle) for 3D shape control of single cells [111].  
(a) Schematics of the fabrication procedure.  
(b) DIC and fluorescent confocal images are shown of cell nuclei (blue) and actin cytoskeletal 
networks (green). HUVECs were cultured for 24 h.  
 
Sasuga and co-workers at the Tokyo Metropolitan Institute of Medical Science, Japan 
[112], developed a microwell-based single-cell lysis method by using a dense array of 
microwells with 10–30 pl volume (Figure 2.14). Cuboidal microwells of PDMS with 
different sizes (20 × 20, 30 × 30 or 40 × 40 µm
2
) and a uniform depth of 20 μm were 
fabricated by soft lithography and arrayed on a 24 × 32-mm
2
 coverslip with a well-to-well 
spacing of 30 μm. Single-cell analysis of rat pheochromocytoma cells (PC12) was performed 
in 3 steps: (1) cell trapping in an array of picoliter-scale microwells; (2) chemical lysis in the 
closed microwell; and (3) fluorescent detection of immunosignals or enzymatic activities in 
the microwell. Using this device, enzymatic activities of a single PC12 cell in each well were 
continuously monitored under several different conditions. 
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Figure 2.14: A microwell-based single cell lysis method [112].  
(a) Schematic drawing of the single-cell lysis procedures. 
(b) An overview of the PDMS sheet (scale bar, 10 mm) and a microscopic image of the 
microwells (scale bar, 100 μm). 
(c) A microscopic image of a PC12 cell-trapped microwell. 
 
Molter and co-workers at the University of Washington, USA [113], developed an MA 
device capable of measuring cellular parameters and single-cell oxygen consumption rates 
(OCRs) in each well while minimizing the disruption of normal cell function (Figure 2.15). 
The rounded-cylindrical glass microwells had a diameter of approximately 65 μm, a depth of 
25 μm, and a volume of 80 pl and were arrayed with a center-to-center space of 300 μm. 
Phosphorescent oxygen sensors were integrated inside each microwell by sintering 
FluoSpheres
®
 Platinum carboxylate-modified microspheres adhering to the plasma-treated 
surface of the microwell on a 120°C hot plate for 10 min. Oxygen consumption in the murine 
macrophage cell line (RAW264.7), human epithelial lung cancer cell line (A549), and human 
Barrett’s esophagus cell line (CP-D) in each sealed microwell was measured by optimized 
rapid lifetime determination (ORLD) methods. An OCR experiment performed on the array 
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showed different oxygen-concentration depletion rates inside microwells containing 0, 1, or 2 
cells and different oxygen consumptions according to cell types, that is, 0.61, 0.91, and 
1.32 fmol/min for RAW264.7, A549, and CP-D cells, respectively. 
 
Figure 2.15: A microwell array measuring oxygen consumption rate (OCR) [113].  
The cells residing in the 100-µm-in-diameter and 30-µm-deep microwells with the oxygen 
sensor are diffusionally sealed from the external surroundings. Polystyrene beads (diameter, 
1 µm) tend to clump and attach to the microwell in areas other than the side wall. An OCR 
experiment performed on the array yields a plot of oxygen concentration versus time for each 
sealed microwell in the array after a lid has been lowered. 
 
Leong and co-workers at the University of Washington, USA [70], fabricated a single-
cell array of PDMS microwells chemically modified by a SAM (Figure 2.16). The bottom of 
the microwells was sputtered with a 25-nm-thick gold layer, functionalized by a SAM of (10-
mercaptomethyl-9-anthyl)(4-aldehydephenyl)acetylene (MMAAPA), and then coated with 
collagen, an adhesion receptor ligand, covalently bound to the SAM by using Schiff 
chemistry. Collagen is a long fibrous structural protein that enhances the attachment and 
proliferation of various cells, including endothelial cells, fibroblasts, hepatocytes, and 
epithelial cells. Optimal microwell geometry in an array for single mouse pituitary tumor 
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cells (AtT-20; diameter, ~15 μm) was a diameter of 20 µm and interstitial spacing of 250 µm, 
with ranges of 10–50 µm and 20–250 µm, respectively. 
 
Figure 2.16: A single cell array of PDMS microwells chemically modified by a self-assembled 
monolayer (SAM) [70].  
 
Liu and co-workers at Tsinghua University, China [114], reported a fabrication method 
for rounded-bottom MAs (Figure 2.17), shaped like those of Deutsch et al. [110] (see Figure 
2.12). PS microspheres were self-assembled on a glass slide and were partially melted at 
240°C for 3 min on a hot plate to increase the adhesive force with the substrate. The array of 
PDMS microwells was fabricated by soft lithography, and the microwell depth was 8.1 µm 
for highly ordered microspheres with a diameter of 20 μm. The rate of cellular occupancy in 
each well for Ramos cells (Burkitt’s lymphoma; human B-lymphoblast) was 90% ± 1% and 
84% ± 3% for single cells seeded at cell densities of 1 × 10
6
 cells/ml and 1 × 10
5
 cells/ml, 
respectively. 
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Figure 2.17: A rounded bottom microwell array (MA) of PDMS by molding a monolayer of 
highly ordered polystyrene (PS) microspheres [114].  
(a) Schematic fabrication of PDMS microwell arrays. 
(b) Cell arrays on the microwells. [A] Micrograph of dense trapping of Ramos cells. [B, C] The 
SEM images of Ramos cells located in microwells. Scale bars are 20 μm. 
 
Ferrell and co-workers at Ohio State University, USA [115], fabricated an array of 
microwells composed of a polymer (PMMA or PS) wall and a bottom made of commercially-
available porous membranes, allowing the use of vacuum-assisted cell seeding (similar to the 
pipette-like microfluidic technique) (Figure 2.18). Three different porous membranes were 
used: track-etched polycarbonate membranes, anodized alumina membranes, and polyester 
membranes. Cell suspensions of fibroblasts (NIH3T3), pancreatic ductal epithelial-like cells 
(PANC-1), and monocytic leukemia cells (THP-1) were placed in a vacuum filtration 
apparatus to suck culture medium through the microdevice. The cells were trapped in the 
microwells by applying vacuum for 0.5–5 min and sucking the cell culture medium through 
the membrane. The cellular occupancy of each cell line was determined for different 
geometries of cylindrical microwells (diameter of 15, 20, or 50 µm) at various cell densities 
(300, 400, or 600 cells/mm
2
). Single cells of NIH3T3 and THP-1 were isolated in microwells 
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with a diameter of 20 µm and 15 μm, respectively. The cellular occupancy of NIH3T3 in 20-
μm microwells was ~45% that of single cells, but the microwells were ~41% empty at the 
cell density of 300 cells/mm
2
. The occupancy for THP-1 cells was ~50% that of single cells, 
but was ~35% that of 2 cells at the cell density of 300 cells/mm
2
. 
 
Figure 2.18: An array of microwells composed of wall of polymer and bottom of commercially 
available porous membranes to use vacuum-assisted cell seeding [115].  
(a) Schematic illustration of experimental setup for cell isolation.  
(b) Fluorescence/phase contrast merged images. [A] NIH 3T3 cells were in 20-µm-diameter 
wells. [B] THP-1 cells were in 15 μm diameter wells.  
(c) Number of NIH 3T3 cells per microwell as a percentage of the total number of microwells: 
[A] Cells seeded at 300, 450, and 600 cells/mm
2
 in the circular microwells (diameter, 
20 μm); [B] Cells seeded at 100, 200, and 300 cells/mm2 in the circular microwells 
(diameter, 50 μm). 
 
Park and co-workers at the University of Michigan, USA [116], investigated the optimal 
geometry of microwells in a microfluidic channel by a flow method designed to trap single 
cells (Figure 2.19). All the microwells were constrained to a side length of 50 µm and depth 
of 20 µm to allow sufficient attachment and differentiation of captured cells. The microwells 
were arrayed with a spacing of 50 µm to provide a total of ~10,000 microwells in a 
microchannel with a height of 200 µm, width of 5 mm, and length of 15 mm. Among various 
shapes (triangle, square, circle, diamond, and cone), triangular microwells were the most 
efficient for single-cell trapping because of a strong flow recirculation, efficiently trapping 
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cells inside the microwell. The presence of a single cell in the microwell changed the flow 
pattern, thereby preventing the trapping of subsequent cells. In this device, cellular 
occupancy of single human prostate cancer cells (PC3) in triangular microwells was ~62% 
after a 20-min loading procedure. 
 
Figure 2.19: Flow method to find the effective shape of microwells for single cell trapping in a 
microfluidic channel [116]. 
The geometry of microwells affects the trapping rate; The triangular well provides different 
trapping possibilities when the cell travels through the middle path and side paths. A capture 
rate of 62% was observed for PC3 cells with less than 6% of multiple cells trapping. Scale bar is 
100 µm. 
 
Broderick and co-workers at the University of Wisconsin in Madison, USA [71], 
fabricated 3D polyurethane-based microwell cell culture arrays selectively functionalized 
inside the wells to promote cell adhesion and on the plateau of wells to resist cell adhesion 
(Figure 2.20). The interior of the cuboidal microwells (size, 300 × 300 µm
2
; depth, 120 µm) 
was coated with a layer-by-layer assembly of multilayers by using branched poly-
ethyleneimine (BPEI) and the azlactone-functionalized polymer poly(2-vinyl-4,40-dimethyl-
azlactone) (PVDMA), while the exterior of microwells was coated by amine-functionalized 
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molecules by using the micro-contact printing method. Cellular patterns of African green 
monkey kidney fibroblasts (COS-7 cells) were determined for up to 28 d. 
 
Figure 2.20: 3D polyurethane-based microwell cell culture arrays selectively functionalized 
inside the wells to promote cell adhesion and on the plateau of wells to resist cell adhesion [71]. 
(a) Schematic fabrication of PDMS microwell arrays. 
(b) Representative phase contrast and fluorescence micrographs of COS-7 cells on film-coated 
microwell arrays. [A–D] Arrays functionalized selectively to introduce glucamine in areas 
between the microwells prior to cell seeding result in preferential attachment and growth of 
cells inside the microwells. Microwell dimensions are 300 μm on each side. 
 
Wang and co-workers at the University of North Carolina, USA [117], presented a 
simple low-cost microarray PDMS platform that can trap tens of thousands of mammalian 
cells for dynamic single-cell analysis by using the elasticity of PDMS (Figure 2.21). After 
seeding and then allowing murine hematopoietic (Ba/F3) cells to settle for 5 min, the 
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diameters of individual microwells (depth, 15 µm) were expanded from 12 to 20 µm at ~1 Hz 
to assist settling into the microwells; then, the tension was slowly released. For Ba/F3 cells 
with an average diameter of 14.1 µm, the cell trapping efficiency was 65.3% ± 7.6% (n = 3) 
at a cell density of 1.25 × 10
6 
cells/cm
2
. Using this device, trapped cells were subjected to 
multicolor analysis and individual cells were analyzed by measuring real-time calcium flux 
after exposure to the calcium ionophore ionomycin. 
 
Figure 2.21: A simple, low-cost microarray platform of PDMS that can trap tens of thousands 
of mammalian cells for dynamic single-cell analysis using the elasticity of PDMS [117].  
(a) Reversible stretching of PDMS microwells and loading of cells on the array. 
(b) High-density, single-cell array on the stretchable traps. Scale bar is 20 μm. 
 
Jen and co-workers at National Chung Cheng University, Taiwan [118], fabricated 
microfluidic chips with arrays of microwells that were developed for single-cell chemical 
lysis (Figure 2.22). The main fluidic channel was 15 mm wide, 160 µm high, and 65 mm 
long, and microwells with a diameter of 20 µm or 30 µm and a depth of 20 µm were arrayed 
(10 × 10) at 15 sites on the bottom layer. Human cancerous cervix epithelial cells (HeLa) at a 
cell density of 1 × 10
7
 cells/ml were loaded into the microfluidic channel at injection flow 
rates varying from 2.8 to 4.0 μl/min. At an injection flow rate of 2.8 μl/min, the HeLa cellular 
occupancy rate was maximized. The cellular occupancy was 91.45% and 83.19% in 
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microwells with a diameter of 30 and 20 μm, respectively. Most 20-μm microwells and 85% 
of the 30-μm microwells were occupied by single cells. 
 
Figure 2.22: Microfluidic chips with arrays of microwells were developed for single-cell 
chemical lysis [118].  
(a) Photograph of the completed microfluidic chip with tubing.  
(b) Bright and fluorescence images of micropatterned HeLa cells in microwells with diameters 
of [A] 30 μm and [B] 20 μm. The injection flow rate of the cell sample is 2.8 μl/min.  
(c) Distributions of cellular occupancy of HeLa cells in the microwells with diameter of 20 μm 
and 30 μm at various injection flow rates. The experimental data are based on manual counts 
of cells in three arrays of 10 × 10 microwells. Error bar is standard error of the mean (SEM). 
 
 Geometry and substrates of microwells 2.5.1
Both geometry and substrate of microwells play a crucial role in retaining a single target 
cell per microwell and maintaining cells with native 3D cellular morphology by supporting 
cells, by an extracellular matrix, or by growth factors and thereby in vivo cellular metabolism 
and function, including morphogenesis, gene expression, and differentiation [36-38]. 
Single-cell occupancy depends strongly on the geometry of microwells, such as size, 
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depth, and shape, according to the target cell and whether the cells were seeded by gravity or 
flow. The optimal size of microwells is slightly bigger than the diameter of the target cell, 
that is, by ~5–15 µm. For example, the highest single-cell occupancy of RBL-1 (7.74 µm) 
and AtT-20 (~15 µm) is in 20-µm microwells, NIH3T3 (16–20 µm) in 25-µm microwells, 
and HeLa (21 ± 4.4 µm) in 30-µm microwells [38, 70, 80, 118-120]. 
Rettig and Folch [38] showed that the optimal ratio of size and depth was ~1, from 
analysis of single-cell occupancy among various sizes and depths of cylindrical microwells. 
Single-cell occupancy dramatically increased as the ratio of size and depth increased up to ~1, 
and then slightly decreased. Considering that the optimal size of the microwell was similar to 
that of the cell, microwell depth was also similar to the target cell. Wang et al. [117] also 
used 15-µm-deep microwells to match the size of Ba/F3 cells (diameter, 14.1 ± 1.4 µm) and 
achieve high single-cell occupancy. 
Microwell shape is not a consideration when seeding target cells with uniform shape 
(i.e., cylindrical [38, 113, 115, 117], cuboidal [112], or hemispherical [110, 114]) in the 
microwells by gravity. Park et al. [116] described the effect of microwell shape (constant size) 
by flow simulation when the cells were seeded by flow in a microchannel. The triangular 
shape was found to be most efficient for single-cell trapping because of strong flow 
recirculation, which efficiently trapped cells inside the microwell. 
Polydimethylsiloxane (PDMS) is commonly used in the fabrication of microwells to trap 
single cells [38, 112, 114, 117, 118]. PDMS enables numerous replications at both micro- or 
nanometer scale from a micro- or nanofabicated mold with high precision. However, the 
inherent properties of PDMS do not allow for cellular adhesion, which, due to the absence of 
supporting cells, extracellular matrix, and growth factors, could affect the natural behavior of 
anchorage-dependent cells that can survive only when they adhere to substrates. Therefore, 
the significant function of microwells with respect to maintaining the native 3D morphology 
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of anchorage-dependent cells is feasible only when the inner surface of the microwell is 
conducive for cell adhesion. Ochsner et al. [111] fabricated a cell-adhesive surface inside 
microwells in order to control 3D cellular shape by using various shapes of microwells, 
including squares and spindles. The surface was plasma-treated PDMS adsorbed with cell-
adhesive fibronectin. Leong et al. [70] fabricated microwells containing a cell-adhesive SAM. 
However, SAM was located on the bottom, not including the wall, and was not predicted to 
provide native 3D cellular morphology. 
 Cell types and seeding conditions 2.5.2
Interactions between cells placed in a microwell and the surface of the microwell are 
strongly dependent on the characteristics of cells, whether adherent or non-adherent. Given a 
cell-adhesive microwell surface, adherent cells firmly adhere to the microwell while non-
adherent cells are just mechanically trapped inside the microwell. Higher single-cell 
occupancy is expected for adherent cells rather than nonadherent cells. 
However, single-cell occupancy of non-adherent cells is often higher than that of 
adherent cells [38, 114, 118]. The single-cell occupancy of non-adherent RBL-1 and Ramos 
cells reached 92.2% and 90% [114], respectively. In the case of adherent cells, NIH3T3 and 
HeLa cells showed single-cell occupancy of 84.5% [38] and 83.19% [118], respectively. The 
disparate single-cell occupancy between adherent and non-adherent cells might be due to the 
different shapes of both cell types. 
A seeding cell concentration of ~1.0 × 10
6
 cells/ml is commonly used for static culture 
[70, 110, 114, 116, 117]. Liu et al. [114] showed the effect of cell concentration on single-
cell occupancy by varying cell concentrations from 1 × 10
5
 to 1 × 10
7
 cells/ml. The single-
cell occupancy of Ramos cells was found to be 90% ± 1% and 84% ± 3% at cell densities of 
1 × 10
6
 and 1 × 10
5
 cells/ml, respectively. Higher cell seeding densities (exceeding 
1 × 10
6
 cells/ml) do not have an obvious effect on cell occupancy. The results indicate that 
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1.0 × 10
6
 cells/ml of cell density is an optimal concentration for an isolated single cell array. 
When seeding cells by flow in a microchannel, the flow rate is a dominant parameter for 
single cell loading in the microwells. Park et al. [116] determined that the optimal flow rate 
for cell trapping in triangular microwells located in a microchannel was 0.05–0.15 ml/h (14–
42 µm/s) among various flow rates. Jen et al. [118] showed that the highest single-cell 
occupancy in a 15-mm-high and 160-µm-wide microchannel was achieved at a flow rate of 
2.8 µl/min, which had been calculated on the basis of flow velocity in the microchannel, that 
is, 19.4 µm/s (calculated on the basis of the dimensions of the microchannel). 
 System integration 2.5.3
Arrays of microwells for single-cell isolation were integrated by material properties 
[117], microfluidics [115, 116, 118], or biosensors [113]. Wang et al. [117] used the elasticity 
of soft PDMS to mechanically grasp the cells by changing the size of microwells from 20 µm 
to 12 µm after seeding cells. Loading cells into microwells by using the flow in 
microchannels is more effective than the conventional method, which involves the use of 
gravity for this purpose, with respect to loading time and cellular occupancy. The flow 
necessary to carry target cells is controlled by microwell geometry [116, 118] or vacuum 
pump [115]. The microwell shape and flow rate are dominant factors for increasing single-
cell occupancy when an array of microwells is integrated by a microfluidic system [116, 118]. 
Molter et al. [113] fabricated an oxygen sensor integrated in microwells for measuring and 
analyzing oxygen consumption rate according to cell type and the number of cells per well. 
Although the microwells were bigger than the ideal size for a single cell per well, the 
capability of individual single-cell analysis was shown by integration of the oxygen sensor. 
Microfluidic applications must account for the fundamental elements of the cellular 
environment at the microscale level for cell culture in an array. In a microchannel, 
replenishment of nutrient media components to arrayed single cells is necessary whether 
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static or perfusion culture techniques are being used. An effective culture time (ECT) is a 
proper feeding interval for static cell culture and is mathematically calculated by the ratio of 
the height of medium in a microchannel and in a conventional petri dish. For example, the 
medium (height, 1.2 mm) in a petri dish is generally replaced every 48 h, and thus, medium 
in a 200-µm-high microchannel should be replenished every 8 h, since the expected ECT is 
reduced by a factor of ~6. In the case of perfusion culture, an appropriate perfusion rate 
(critical perfusion rate [CPR]) is determined by calculating the time required for chemical 
molecules to completely diffuse from the top to bottom of a microchannel during transit from 
the inlet to the site of the arrayed cells. 
 Differences and significance of the previously presented microwells 2.5.4
Depending on the intended application and system integration, a microwell device can 
be designed in numerous different ways by selecting different parameters, such as geometry, 
surface materials, the number of wells, cell density, and flow rate. In Table 2.4, the optimal 
parameters and unique features of the summarized papers are described in detail. 
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Table 2.4:  Comparison and significance of the previous single cell arrays of microwells. 
 Geometry and material of microwell Cells Single-cellular occupancy of optimal conditions 
Author & Features Shape Size (µm) 
Depth 
(µm) 
Material Type Diameter (µm) 
Incubation time @ Initial 
seeding concentration 
Occupancy (%) @ optimal 
size × depth (µm) of microwell 
Rettig et al. [38] 
Seeding by gravity 
Circle 
15, 20, 25,30, 
35, 40 
16, 21, 
27 
PDMS 
NIH3T3* 
RBL-1§ 
16–20 [80] 
7.74 [120] 
40 min 
@ 2500―6200 cells/mm2 
84.5 ± 0.2 @ 25 × 27 
92.2 ± 2.2 @ 20 × 21 
Deutsch et al. [110] 
Seeding by gravity 
Hemisphere 20 ~ 8 Glass 
MOLT-4§ 
U937§ 
Jurkat§ 
K-562§ 
11.4 ± 1.3 [121] 
13.0 ± 1.8 [121] 
10–15 [122] 
14.3 ± 1.6 [121] 
4 h @ 3.5 × 106 cells/ml ~75.3 
Ochsner et al. [111] 
3D cell adhesion 
Square 
Spindle 
100, 14, 10 
50 × 20 
10 
Plasma treated  
PDMS 
HUVEC* 33.28 ± 0.85 [123] — — 
Sasuga et al. [112] Square 20, 30, 40 20 PDMS PC12§ ~14 [124] 12 h @ 2 × 107 cells/ml ~40 (1–3 cells) @ 40 × 20 
Molter et al. [113] 
Sensor integrated 
Circle 65 25 glass 
RAW264.7‡ 
A549* 
CP-D* 
10−15 [125] 
~40 [126] 
– 
1 h @ 10,000 cells ~ 85 ± 25(SD) (n = 3) 
Leong et al. [70] 
Cell adhesive bottom  
Square 
Circle 
50 
20, 10 
25 
B : SAM 
W : PDMS 
AtT-20* ~ 15 24 h @ 1.0 × 106 cells/ml ∼83  
Liu et al. [114] 
Seeding by gravity 
Hemisphere 20 8.1 PDMS 
Ramos§ 
HeLa* 
— 
21±4.4 [119] 
5-10 min @ 1 × 106 cells/ml 
— 
90 ± 1 
— 
Ferrell et al. [115] 
Vacuum assisting  
Circle 15, 20, 50 – 
B : porous PC, 
Alumina, PET 
W : PMMA, PS 
NIH3T3* 
PANC-1* 
THP-1* 
16–20 [80] 
22.3 [127] 
15 / 13.0 ± 1.8 
[121] 
1–2 h @ 600 cells/mm2 ~50 @ 20 × —  
Park et al. [116] 
Seeding by flow 
Triangle, 
Square, Circle, 
Diamond, Cone 
50 20 – PC-3* 18 [128] 
10 min @ 1.5 × 106 cells/ml 
Flow rate: ~28 µm/s 
62 ± 10 @ triangle 50 × 20 
Broderick et al. [71] 
3D cell adhesion 
Square 300 120 BPEI/PVDMA COS-7* 30–50 [129] 20 min @ 600 cells — 
Wang et al. [117] 
PDMS elasticity 
Circle 20  12 15 PDMS Ba/F3* 14.1 ± 1.4 — @ 1.25 × 106 cells/cm2 65.3 ± 7.6 
Jen et al. [118] 
Seeding by flow 
Circle 20, 30 20 PDMS HeLa* 21 ± 4.4 [119] 
— @ 107 cells/ml  
Flow rate: 2.8 μl/min 
83.19 @ 20 × 20 
 
Notes: (B) is surface of bottom. (W) is surface of wall. (*) is an adherent (anchorage-dependent) cell. (§) is non-adherent (anchorage-independent) cell. (‡) 
is a semi-adherent cell. (—) is non-available. 
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 HeLa Cells for Microengineering Chapter 3. 
 Introduction 3.1.
Cellular behaviors and phenotypes differ widely depending on cell type. In this study, 
surface treatment techniques for optimizing cellular immobilization were determined 
according to the target cell type using chemical and/or physical methods. Cell lines should be 
carefully chosen with respect to their potential biological significance for clinical diagnosis 
and applicability to microplatforms for single cell analysis. 
 Human cancer cell lines 3.1.1
Although clinical trials in humans are essential for determining the efficacy of 
anticancer therapies, they are enormously expensive and difficult to perform for logistical, 
regulatory, legal, and ethical reasons. Therefore, in vitro cellular model systems are required 
to adequately explore the molecular basis of drug activities, despite the inability of this model 
system to accurately reflect many aspects of a drug’s behavior in the human body [130]. 
Recently, large-scale resources for human cancerous cell lines (~1,000 unique cell lines) have 
become publicly available for use in in vitro assays; these cell line resources are described in 
the Cancer Cell Line Encyclopedia [131]. This type of public resource for all cancerous cell 
lines allows us to predict intrinsic cell sensitivity and resistance to various existing drugs or 
potential future drugs [130]. Panels of human cancer cell lines and xenografts were 
established in Europe in 1988 (40 cell lines) [132], in the USA in 1990 (60 cell lines) [133], 
and in Japan in 2003 (39 cell lines) [134], supporting the conduct of in vitro assays to effi-
ciently evaluate test compounds for potential anticancer activity. Although these panels are 
limited in the number of available cell types, they have been used to test more than 100,000 
chemically defined potential drugs and a larger number of natural-product extracts [130]. 
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Table 3.1: Panels of human cancer cell lines and xenografts for in vitro assays in Europe [132], 
the USA [133], and Japan [134]. Numbers in parenthesis are the total number of cell lines 
available. 
Organs Europe (40) USA (60) Japan (39) 
Brain 
  U251, SF-268, SF-295, 
SF-539, SNB-75, SNB-78 
Breast 
MAXF 401, MAXF 449,  
MAXF 583, MAXF 857 
BT-549, MCF7,  
MDA-MB-231/ATCC, 
HS-578T, T-47D 
HBC-4, BSY-1, HBC-5, 
MCF-7, MDA-MB-231 
CNS 
 SF-268, SF-295, SF-539, 
SNB-19, SNB-75, U251 
 
Colon 
CXF 158, CXF 233,  
CXF 243, CXF 280 
COLO-205, HCC-2998, 
HCT-116, HCT-15,  
HT29, KM12, SW-620 
HCC-2998, KM-12,  
HCT-116, HCT-15,  
HT-29 
Head and 
Neck 
HNX-Hep-2, HNX-LP, 
HNX-14A, HNX-14C,  
HNX-PI 
  
Kidney 
 786-0, A498, ACHN, CAKI- 
I,RXF-393, 
SN12C, TK-10, UO-31 
 
Leukemia 
 CCRF-CEM, HL-60(TB),  
K-562, MOLT-4,  
RPMI-8226, SR 
 
Lung 
EVXOA, AHXOL,  
LXFE 397, LXFE 409,  
LXFL 529, LXFA 629,  
NXEE 002, CXEA 117 
LBXOS, LSFS 538,  
LXFS 605, LSFS 638,  
LXFS 638, LXFS 650,  
NXES 004, WXES 322 
A549/ATCC, EKVX,  
HOP-62, HOP-92,  
NCI-H226, NCI-H23,  
NCI-H322M, NCI-H460, 
NCI-H522 
A549, DMS273,  
DMS114, NCI-H226,  
NCI-H23, NCI-H460,  
NCI-H522 
Melanoma 
THXO, FEMXO,  
MEXF 274, MEXF 394, 
MEXF 514 
LOX-IMVI, MALME-3M, 
M14, SK-MEL-2,  
SK-MEL-28, SK-MEL-5, 
UACC-257, UACC-62 
RXF-631L 
Ovarian 
Ov.Pe, Ov.He, FMa,  
Ov.G1, Ov.Ri, FKo 
IGROV1, OVCAR-3, 
OVCAR-4, OVCAR-5, 
OVCAR-8, SK-OV-3 
OVCAR-3, OVCAR-4, 
OVCAR-5, OVCAR-8,  
SK-OV-3 
Prostate  DU-145, PC-3 DU-145, PC-3 
Renal   LOX-IMVI, ACHN 
Stomach 
  MKN-1, MKN-7,  
MKN-28, MKN-45, 
MKN-74, St-4 
Uncertain 
 NCUIADR-RES * 
MDA-MB-435** 
MDA-N** 
 
Notes: *, Formerly designated as breast, but its origin is now considered uncertain. **, Formerly 
designated as breast, but our analysis shows that they are more like melanomas or at least have 
the activity and protein expression signatures of melanoma. CNS: central nervous system. 
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 Human cancerous cervical epithelial HeLa cells 3.1.2
 Significance of the HeLa cell line in biology 3.1.2.1
Modern biomedical research relies heavily on experiments conducted using HeLa cells, 
derived from human cancerous cervical epithelium, despite of the absence of HeLa cells in 
representative panels of human cancer cell lines for in vitro assays [132-134]. HeLa cells are 
adherent and immortal, allowing them to divide continuously assuming the culture conditions 
permit cell survival.  
The HeLa cell line has a complex and relevant history. Originally described in 1952, 
HeLa cells were established as the first immortal human cancer line [135]; they have been 
widely used to investigate almost every cellular pathway and process because, although they 
are cancer cells, HeLa cells share many characteristics with noncancerous cells. Therefore, 
HeLa cells are used as a universal human cell to study active biochemical pathways in both 
normal and diseased tissues [40]. Generally, aggressive cancers (e.g., that from which HeLa 
cells were derived) have unique phenotypes and genotypes [136], and some genetic drift and 
phenotypic changes may occur during cell growth and passaging within a laboratory [137, 
138]. However, HeLa cells have been shown to remain relatively stable under standard 
laboratory culturing conditions. This stability, coupled with the similarities between HeLa 
cells and normal cells, make HeLa cells highly relevant in biomedical and basic research. 
Consequently, HeLa cells are also used to produce standardized nutrient media that can be 
employed during studies of the growth of other cell lines [139]. 
The first remarkable achievement involving the use of HeLa cells was the development 
of a vaccine against polio in 1953 [39]. A large number of HeLa cells were needed to begin 
large-scale production of the polio vaccine. Production facilities for HeLa cells were set up, 
and HeLa cells became the first cell line to be produced industrially. After this milestone, 
HeLa cells were distributed worldwide and became a general go-to laboratory model for 
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cancer cells [40]. HeLa cells were also used to create the first hybrid cell, heterokaryon cells 
[140]. Moreover, using HeLa cells, researchers developed viable cells from a fusion of 
human and animal cells [141], enabling the regulation of DNA synthesis to be more 
thoroughly investigated. HIV-infected HeLa cells have been used to support the development 
of new drugs and therapies against AIDS [142] and cancer [41]. 
 Application of the HeLa cells in microengineering 3.1.2.2
The development of microbiochips has enabled us to control the complete cellular 
microenvironment and to analyze single cells, leading to new questions and discoveries. 
Among the potential mammalian cell models for microengineering, HeLa cells were widely 
used because of their biological relevance to cancer treatment and their ability to adhere to 
hydrophilic surfaces controlled by microtechniques [39-42, 143]. The biological 
characteristics of HeLa cells have been well described in a range of studies [39-41, 135, 137-
142]; however, few reports have adequately described the physical properties of HeLa cells 
as they related to the construction of a customized microplatform for single HeLa cell 
analysis [119, 144-147]. In the design and fabrication of microwells for single cell arrays, the 
physical properties of the cell may strictly limit the size of microwells. The optimal size for 
microwells is just slightly larger than the diameter of the target cell, i.e., by approximately 
10 µm [38, 70, 80, 118-120]. Moreover, in addition to cell diameter, successful integration of 
versatile microplatforms also requires more information on other cellular characteristics, such 
as shape, mass, volume, and settling velocity. 
 Physical properties of HeLa cells for microengineering 3.1.3
In this study, we sought to define the relevant physical properties of HeLa cells for use 
in microengineering applications. We collected information describing the physical 
characteristics of HeLa cells from previously published papers and the technical 
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specifications provided by the cell vendor. Next, the diameter and volume of HeLa cells were 
measured using a CASY cell counter. The significance of the gathered information was 
analyzed to determine the correlation between the collected and measured values. Settling 
velocity of HeLa cells at room temperature (RT, 23°C) was theoretically analyzed and 
measured at the cell population level in time-lapse format for application to cell adhesion 
assays. Additionally, in this analysis, the density and viscosity of various liquids used in 
biological experiments, including phosphate buffered saline (PBS), RPMI 1640 
supplemented with fetal calf serum (FCS), and Opti-MEM, were determined, based on the 
properties of pure water. Settling velocity was analyzed by curve fitting of the line plot 
profile. Using these analyzed data and estimations, the settling velocity of HeLa cells at 37°C 
and the settling time of HeLa cells in 6-, 12-, or 24-well plates were also determined for 
applicability to cell adhesion assays. 
 Materials and methods 3.2.
 Culture of HeLa cells 3.2.1
HeLa cells (Deutsche Sammlung für Mikroorganismen und Zellkulturen GmbH 
[DSMZ], Germany) were cultivated in an incubator at 37°C and 5% CO2. In all experiments, 
we used RPMI 1640 medium (PAN Biotech GmbH, Germany) supplemented with 10% fetal 
bovine serum (FBS, Sigma-Aldrich) and 2% penicillin/streptomycin (Sigma-Aldrich) without 
phenol red. Confluent cultures of HeLa cells were passaged by 1:3 (v/v) every 3 days using a 
trypsin/EDTA solution (Sigma-Aldrich) for 5 min in an incubator at 37°C and 5% CO2. Cells 
were washed 3 times with 400 μl PBS to remove trypsin after centrifugation for 3 min at 
200 × g. HeLa cells were subsequently resuspended in growth medium to achieve a seeding 
concentration of 1 × 10
6
 cells/80 cm
2
. 
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 Measurement of cell diameter and volume 3.2.2
To measure the diameter and volume of HeLa cells, adhered HeLa cells were first 
detached using trypsin/EDTA. The HeLa cell suspension was then washed 3 times with 
400 μl PBS and diluted in PBS to achieve a concentration of 5 × 105 cells/ml. The diameter 
and volume of HeLa cells were measured 3 times for each trial using a CASY cell counter 
(CASYton, Schärfe System GmbH, Germany).  
The CASY cell counter utilizes electric current exclusion and pulse area analysis to 
count dead and viable cells in the cell suspension. Cell viability is determined by measuring 
the integrity of the plasma membrane for dead and viable cells (see Figure 3.1).  
 
Figure 3.1: CASY cell counter and the principles used to measure cell size. 
(a) CASY cell counter (DT model, Schärfe System GmbH, Germany). 
(b) Principle of counting cells. The number and size of cells were measured when the cells 
passed through a measuring pore in a low-voltage field. 
(c) Cell viability was measured by determining the difference in electrical current exclusion of 
the cell membrane between viable and dead cells. 
 
When a low-voltage field is applied to viable cells, the electrical current cannot 
penetrate the intact membrane, which acts as an electric insulator. In contrast, the membrane 
of injured cells is often broken and contains pores, allowing the electrical field to penetrate 
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the membrane. In both viable and dead cells, the measured cell size cannot be smaller than 
the nucleus. Therefore, the criterion for determining whether cells are viable or dead was 
based on the size of the nucleus in the target cells. 
 Measurement of cell Stokes velocity 3.2.3
PS cuvettes (Plastibrand, Garlroth GmbH, Germany) with inner dimensions of 
10 × 10 × 42 mm
3
 were sterilized by 95% ethanol for 5 min and dried at RT. On the backside 
of a cuvette, a black ruler with white grids was printed for determining the appearance of 
high-density HeLa cells, which are white and opaque enough to cover the white grids in the 
suspension. For measuring the settling velocity, HeLa cells were resuspended to a 
concentration of 2.2 × 10
6
 cells/ml in PBS. The HeLa cell suspension (2 ml) was then added 
to the marked cuvette at RT. Changes in the height of the HeLa cell suspension were 
recorded every 3 min for 45 min by photography. Grayness values of the cell suspension at 
each time point were obtained using ImageJ software (version 1.45; http://rsbweb.nih.gov/ij/) 
as a function of the surface plot profile (SPP) and line plot profile (LPP), as shown in Figure 
3.2. The line for the LPP was perpendicularly located on the grids of the ruler for zero 
adjustment of the grayness values at each time point. 
 
Figure 3.2: Analysis of the settling velocity of cells. 
Surface and line plot profiles were used to measure grayness values from the height of settling 
HeLa cells over time. The grids of the ruler in the analyzed area or line were used for the zero 
adjustment of the grayness values at each time point. 
 
Grayness values of HeLa cells over time were obtained by determining the LPP and 
were modified by polynomial curve fit of the value at 0 min to reduce the interference of 
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external lighting effects in the photos. The height of the HeLa cell suspension was 
determined by comparing 5 plots of the neighbor measuring times (e.g., 0–12, 12–24, 24–36, 
and 33–45 min). Settling velocities were calculated by determining the change in height of 
the HeLa cell suspension for each time interval. Ranges of the constant settling velocity 
(Stokes velocity) of HeLa cells were determined by Boltzmann sigmoidal curve fit of the 
heights of HeLa cell suspensions over time. 
The Boltzmann sigmoid is a logistic function or curve that generally models growth for 
some populations that exhibit S-shaped behaviors [148]. The sigmoidal curve is used for 
modeling growth of tumors, neural networks, chemical reactions, etc. The sigmoidal curve is 
a function (Equation 3.1) of the initial value (  , bottom), final value (  , top), center (  ) – 
the half value between the bottom and top – and time constant (  ). From these parameters, 
the Boltzmann sigmoid becomes shaped as shown in Figure 3.3. 
𝑦 =   + 
𝐴2−𝐴1
 +𝑒
𝑥0−𝑥
𝑑𝑥  
. Equation(3.1) 
 
 
Figure 3.3: Boltzmann sigmoidal curve using the following parameters: initial value (  ), final 
value (  ), center (  ), and time constant (  ). 
Using the analyzed settling velocity of HeLa cells at RT, the settling velocity of HeLa cells at 
37°C (cell culture conditions) and settling time of HeLa cells in 6-, 12-, and 24-well plates were 
determined for application in cell adhesion assays. 
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 Results 3.3.
 Culture of HeLa cells 3.3.1
HeLa cells are epithelial-like cells that grow in monolayers on the surface of culture 
dishes. HeLa cells are generally grown in MEM (90%) with Earle’s salts containing 10% 
FBS, 2 mM L-glutamine, and nonessential amino acids or RPMI 1640 (90–95%) containing 
5–10% FBS. Confluent cultures should be passaged at 1:4 to 1:6 ratios every 3–5 days using 
trypsin/EDTA to achieve a seeding concentration of 1–2 × 106 cells/80 cm2. When incubated 
at 37°C with 5% CO2, HeLa cells have a doubling time of ~48 h, and 5–15 × 10
6
 cells can be 
harvested from 175 cm
2
 plates. This information on the growth and passaging of HeLa cells 
was found in a technical note from DSMZ (http://www.dsmz.de). 
The growth rate in terms of incubation time was calculated using Equation 3.2 and 
Equation 3.3, which are based on the doubling time (48 h) of the HeLa cell population. 
𝐺𝑅ℎ =  
1 
𝐷𝑇ℎ =  
1
48 = √ 
48
, Equation(3.2) 
𝐺𝑅ℎ.𝑛 =  
𝑛 48⁄ . Equation(3.3) 
 
𝐺𝑅ℎ is the growth rate of the HeLa cell population every 1 h,   ℎ is the doubling time of 
HeLa cells, and  𝑅ℎ.𝑛 is the growth rate of HeLa cells over an  -h incubation. Cultivated 
HeLa cells are expected to increase in number by 1.5% during the first hour, 4.4% during a 3-
h incubation, and 9.1% during a 6-h incubation. 
Cell harvesting densities can be used to indicate the maximum number of cells that can 
be grown on the culture plate in order to keep the cells viable and healthy. The harvesting 
density for HeLa cells was between 285 and 857 cells/mm
2
, which was calculated based on 
the estimated cell density provided by the vendor (5–15 × 106 cells/175 cm2). 
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Table 3.2: Growth rate of HeLa cells at various incubation times. 
Incubation 
time (h) 
Growth 
rate (%) 
Incubation 
time (h) 
Growth 
rate (%) 
Incubation 
time (h) 
Growth 
rate (%) 
Incubation 
time (h) 
Growth 
rate (%) 
1 101.5 13 120.7 25 143.5 37 170.6 
2 102.9 14 122.4 26 145.6 38 173.1 
3 104.4 15 124.2 27 147.7 39 175.6 
4 105.9 16 126.0 28 149.8 40 178.2 
5 107.5 17 127.8 29 152.0 41 180.8 
6 109.1 18 129.7 30 154.2 42 183.4 
7 110.6 19 131.6 31 156.5 43 186.1 
8 112.2 20 133.5 32 158.7 44 188.8 
9 113.9 21 135.4 33 161.0 45 191.5 
10 115.5 22 137.4 34 163.4 46 194.3 
11 117.2 23 139.4 35 165.8 47 197.1 
12 118.9 24 141.4 36 168.2 48 200.0 
 
 Physical properties of HeLa cells 3.3.2
 Diameter and volume of HeLa cells 3.3.2.1
The diameter and volume of HeLa cells were measured using a CASY cell counter 
(n = 15). The criterional size used to distinguish between viable and dead HeLa cells was set 
at 12 µm, which was calculated on the basis of the diameter of HeLa cell nuclei (~11 µm) 
calculated from the measured HeLa nucleus volume of 690 µm
3
 [145]. Figure 3.4 shows the 
size distribution of HeLa cells. The distribution of viable HeLa cells resembled a Gaussian 
curve. The size of cell debris ranged from 0 to 7 µm, while the size of dead HeLa cells ranged 
from 7 to 12 µm in diameter. The measured diameter and volume of viable HeLa cells were 
16.17 ± 2.4 µm (range 12–30 μm) and 2,385 ± 91 µm3 (mean ± SD), respectively. 
Calculation of cell volume using the measured diameter of HeLa cells did not directly 
correspond to the measured volume. Using the measured diameter (16.17 μm), the calculated 
volume (2,225 µm
3
) was 6.7% less than the measured volume (2,385 µm
3
). Similarly, using 
the measured volume to calculate the diameter resulted in a calculated diameter (16.58 µm) 
that was 2.5% larger than the actual measured diameter. 
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Figure 3.4: Size distribution of HeLa cells. Debris measured less than 7 µm, dead HeLa cells 
measured from 7 to 12 µm, and viable HeLa cells measured from 12 to 30 µm. 
 
 Mass of HeLa cells 3.3.2.2
The density of HeLa cells has been reported to be 1,060 kg/m
3
 [149, 150]; using this 
reported density and Equation 3.4, the mass of a HeLa cell was calculated to be 2.359 ng 
based on the measured diameter and 2.528 ng based on the measured volume.  ℎ is the 
volume of a HeLa cell, and  ℎ is the diameter of a HeLa cell. 
 ℎ = 
𝜋 𝐷ℎ
3
6
. Equation(3.4) 
 
 Spread area and concentration of HeLa cells 3.3.2.3
When HeLa cells adhere to the substrate, their spread area is 1600 ± 500 µm
2
 [146]; this 
indicates that the number of the adhered HeLa cells in an area of 1 mm
2
 would be 
approximately 625 cells, which falls in the range of the harvesting density (285–
857 cells/mm
2
). In cell adhesions assays, the concentration of HeLa cells cannot exceed the 
harvesting density because over-proliferated cells are eliminated by self-destruction 
mechanisms, i.e., apoptosis, during which cells develop abnormal phenotypes [151]. 
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 Stokes velocity of HeLa cell settling 3.3.3
 Theoretical calculation of the Stokes velocity of a cell from the measured 3.3.3.1
diameter 
Stokes velocity can be used to describe the settling of a large number of dispersed HeLa 
cells with random positions through Newtonian fluid under gravitational laws. The 
calculation of cell settling velocity in liquid is based on Stokes’ law under the following 
assumptions of cell behavior in a liquid: 
- Laminar flow  
- Spherical and rigid particles 
- Homogeneous (uniform in composition) material 
- Smooth surface 
- Particles do not interfere with each other. 
 
Figure 3.5: Forces acting on a settling cell in liquid. 
Settling velocity varies until the net forces are equivalent: buoyancy force, gravitational force, 
and drag force. The terminal settling velocity is the Stokes velocity.  
 
In particular, settling cells exhibit creep-flow movement in liquids, with a Reynolds 
number (Re) of below 1. The settling of cells in a liquid is mainly governed by 3 forces: (1) 
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gravitational force, (2) buoyancy force, and (3) drag force (flow friction force). Brownian 
forces on the cells are ignored because they are considerably lower and act in random 
directions. A cell settles by gravitational force because it has a greater density than liquid. In 
contrast, buoyancy force acts upward on the cell, and drag force, a form of flow resistance, 
acts against the direction of a moving cell (Figure 3.5). 
The gravity force of a cell (  ) is calculated by the equation  
  = 𝑀𝐶𝑔 = 
𝜋𝜌𝐶𝑔 𝐶
3
6
 Equation(3.5) 
 
where 𝑀𝐶 is the mass of the cell, 𝑔 =   .     
 ⁄  is the acceleration of gravity, 𝜌𝐶 is the 
density of the cell, and   is the diameter of the cell. The buoyancy force (  ) of a cell is 
calculated by the equation  
   =  𝐶𝜌𝐿𝑔 =  
𝜋𝜌𝐿𝑔 𝐶
3
6
 Equation (3.6) 
 
where  𝐶 is the volume of the cell as calculated by Equation 3.4 and 𝜌𝐿 is the density of 
the liquid. The drag force of a cell ( 𝐷) is calculated by Stokes’ equation (Equation 3.7): 
  𝐷 = 
 
 
 𝐷 𝜌𝐿𝑣𝑠𝑡
  𝑃 =
 
 
(
 4 𝜇𝐿
𝜌𝐿𝑣𝑠𝑡 𝐷𝐶
) 𝜌𝐿  𝑣𝑠𝑡
 ( 
 
4
 𝐶
  𝜋) 
                                 =  3 𝜋 𝑣𝑠𝑡𝜇𝐿 𝐶 
Equation (3.7) 
 
where CD is the drag coefficient from Stokes’ law at Re < 1 as calculated by Equation 3.8, 
𝑣𝑠𝑡 is the Stokes velocity (a terminal and constant settling velocity) of the cell,  𝑃 is the 
projected area to the direction of a settling cell, and 𝜇𝐿 is the dynamic viscosity of the liquid.  
 𝐷 =
 4
𝑅𝑒𝐶
= 
 4 𝜇𝐿
𝜌𝐿𝑣𝑠𝑡 𝐶
 Equation (3.8) 
 
𝑅𝑒𝐶, the Reynolds number (Re) of a settling cell, is calculated by Equation 3.9: 
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𝑅𝑒𝐶 = 
𝜌𝐿𝑣𝑠𝑡  𝐶
 𝜇𝐿
 Equation (3.9) 
 
The projected area of HeLa cell ( 𝑃) is calculated by the equation  
 𝑃 = 
 
4
 𝐶
  𝜋 Equation (3.10) 
 
The Stokes velocity of a cell is calculated by Stokes’ equation in the equilibrium state of 
buoyancy, gravitational, and drag forces acting on a cell, according to Equation 3.11 and 
Equation 3.12: 
 𝐷 =   −    Equation (3.11) 
3 𝜋 𝑣𝑠𝑡  𝜇𝐿 𝐶 = 
𝜋𝜌𝐶𝑔 𝐶
3
6
− 
𝜋𝜌𝐿𝑔 𝐶
3
6
 =  
𝜋(𝜌𝐶 − 𝜌𝐿)𝑔 𝐶
3
6
 Equation (3.12) 
 
The Stokes velocity of a cell can be calculated as  
 𝑣𝑠𝑡 = 
(𝜌𝐶 − 𝜌𝐿)𝑔 𝐶
 
   𝜇𝐿
 Equation (3.13) 
 
Stokes velocity is proportional to the differences in density between cells and liquids and the 
square of diameter of a cell and is inversely proportional to the dynamic viscosity of the 
liquid. 
 Theoretical calculation of the Stokes velocity of a cell using the measured 3.3.3.2
diameter and volume 
While the measured diameter and volume of HeLa cells did not correspond 
mathematically, Stokes velocity was calculated by Equation 3.15 based on the measured 
diameter and volume:  
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3 𝜋 𝑣𝑠t 𝜇𝐿 𝐶 =  𝐶𝜌𝐶𝑔 −  𝐶𝜌𝐿𝑔 =   𝐶(𝜌𝐶 − 𝜌𝐿)𝑔 Equation (3.14) 
 𝑣𝑠t = 
 𝐶(𝜌𝐶 − 𝜌𝐿)𝑔 
3𝜋𝜇𝐿 𝐶
 Equation (3.15) 
 Density and dynamic viscosity of various liquids  3.3.3.3
Liquid parameters, such as density and dynamic viscosity, are needed to calculate the 
Stokes velocity of a cell. The general types of liquids used in cellular experiments are PBS, 
RPMI 1640 supplemented with 10% FBS or FCS, and Opti-MEM (serum-free medium). The 
density and dynamic viscosity of these liquids are nearly identical to those of water and are 
dependent on temperature. Table 3.3 indicates the density and dynamic viscosity of pure 
water at different temperatures [152]. The values at RT and 37°C were obtained by a linear 
interpolation method. 
Table 3.3: Density and dynamic viscosity of pure water at different temperatures [152]. 
Temperature 
(°C) 
Density, ρ 
(kg/m
3
) 
Viscosity, μ 
(mN·s/m
2
) 
Temperature 
(°C) 
Density, ρ 
(g/cm
3
) 
Viscosity, μ 
(mN·s/m
2
) 
10 999.73 1.3069 37 993.34 0.6931 
20 998.23 1.0020 40 992.25 0.6535 
23 997.54 0.9350 45 990.24 0.5963 
25 997.08 0.8903 50 998.07 0.5471 
30 995.68 0.7975 60 983.24 0.4666 
35 994.06 0.7195 70 977.81 0.4089 
 
PBS is a buffer solution commonly used in biological research. It is a water-based salt 
solution containing sodium chloride, sodium phosphate, and, in some formulations, 
potassium chloride and potassium phosphate. The buffer’s phosphate groups help to maintain 
a constant pH (i.e., 7.4). The osmolarity and ion concentrations of the solution usually match 
those of the human body (isotonic). The components in PBS are shown in Table 3.. Although 
ionic components are found in PBS, the density and dynamic viscosity of PBS are generally 
similar to those of pure water. 
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Table 3.4: Components of phosphate buffered saline (PBS). 
Chemicals Proportion (wt%) Density, ρ (g/cm3) 
Sodium chloride (NaCl) 0.80 % 2.165 g/cm
3
 
Potassium dihydrogen phosphate (KH2PO4) 0.02 % 2.34 g/cm
3
 
Disodium hydrogen phosphate (Na2HPO4) 0.10 % 0.5–1.2 g/cm
3
 
Potassium chloride (KCl) 0.02 % 1.984 g/cm
3
 
Water (H2O) 99.00 % 0.9975 g/cm
3
 
 
The specific gravity of RPMI 1640 is 1.0004231667, as measured by the heat transfer 
experiment [153]. The dynamic viscosity of RPMI 1640 supplemented with 10% FCS and L-
glutamine is similar to that of water [154]. The dynamic viscosity of Opti-MEM is 
0.737 mN·s/m
2
 at 37°C, as measured using a capillary viscometer [155]. From the collected 
data, the densities and dynamic viscosities of various liquids are summarized in Table 3.5 at 
RT and in Table 3.6 at 37°C. 
Table 3.5: Densities and dynamic viscosities of 4 different liquids: pure water, PBS, RPMI 
1640, and Opti-MEM at 23°C (RT). 
Liquid type (at 23°C) Density, ρ (kg/m3) Dynamic viscosity, μ (mN·s/m2) 
Pure water 997.54 [152] 0.935 [152] 
PBS 997.54 0.935 
RPMI 1640 997.96 [153] 0.935 [154] 
Opti-MEM 997.54 0.990 
 
Table 3.6: Densities and dynamic viscosities of 4 different liquids: pure water, PBS, RPMI 
1640, and Opti-MEM at 37°C. 
Liquid type (at 37°C) Density, ρ (kg/m3) Dynamic viscosity, μ (mN·s/m2) 
Pure water 993.34 [152] 0.696 [152] 
PBS 993.34 0.696 
RPMI 1640 993.76 0.696 [154] 
Opti-MEM 993.34 0.737 [155] 
 
 Calculation of the Stokes velocity of HeLa cells using the measured diameter 3.3.3.4
The Stokes velocity of HeLa cells at 23°C (RT) and 37°C (Equation 3.13) was 
calculated based on the measured diameter (16.17 µm), as determined using a CASY cell 
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counter. The calculated Stokes velocity of HeLa cells in PBS was 9.52 µm/s at 23°C and 
13.65 µm/s at 37°C. HeLa cells in RPMI 1640 settled at the Stokes velocity of 9.46 µm/s at 
23°C and 13.56 µm/s at 37°C. The higher Stokes velocity at 37°C in both liquids was caused 
by the decreasing dynamic viscosity of the liquid as the temperature increased. The Stokes 
velocities of HeLa cells in various liquids at 23°C and 37°C are described in Table 3.7. 
Table 3.7: Calculated Stokes velocities of HeLa cells in 4 different liquids: pure water, PBS, 
RPMI 1640, and Opti-MEM at 23°C and 37°C using the measured diameter. 
HeLa 
23°C 37°C 
 𝑣𝑠𝑡  (µm/s)  𝑣𝑠𝑡  (µm/min)  𝑣𝑠𝑡  (µm/s)  𝑣𝑠𝑡  (µm/min) 
Water 9.52 571.2 13.65 818.9 
PBS 9.52 571.2 13.65 818.9 
RPMI 1640+10% FCS 9.46 567.3 13.56 813.7 
Opti-MEM 8.99 539.4 12.89 773.3 
 
From the calculated Stokes velocity of HeLa cells, the Reynolds number of HeLa cells 
(𝑅𝑒 ) was 1.45–3.18 × 10
-4, supporting the assumption of Stokes’ law (Re < 1) for the drag 
coefficient ( 𝐷) (Table 3.8). 
Table 3.8: Reynolds numbers of settling HeLa cells in 4 different liquids: pure water, PBS, 
RPMI 1640, and Opti-MEM at 23°C and 37°C. 
Reynolds number of HeLa  
Temperature 
23°C 37°C 
Water 1.64 × 10
-4
 3.18 × 10
-4
 
PBS 1.64 × 10
-4
 3.18 × 10
-4
 
RPMI 1640 + 10% FCS 1.63 × 10
-4
 3.16 × 10
-4
 
Opti-MEM 1.45 × 10
-4
 2.81 × 10
-4
 
 
 Calculation of the Stokes velocity of HeLa cells using the measured diameter 3.3.3.5
and volume 
The Stokes velocity of HeLa cells, as calculated by using the measured diameter 
(16.17 µm) and volume (2,385 µm
3
), is shown in Table 3.9. The Stokes velocity of HeLa 
cells in PBS was 10.26 µm/s at 23°C and 14.70 µm/s at 37°C. HeLa cells in RPMI 1640 
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settled at 10.19 µm/s at 23°C and 14.61 µm/s at 37°C. Using the measured diameter and 
volume, an increase in the Stokes velocity of HeLa cells (by 3.4%) was observed; this was 
because the measured volume (2,385 µm
3
) was greater than the volume calculated from the 
measured diameter (2,225 µm
3
). 
Table 3.9: Calculated Stokes velocities of HeLa cells in 4 different liquids: pure water, PBS, 
RPMI 1640, and Opti-MEM at 23°C and 37°C using the measured diameter and volume 
(n = 15). 
HeLa 
23°C 37°C 
 𝑣𝑠𝑡  (µm/s)  𝑣𝑠𝑡  (µm/min)  𝑣𝑠𝑡  (µm/s)  𝑣𝑠𝑡  (µm/min) 
Water 10.26 615.3 14.70 882.2 
PBS 10.26 615.3 14.70 882.2 
RPMI 1640 + 10% FCS 10.19 611.2 14.61 876.7 
Opti-MEM 9.69 581.1 13.89 833.2 
 
 Experiments to demonstrate the Stokes velocity of HeLa cells 3.3.3.6
For the following experiments, the HeLa cell concentration was 2.2 × 10
6
 cells/ml, 
which was the maximum concentration we were able to obtain. The expected height of the 
HeLa cell suspension (volume, 2 ml) was 20 mm from the sectional area of a PS cuvette 
(10 × 10 mm
2
). However, the measured height of the cell suspension in the cuvette was 
18.57 mm due to the concave meniscus of the suspension. All cells in PBS were assumed to 
have the same kinetic energy (settling velocity) and the initial settling velocity was assumed 
to be 0 µm/s. Experiments were conducted at RT. The settling time – the time for the cells in 
the suspension to fully settle to the bottom of the cuvette –was expected to be 30.0 min for 
HeLa cells, as shown in Table 3.9. The thickness of the deposited HeLa cell population (   ) 
was calculated as 104.9 μm using the following equation  
   = 
𝑉𝐻 𝑛𝐻
𝐴𝑐
, Equation (3.16) 
 
where the volume of a HeLa cells (  ) was 2,385 µm
3
, the total number of HeLa cells in the 
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suspension (  ) was 4.4 × 10
6
, and the cross sectional area of the cuvette (  ) was 100 mm
2
.  
The settling velocity of HeLa cells was measured over time. Photographs of settling 
HeLa cells in the PS cuvette were obtained every 3 min for 45 min, as shown in Figure 3.6. 
The clearness of the background ruler gives an indication as to how far the cells have settled 
in each frame. All images exhibited external interference from the bottom of the cuvette 
(0 mm) to 12 mm in height due to the reflection of light. 
 
Figure 3.6: Photographs of settling HeLa cells in PBS (2 ml volume, 2.2 × 10
6 
cells/ml) in a PS 
cuvette with inner dimensions of 10 × 10 mm
2
.  
Photographs were taken every 3 min for 45 min. From the meniscus of cell suspension, the 
maximal height of PBS was 18.57 mm. External interference was observed from the bottom of 
the cuvette to the 12-mm mark. 
 
Grayness values for the HeLa cell suspension in SPP are shown in Figure 3.7. The 
highest and lowest grayness values were 256 (white) and 0 (black), respectively. The highest 
values, which resemble a wall at the rear of each graph, represent the white meniscus of the 
HeLa cell suspension. As HeLa cells settled, the white grids of the black ruler appeared from 
the top, and the range showing the grids extended from the top. 
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Figure 3.7: Surface plot profile of the grayness values of the HeLa cell suspension.  
The appearance of a wall at the rear of each graph represents the white meniscus of the cell 
suspension. The peaks indicate the white grids appearing from the top of the cell suspension, 
and the range showing the grids grew as the HeLa cells settled. 
 
The LPP of settling HeLa cells at every time point is shown in Figure 3.8. The plot for 
each increasing time point was separated by an offset of 20 in order to distinguish between 
plots. The meniscus of the HeLa cell suspension located at 18–19 mm caused a dramatic 
increase in the grayness value. At 0 min, the HeLa cells were uniformly dispersed in the 
suspension and covered the entire range of white grids, with grayness values of 50–130. The 
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slopes of the LPPs were caused by the external interference observed in the photographs. As 
the HeLa cells settled, the white grids – peaks of LPPs – appeared from top, and the range 
showing the grids extended from the top. 
 
Figure 3.8: Line plot profile of HeLa cells every 3 min for 45 min. The plot for each increasing 
time point was separated by an offset of 20 in order to distinguish between plots. 
 
To reduce the effects of external interference on the photographs (the slopes of the 
LPPs), the obtained LPPs for the time course experiment were modified by the polynomial 
curve fit of the LPP at 0 min. The degree of polynomial fitting was determined by comparing 
the original LPP and the polynomial fits of various degrees (e.g., 5, 7, 8, and 9). As shown in 
Figure 3.9, the 9th-degree polynomial fit most closely resembled the LPP at 0 min. This 
polynomial was 
𝑓( ) = 73.5  +  34.     –  54.46    +   7.3   3 –  6.    4 
               +  .    5 –   .7 ×   −   6  +  4.46 ×   −3  7–   . 5 ×   −4  8  
               +  .47 ×   −6  9 
 
Equation (3.17) 
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Figure 3.9: Polynomial curve fits of the line plot profile of the HeLa cell suspension at 0 min.  
Among various degrees of polynomials (e.g., 5, 7, 8, and 9), a 9th-degree polynomial fit most 
closely resembled the line plot profile at 0 min. The function of this polynomial fit was f(x) = 
73.51 + 34.01 x – 54.46 x2 + 27.31 x3 – 6.92 x4 + 1.00x5 – 87.08 × 10–2 x6 + 4.46 × 10–3 x7 – 
1.25 × 10
–4
 x
8
 + 1.47 × 10
–6
 x
9
. 
 
The effect of the polynomial fit on reducing the interference of LPPs was demonstrated 
by the relative grayness values – subtraction the polynomial fit of the LPP at 0 min from that 
of the LPP at 45 min (Figure 3.10). The slope of the modified LPP at 0 min was almost flat, 
and all values were close to 0. The valleys of the modified LPP at 45 min were also 
positioned in a narrow range of variance (~10) from 0 to 18 mm.  
 
Figure 3.10: Line plot profiles at 0 min (black) and at the final measuring time of 45 min (red) 
for HeLa cells in the suspension.  
(a) Graph of the original line plot profile data. The slopes of both lines ranged from 0 to 12 mm 
and was caused by external interference. 
(b) Graph of the modified line plot profile by the 9th-degree polynomial fit.  
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The modified LPPs for HeLa cell settling over time are shown in Figure 3.11. The plot 
for each increasing time point was separated by an offset of –20 in order to distinguish 
between plots. 
 
Figure 3.11: Modified line plot profiles of HeLa cells. Photographs were taken every 3 min for 
45 min. The modified line plot profiles indicate relative values of the original data to the 9th-
degree polynomial fit of the plot at 0 min. The plot for each increasing time point was separated 
by an offset of –20 in order to distinguish between plots. 
 
Heights of the HeLa cells were determined by comparing the 5 plots of the neighboring 
measured times (e.g., 0–12, 12–24, 24–36, and 33–45 min) by magnifying the range of the 
heights. In Figure 3.12, the magnified range of the height was 9–19 mm for 0–12 min (a), 5–
15 mm for 12–24 min (b), 0–10 mm for 24–36 min (c), and 0–10 mm for 33–45 min (d). 
The height of the HeLa cell suspension at each time point was determined by taking the 
minimum value below the appearance of the white grid (peak point), whether it was high or 
low. These measured heights are shown in Table 3.10.  
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Figure 3.12: Heights of the HeLa cell suspension as determined by comparing the neighboring 
measured times the neighbor modified line plot profiles. The arrows indicate the height of the 
HeLa cells in the suspension, and the arrow color corresponds to the color of the line.  
(a) The modified LPPs at 0–12 min. The valley at 18.57 mm indicates the height of the HeLa 
suspension (2 ml) in the cuvette. The height of the HeLa cells was 18.57 mm at 0 min, 
17.86 mm at 3 min, 16.86 mm at 6 min, 15.71 mm at 9 min, and 14.57 mm at 12 min. 
(b) The modified LPPs at 12–24 min. The height of the HeLa cells was 12.71 mm at 15 min, 
10.38 mm at 18 min, 9.43 mm at 21 min, and 7.57 mm at 24 min.  
(c) The modified LPPs at 24–36 min. The height of the HeLa cells was 4.57 mm at 27 min, 
2.57 mm at 30 min, 1.14 mm at 33 min, and 0.86 mm at 36 min.  
(d) The modified LPPs at 33–36 min. The height of the HeLa cells was 0.57 mm at 39 min, 
0.71 mm at 42 min, and 0.57 mm at 45 min.  
Table 3.10: The heights and settling velocities of the HeLa cell suspension at various times. 
The velocity at each time point is shown as the mean velocity from the previous time to the 
indicated time. 
Measuring 
time (min) 
Height 
(mm) 
Settling velocity Measuring 
time (min) 
Height
(mm) 
Settling velocity 
(µm/min) (µm/s) (µm/min) (µm/s) 
0 18.57 – – 24 7.57 620.0 10.33 
3 17.86 190.0 3.17 27 4.57 1,000.0 16.67 
6 16.86 333.3 5.56 30 2.57 666.7 11.11 
9 15.71 383.3 6.39 33 1.14 476.7 7.94 
12 14.57 380.0 6.33 36 0.86 93.3 1.56 
15 12.71 620.0 10.33 39 0.57 96.7 1.61 
18 10.38 776.7 12.94 42 0.71 –46.7 –0.78 
21 9.43 316.7 5.28 45 0.57 46.7 0.57 
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The settling velocity of HeLa was slow, but increased from its initial state until 9 min. 
After 9 min, the Stokes velocity of HeLa cells was 11.11 ± 2.46 µm/s from 12 to 30 min 
(n = 6). After 30 min, the settling velocity dramatically decreased. The slow settling velocity 
of HeLa cells during the initial and final phases makes it difficult to measure the Stokes 
velocity of HeLa cells using the entire time range; thus, the settling time was postponed. The 
height of the HeLa cell suspension did not reach 104.9 µm until 45 min, despite the fact that 
theoretical methods predicted a settling time of 30.0 min for these cells. 
 
Figure 3.13: Boltzmann sigmoid of the height of HeLa cells in the suspension over time. The 
Boltzmann sigmoid was characterized by the following parameters: center (  ) of 20.20 min, 
initial value (  ) of –0.369 mm, final value (  ) of 18.94 mm, and time constant (  ) of 
6.49 min. 
 
Because of the slow settling velocities in the initial and final phases of settling, the 
height of the HeLa cells in the suspension resembled an S-shaped Boltzmann sigmoid 
(Figure 3.13).  
The sigmoid for the heights of HeLa cells in the suspension over time can be described 
by the equation  
𝑦 = − .37 + 
  . 5 +  .37 
 + 𝑒
 −  . 
6.49
  Equation (3.18) 
 
Using this equation, the center (  ) was 20.2 min, the initial value (  ) was –0.37 mm, 
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and the final value (  ) was 18.95 mm. The time constant (  ) was 6.49 min. According to 
this Boltzmann sigmoid, HeLa cells have a settling time of 44.1 min, the time required for the 
height of HeLa cells in the suspension to reach 104.9 µm; this time was 47.0% longer than 
the expected time of 30.0 min. 
In our study of the settling velocity, the time range during which we could measure the 
Stokes velocity (12–30 min) was roughly assumed; however, it is necessary to define the 
optimal time range for determining the Stokes velocity of HeLa cells, i.e., the linear range of 
the Boltzmann sigmoidal fit of the heights over time. For this reason, the linear range of the 
Boltzmann sigmoid was analyzed by a standard Boltzmann sigmoid with different time 
constants (  ): 1/4, 1/3, 1/2, 2/3, 1, 3/2, 2, and 3, as shown in Figure 3.14 (a). The x-axis 
ranged from –1 to 1 and was inversely proportional to the time constant (Table 3.11). For 
example, when the time constant was 1/4, the range of the x-axis showed a 4-fold time 
constant, while the time constant of 3 had a range of –1/3 to 1/3 of the time constant.  
Table 3.11: The range of the x-axis from –1 to 1 in terms of various time constants for the 
standard Boltzmann sigmoid. 
Time constant 
(  ) 
Range of x-axis from –1 to 1  
in terms of time constant 
Time constant 
(  ) 
Range of x-axis from –1 to 1 
in terms of time constant 
1/4 4 ×    1 1 ×    
1/3 3 ×    3/2 2/3 ×    
1/2 2 ×    2 1/2 ×    
2/3 3/2 ×    3 1/3 ×    
 
The linear fits of the different Boltzmann sigmoidal curves overlapped, as shown in 
Figure 3.14 (a). Errors of the linear fits to the different sigmoid functions are also shown in 
Figure 3.14 (b). The error of the linear fits was less than 1% when the range of the x-axis 
was less than 1-fold the time constant (    ) in the graph. Therefore, the optimal range for 
the constant differential value – the Stokes velocity – was from the – time constant to the + 
time constant, from the center of the sigmoid function (from   −    to   +   ).  
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Figure 3.14: Linear fits of the standard Boltzmann sigmoid with various time constants, ranging 
from 1/4 to 3. 
(a) Boltzmann sigmoidal curves with various time constants (  ) (1/4, 1/3, 1/2, 2/3, 1, 3/2, 2, 
and 3) and their linear fits. The x-axis ranged from –1 to +1,  
(b) Graph of the errors of linear fits to the Boltzmann sigmoid curves. The error of the linear fit 
was less than 1% when the x-axis ranged from −   to +  . 
 
Boltzmann sigmoids of the heights of HeLa cells in suspension revealed a Stokes 
velocity of 11.14 µm/s in the range of 13.71–26.69 min, with a center of 20.20 min and a 
time constant of 6.49 min. The theoretical and experimental Stokes velocities of HeLa cells 
are summarized in Table 3.12. Errors were based on the Stokes velocity calculated using the 
measured diameter and volume of HeLa cells. The error of the Stokes velocity using the 
Boltzmann sigmoid was 11.1%. 
Table 3.12: Theoretical and experimental Stokes velocities of HeLa cells in PBS at 23°C. 
Method in PBS at 23°C Stokes velocity (µm/s) Error (%) 
Theory : measured diameter (16.17 µm) 9.52 –7.2 
Theory : measured diameter (16.17 µm) and volume  
(2,385 µm
3
) 
10.26 — 
Experiment : measured heights in 15–24 min 9.72 –5.2 
Experiment : sigmoidal function in 13.71–26.69 min 11.14 11.1 
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 Settling time of HeLa cells in cell adhesion assays 3.3.4
Cell adhesion assays are generally conducted in 6-, 12-, or 24-well plates (Figure 3.15) 
at RT or 37°C. The diameter of the cylindrical wells is 34.80 mm for 6-well plates, 22.11 mm 
for 12-well plates, and 15.62 mm for 24-well plates. Typical working volumes for liquids are 
2.7–3.2 ml for 6-well plates, 1.4–2.3 ml for 12-well plates, and 0.7–0.9 ml for 24-well plates. 
 
Figure 3.15: Different types of well plates for cell adhesion assays: (a) a 6-well plate with a 
well diameter of 34.80 mm, (b) a 12-well plate with a well diameter of 22.11 mm, and (c) a 24-
well plate with a well diameter of 15.62 mm. 
 
Different working volumes yield different liquid heights in wells of these plates (Table 
3.13). For our analysis, we used working volumes of 0.7–0.9 ml for 24-well plates, 1.5–
2.5 ml for 12-well plates, and 2.5–3.5 ml for 6-well plates. 
Table 3.13: Heights of liquids with the different working volumes in 6-, 12-, and 24-well plates  
Working Volume 0.7 ml 0.9 ml 1.5 ml 2.0 ml 2.5 ml 3.0 ml 3.5 ml 
Height (mm) 
in 6-well plate  
– – – – 2.63 3.15 3.68 
Height (mm) 
in 12-well plate  
– – 3.91 5.21 6.51 – – 
Height (mm) 
in 24-well plate  
3.65 4.70 – – – – – 
 
The settling times for HeLa cells in 6-, 12-, and 24-well plates were determined 
according to these different working volumes for cell adhesion assays, using the settling time 
calculated for the 18.57-mm HeLa cell suspension at RT by the Boltzmann sigmoid function 
(44.61 min). Table 3.14 shows the settling times of HeLa cells in PBS for different working 
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volumes in 6-, 12-, or 24-well plates at RT and 37°C. The settling time of HeLa cells in 
RPMI 1640 supplemented with 10% FBS or FCS was similar to that in PBS (ratio, 0.994; 
Table 3.7). 
Table 3.14: Settling time of HeLa cells in PBS according to working volume in 6-, 12-, or 24-
well plates at 23°C and 37°C. 
PBS 0.7 ml 0.9 ml 1.5 ml 2.0 ml 2.5 ml 3.0 ml 3.5 ml 
Settle time (s)  
in a 6-well plate 
23°C – – – – 379.1  454.0 530.4 
37°C – – – – 264.4 316.7 370.0 
Settle time (s)  
in a 12-well plate 
23°C – – 563.6 750.9 938.3 – – 
37°C – – 393.1 523.7 654.4 – – 
Settle time (s)  
in a 24-well plate 
23°C 526.1 677.4 – – – – – 
37°C 366.9 472.5 – – – – – 
 
 Discussion 3.4.
 Physical properties of HeLa cells 3.4.1
In this study, we found that the measured diameter of HeLa cells could not be used to 
accurately predict the volume, and vice versa. One explanation for the larger measured 
volume may be the presence of long cilia on the surface of HeLa cells or the occurrence of 
cell division (Figure 3.16).  
 
Figure 3.16: Images of a HeLa cell and the cell division process.  
(a) Scanning electron microscope image of a HeLa cell. HeLa cells have long, narrow cilia on 
their surface [(http://www.smithsonianmag.com).  
(b) In cell division, spherical cells grow and elongate in one direction. In the final state of cell 
division, 2 small daughter cells appear (http://www.davidicke.com). 
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However, the effect of cilia on differences between the measured and calculated 
diameters and volumes would seem insignificant because the CASY cell counter measures 
the diameter and volume of HeLa cells spontaneously. The other possible cause is the 
spheroidal shape of HeLa cells during cell division [Figure 3.16 (b)], which occurs in normal 
HeLa cells undergoing mitosis. The shape of the HeLa cell was assumed to be spheroidal 
with two minor axes (a) and a major axis (b). 
 
Figure 3.17: Spheroidal shape of the HeLa cell. The lengths are (a) for the two minor axes and 
(b) for the major axis. 
 
The measured volume and radius were calculated using the length of the major (b) and 
minor (a) axes of the spheroid (Equation 3.19 and Equation 3.20). The radius of a HeLa cell 
was calculated as the geometric mean of the minor axis (a) and major axis (b). From this, we 
found that the volume (  ) and radius (  ) of a HeLa cell were 2,385 µm
3
 and 8.09 µm, 
respectively. 
  = 
4𝜋
3
 𝑎 𝑏  
 
Equation (3.19) 
 
  = √𝑎𝑏  Equation (3.20) 
 
Combining Equation 3.19 and Equation 3.20, the length of the minor (a) and major (b) 
axes were 7.51 µm and 8.71 µm, respectively. The minor axis was less than the measured 
radius by 0.58 µm, while the major axis was longer than the measured radius by 0.62 µm. 
Using Equation 3.21, the eccentricity of HeLa cells (𝑒 ) was 0.507.  
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 𝑒 = √ − ( 
𝑎
𝑏
 )
 
 Equation (3.21) 
 
 Stokes velocity of HeLa cells 3.4.2
Our mathematical model of settling HeLa cells was reasonable, with a maximum error 
of 11.4% ( Table 3.12), despite the presence of cilia on the surface of the cell (see Figure 
3.16) and the spheroidal shape of HeLa cells (see Figure 3.17), which violate the 
assumptions of Stokes’ law (spherical particles and a smooth surface). These violations may 
explain the slow development of the settling velocity during the initial phase of settling and 
the exponential decrease in the settling velocity during the final phase of settling (see Figure 
3.13). According to the Boltzmann sigmoid, the settling velocity accelerated until 13.71 min 
during the initial phase and slowed beginning at 26.69 min during the final phase (Table 
3.11). 
 Development of the settling velocity of HeLa cells during the initial phase 3.4.2.1
To provide insight into the mechanisms mediating the initial phase of settling, 
developing time (i.e., the time required for HeLa cells to reach the Stokes velocity) was 
calculated. If the developing time was the same as that determined using the Boltzmann 
sigmoid (13.71 min), analysis of the slow settling velocity in the initial phase would not be 
required.  
We calculated the developing time for HeLa cells using a differential equation. Before 
reaching the developing time, the settling velocity must increase until it reaches an 
equilibrium state where all forces (gravity, buoyancy, and drag) are equal (Equation 3.22), 
allowing cells to settle at the Stokes velocity of 10.26 µm/s. The settling velocity of HeLa 
cells was calculated using Equation 3.24.  
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 𝐶 =   −   −  𝐷 Equation (3.22) 
 
The acceleration of a settling cell (𝑎𝐶) is the time derivative of the settling velocity of a 
cell (𝑣𝐶), that is, 𝑎𝐶 =  𝑣𝐶   ⁄ .  
𝜌𝐶 𝐶
 𝑣𝐶
  
 = (𝜌𝐶 − 𝜌𝐿) 𝐶  𝑔 − (
 
 
 𝐷 𝜌𝐿 𝑃) 𝑣𝐶
  
 
Equation (3.23) 
 
 𝑣𝐶
  
 =
(𝜌𝐶 − 𝜌𝐿)
𝜌𝐶
 𝑔 − (
 𝐷𝜌𝐿 𝑃
 𝜌𝐶 𝐶  
) 𝑣𝐶
  Equation (3.24) 
 
By assumption, the initial velocity of a HeLa cell in a liquid (𝑣   ) is 0 µm/s when the 
time ( ) is 0 s. 
 𝑣𝐶
  
 =
(𝜌𝐶 − 𝜌𝐿)
𝜌𝐶
 𝑔 − (
 𝐷𝜌𝐿 𝑃
 𝜌𝐶 𝐶  
) 𝑣𝐶
  
 
Equation (3.25) 
 
 𝑣𝐶 = −𝑁 (𝑣𝐶
 − 𝐾 )     (𝑁 =  
 𝐷𝜌𝐿 𝑃
 𝜌𝐶 𝐶  
 𝐾 = 
  ( 𝜌𝐶 − 𝜌𝐿)   
 𝐷 𝜌𝐿  𝑃
 𝑔) Equation (3.26) 
 
𝐾  indicates the Stokes velocity (10.26 µm/s for HeLa cells in PBS at 23°C and 
14.17 µm/s for HeLa cells in PBS at 37°C). In the following differential equation, 𝐾 ≥ 𝑣  
for the full time range and the constant ( ̃) is 0 because 𝑣   =  . 
∫
 
𝑣𝐶
 − 𝐾  
 𝑣𝐶 = −∫𝑁    
 
Equation (3.27) 
 
 
 𝐾
𝑙 
𝐾 + 𝑣 
𝐾 − 𝑣 
= 𝑁  +  ̃  
 
Equation (3.28) 
 
𝑣𝐶( ) = 𝐾 
 − 𝑒−𝑃𝑡
 + 𝑒−𝑃𝑡
 (𝑃 =  𝐾𝑁)  Equation (3.29) 
 
Time constant (𝑃) for HeLa cells in PBS was 1.13 × 105 at 23°C and 8.71 × 104 at 37°C. 
As shown in Figure 3.18, the developing time for the settling velocity of HeLa cells during 
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the initial phase was very short (< 100 µs, calculated using Equation 3.29). Therefore, the 
developing time estimated from the Boltzmann sigmoid (13.71 min) was affected by other 
factors. 
 
Figure 3.18: Increase in the settling velocity of HeLa cells during the initial phase of settling (in 
PBS, at 23°C and 37°C). 
 
 Slow developing time for the settling velocity of HeLa cells during the initial 3.4.2.2
phase of settling  
During the initial phase, the slow developing time for the settling velocity of HeLa cells 
was affected by dense debris in the HeLa cell suspension (Figure 3.4). The concentration of 
HeLa cells was 1.024 × 10
6
 cells/ml, with 4.103 × 10
5
 debris particles/ml. These two different 
sized particles (cells and debris) would result in differential sedimentation of the bidispersed 
suspension. The initial phase of differential sedimentation would be instable because of large-
scale fluctuations in particle size, i.e., heavy, large particles – HeLa cells – would settle to the 
bottom, while light, small particles – debris – would rise to the top of the suspension (Figure 
3.19) [156]. This suggests that HeLa cell suspensions should be allowed to settle for some 
time in order to reach a steady settling velocity.  
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Figure 3.19: Large-scale fluctuations of particles occur when heavy, large particles (blue) settle 
to the bottom and light, small particles (red) raise to the top of the suspension [156]. The 
timescale is based on the Stokes time (  ) of particles. 
 
The Stokes time (  ) is the time for an isolated sphere to sediment in terms of its radius 
(    ) [156]. The calculated Stokes time of a HeLa cell in PBS is 788.0 ms at 23°C and 
592.3 ms at 37°C according to the equation 
  =
  
  𝑣𝑠 
  Equation (3.30) 
 
Therefore, particles are still experiencing large-scale fluctuations at the maximal time 
(e.g., 3.3 min at 23°C and 2.5 min at 37°C for HeLa cells in PBS), based on the Stokes time 
(  𝑠⁄ =  5 .3), as shown in Figure 3.19. 
 Exponential decrease in the settling velocity of HeLa cells during the final phase  3.4.2.3
During the final phase, the decreased settling velocity of HeLa cells near the bottom of 
the cuvette was likely dependent on the concentration of HeLa cells in the suspension. This 
phase of settling was probably also affected by the strong cell-cell interactions between HeLa 
cells. HeLa cells, derived from epithelial cells, which are known to pack densely to form the 
 ７９ 
epithelium, interact and attach to each other [157]. These cell-cell interactions constitute 
another violation of the assumptions of Stokes’ law (i.e., that particles do not interfere with 
each other). Marieb [157] demonstrated the effects of particle-particle interactions on the 
settling velocity of particles (Figure 3.20). When the concentration of interacting particles is 
increased, the settling velocity of particles decreases due to interaction between particles. 
Therefore, as the concentration of HeLa cells increased near the bottom of the cuvette, the 
settling velocity exponentially decreased, as shown in Figure 3.20 (b).  
 
Figure 3.20: Effects of particle concentration on particle-particle interactions [157].  
(a) Structure of particles in the suspension with time. (b) The effect of particle concentration on 
settling velocity. 
 
 Conditions of the cell suspension for measuring settling velocity  3.4.2.4
The effects of the dense debris on the initial phase of settling and the effects of cell-cell 
interactions and cell concentration at the bottom of the cuvette on the final phase of settling 
should be further investigated, using different conditions for the cell suspension to measure 
the Stokes velocity. For the initial phase, the density of debris may be reduced by filtration, 
creating a homogeneously dispersed cell suspension to reduce the effects of large-scale 
fluctuations on the settling velocity. For the final phase, the decrease in settling velocity may 
be lessened by using a lower density of HeLa cells or by using nonadherent cells (i.e., T-
lymphocytes or Jurkat cells) that do not exhibit cell-cell interactions. By reducing the density 
of cell debris and using nonadherent cells, the time range during which cells exhibit Stokes 
velocity can be extended. 
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 Conclusion 3.5.
This study demonstrated the physical properties of HeLa cells for potential application 
in microbiochips, which enable us to control the complete cellular microenvironment or to 
analyze single cells, leading to new questions and discoveries. Our results demonstrated that 
HeLa cell populations exhibited insignificant growth for the first 6 h of incubation, with only 
a 9% increase in the number of cells. The harvesting density of HeLa cells on the culture 
plate exhibited a maximum of 857 cells/mm
2
; this value is important to avoid causing 
apoptosis due to overproliferation. Moreover, the diameter and volume of HeLa cells were 
16.17 ± 2.4 µm and 2,385 ± 91 µm
3
, respectively. The spheroidal shape of HeLa cells during 
cell division may explain the mathematical discordance between the measured diameter and 
volume. Using the measured volume, the mass of a HeLa cell was estimated to be 2.528 ng, 
and the density of HeLa cells was 1,060 kg/m
3
.  
The Stokes law in Newtonian fluid dynamics can be used to calculate the Stokes 
velocity – or constant settling velocity – of HeLa cells. The calculated settling velocity of 
HeLa cells in PBS was 10.26 µm/s at 23°C and 14.70 µm/s at 37°C using the measured 
diameter and volume. The higher Stokes velocity of HeLa cells at 37°C than at 23°C was 
caused by the lower dynamic viscosity of PBS at the higher temperature. Importantly, 
experiments to investigate the settling velocity of HeLa cells were performed for cell 
populations in a PS cuvette at 23°C. The 18.57-mm-deep cell suspension was based on the 
volume of PBS at a cell concentration of 2.2 × 10
6
 cells/ml, and the cell height was measured 
every 3 min for 45 min. This time study revealed that the settling velocity developed slowly 
during the initial phase and decreased exponentially during the final phase, leading to a 
Boltzmann sigmoid-shaped curve. The Stokes velocity of HeLa cells was 11.14 µm/s from 
13.71 to 26.69 min by Boltzmann sigmoidal fit. The slow development and exponential 
decrease of the settling velocity in HeLa cells delayed the settling time to 44.1 min, which 
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represented a 46.1% delay from the calculated settling time of 30.0 min by the Boltzmann 
sigmoid. The slow developing time for the settling velocity of HeLa cells was caused by 
large-scale fluctuations between HeLa cells and debris present in the cell suspension. The 
exponential decrease in the settling velocity was caused by the abundant cell-cell interactions 
and high density of HeLa cells near the bottom of the cuvette. 
The assumptions of Stokes’ law were violated by several conditions, including the 
presence of cilia on the surface of the cells, the spheroidal shape of HeLa cells, and cell-cell 
interactions between HeLa cells. However, the measured Stokes velocity exhibited 11.1% 
error compared to the theoretical velocity. The time range of the Stokes velocity may be 
extended by filtration of debris and beginning with a lower density of HeLa cells. Moreover, 
the use of nonadherent cells may reduce the decreased settling velocity during the final phase 
of settling by eliminating cell-cell interactions. 
Finally, we applied these principles and measured the settling velocity and settling time 
of HeLa cells in typical well plates. This information on the expected settle time of HeLa 
cells will be useful for cell adhesion assays in time-course analyses. 
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 Dopaminergic Mesoporous Inorganic-Chapter 4. 
organic Hybrid Resin 
 Introduction 4.1.
 Development of new biomaterials and novel technologies 4.1.1
New biomaterials and novel technologies for surface engineering have been developed 
for a wide range of biological studies and applications, including medicine, pharmacology, 
and bioengineering [43-45]. An ideal biomaterial should be amenable to molecular design for 
biological purposes and easily synthesized [44]. Moreover, for application in micro-
fabrication, a new biomaterial should enable easy fabrication to exacting specifications and 
should be highly stable in both water and organic solvents. 
 Significance of cell adhesion to biomaterials 4.1.2
The most frequently obtained cellular phenotypes on foreign materials are changes in 
cell morphology, adhesion, and proliferation during cultivation for anchorage-dependent cells 
[53, 158, 159]. Among these, cell adhesion is most essential because it is the first step in a 
cascade of events during which cellular interaction with the surface of the biomaterial occurs 
[49]. Cell adhesion also represents the in vitro simulation of physiologically relevant events, 
which may facilitate our understanding of cellular functions and realization of the feasibility 
of tissue engineering of bio-artificial solid organs and systems [160]. Recent adaptation of 
MEMS fabrications to control cell adhesion and micropatterning of cells using cell-surface 
interactions has been applied in cell culture models to better reproduce in vivo functions in 
the form of single cell arrays and coculture systems [27, 28, 30]. 
 Method for promoting cell adhesion by surface engineering 4.1.3
The chemical and physical properties of cell-repellent and cell-adhesive biocompatible 
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materials have been developed and analyzed with a focus on the interactions between cells 
and the surface material. Generally, cells exhibit two distinct mechanisms that mediate 
cellular adhesion during the formation of focal adhesion complexes: (1) mechanical, through 
membrane projections; and (2) biochemical, induced through receptor-ligand binding. Both 
of these mechanisms are used when substrates are modified by both incorporation of surface 
microstructures and adsorption of adhesive ligands whereby maximum adhesion strength and 
motility responses were achieved, indicating the engagement of optimal tractional forces 
mediated by both structural and chemical cues. 
Chemical methods for promoting cell adhesion include self-assembled monolayers 
(SAMs) [79-81], surface charge [83, 84, 87], and wettability [51, 93, 161]. SAMs have been 
used as surface chemical models to interpret the interactions of proteins and cells with 
artificial surfaces. The strength of cell adhesion to fibronectin (Fn)-coated SAMs decreases in 
the following order: OH > COOH = NH2 > CH3 [78]. The surface charge needed to 
immobilize cells is typically positive because nearly all cells are covered with negatively 
charged functional groups at a neutral pH [82]. A positively charged surface is created by 
coating chemical components (i.e., amine functional groups) [83, 87] or by applying DC 
electrical fields to the electrodes to temporarily capture cells (electrophoresis) [84]. 
Wettability has been commonly assessed to determine cell adhesion onto polymers, 
copolymers, and polymers treated by plasma, corona, or surface graft polymerization [51]. 
The representative physical method for promoting cell adhesion is surface roughness on the 
micro- [95, 162] or nanoscale [96].  
Among the various cell adhesion methods, performance of cell adhesion on artificial 
surface decreases in the following order: wettability, surface charge, functional group, and 
surface roughness [49, 88, 92, 158, 159, 162-180]. 
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 Wettability control for promoting cell adhesion 4.1.4
The surface wettability of bio-artificial materials is one of the most important factors 
determining cell adhesion behavior. Surface hydrophilicity and hydrophobicity can be 
determined by measuring the water contact angle on the surface of the material. Measurement 
of the water contact angle is very simple and clearly indicates the comprehensive results for 
various chemical molecules and physical properties of the surface material. The water contact 
angle associate with moderate wettability for cell adhesion is in the range of 40–70° [51, 88], 
while extreme hydrophobicity or hydrophilicity of the surface inhibits cell adhesion [89-91]. 
 Mesoporous inorganic-organic hybrid resin 4.1.5
Kim and colleagues [47, 158], recently reported a series of mesoporous inorganic-
organic hybrid resins (HRs) that presented a good adhesion strength to various substrates, 
high stability against organic solvents, and good biocompatibility. HRs were synthesized for 
biocompatible poly(ethylene glycol)-dimethacrylate (PEG-DMA) to increase adhesion 
strength to various substrates with the help of silica-titania-based inorganic components. The 
wettability of HRs was adjusted by changing the molecular ratio of the inorganic components 
and the organic PEG-DMA component, which were combined with a silane coupling agent 
[158]. However, silane coupling agents are unstable in aqueous environments [181], and thus, 
the stability and function of HRs were guaranteed for just 3 weeks after synthesis. 
 Dopamine 4.1.6
For mussels (Mytilus edulis), permanent bio-adhesion to a surface in an aqueous 
environment is crucial for survival [see Figure 4.1(a)]. The byssus of the mussel, an adhesive 
organelle, consists of byssal thread and plaques (the distal adhesive pad). Byssal plaques 
firmly adhere to a surface and tether the organism to that surface. At least 5 specialized 
mussel adhesive protein (MAP) subtypes of byssal are known to contain the catecholic amino 
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acid DOPA (3,4-dihydroxy-L-phenylalanine, the precursor of dopamine) at concentrations 
ranging from a few mol% to 27 mol% [182, 183]. Polymers utilizing DOPA from MAPs 
demonstrated increasing adhesion strength of nanostructured pillars by 15-fold [184], good 
binding to organic polymers and various metal surfaces [185], and adhesive characteristics 
for even nonadherent cells [186]. 
 Dopaminergic mesoporous inorganic-organic hybrid resin 4.1.7
In this study, a dopaminergic mesoporous inorganic-organic hybrid resin (HR-DOPA) 
was modified using dopamine from previous HRs [47, 158] for long-term stability and good 
cell adhesive characteristics. The surface roughness of HR-DOPA film was measured by 
atomic force microscopy (AFM) and determination of the water contact angle to verify the 
cell adhesion capabilities of the resin. HR-DOPA was also observed over a long-term period 
of two years. 
 Material and Methods 4.2.
 Dopaminergic mesoporous inorganic-organic hybrid resin 4.2.1
HR4-DOPA was kindly provided by Prof. Dong-Pyo Kim at Chungnam National 
University, South Korea. HR4-DOPA is one of a series of HR-DOPA materials created and is 
a derivative of HR4, made by replacing the catecholic salt with dopamine in chemical 
synthesis (Table 4.1). Among the various HR-DOPAs synthesized, HR4-DOPA was used in 
this study because it contained the largest amount of the organic compound (PEG-DMA), 
which lessens the brittleness of HR-DOPA and improves the microfabrication process. The 
chemical composition of HR-DOPA is shown in Figure 4.1. 
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Figure 4.1: Synthesis of dopaminergic mesoporous inorganic-organic hybrid resins (HR-
DOPAs).  
(a) Depiction of a mussel (M. edulis) attached by a byssus to various materials. Adapted from 
Springer Images.  
(b) Chemical structure of dopamine. 
(c) Chemical composition of the dopaminergic mesoporous inorganic-organic hybrid resin (HR-
DOPA). 
 
HR-DOPA synthesis was conducted as described by Chungnam National University as 
follows. Dopaminergic silica-titania (SiO2-TiO2) hybrid materials were prepared by 
consecutive sol-gel-based reactions as follows. Tetraethylorthosilicate (TEOS) was 
prehydrolyzed in a 100:50 (v/v) ethanol:water solution containing HCl at 60°C. The nonionic 
triblock copolymer, Pluronic P123 (EO20PO70EO20), as a structure-directing agent, was 
dissolved in ethanol and added to the TEOS sols. Titania sols were prepared by mixing TiCl4 
in an 80:20 (v/v) water:ethanol mixture at room temperature (RT). Inorganic silica-titania 
composite sols were prepared by mixing silica and titania sols at various ratios, followed by 
stirring for 2 h. As a hydrophilic, biocompatible generator, dopamine (4-(2-aminoethyl) 
benzene-1,2-diol), was subsequently added to the homogeneous silica-titania composite sol, 
and the solutions then instantly changed to a transparent orange color. Composite sols were 
composed at the TEOS:TiCl4:dopamine molar ratio of 1:0.1:0.05. For the preparation of 
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inorganic-organic hybrid resins, inorganic composite sols were mixed by stirring for 3 h with 
the desired amounts of 3-(methacryloyloxy) propyltrimethoxysilane (MPTMS; a silane 
coupling agent) and PEG-DMA (a hydrophilic component) as shown in Table 4.1.  
Table 4.1: Chemical compositions of various dopaminergic mesoporous inorganic-organic 
hybrid resins. 
Samples Molecular ratio HR-DOPA composition 
 TEOS TiCl4 Dopamine MPTMS PEG-DMA 
SR-DOPA 1 0.1 0.05 0 0 
HR1-DOPA 1 0.1 0.05 0.08 0.042 
HR2-DOPA 1 0.1 0.05 0.22 0.104 
HR3-DOPA 1 0.1 0.05 0.44 0.208 
HR4-DOPA 1 0.1 0.05 0.88 0.416 
 
 Preparation of HR4-DOPA film 4.2.2
Borosilicate glass coverslips (Fisher Scientific, Germany; diameter, 22 mm) were 
cleaned by acetone and subsequently washed with ethanol and deionized (DI) water. The 
slides were then dried on a hotplate at 150°C for 10 min. HR4-DOPA was spun on the glass 
slide at 3000 rpm for 20 s using a spin-coater (BLE Laboratory Equipment GmbH, Germany) 
after oxygen plasma treatment at 200 W and 30 mbar for 25 s (Diener Electronic GmbH, 
Germany). These films were cured on a hotplate at 50°C for 5 h and subjected to postheat 
treatment at 100°C for 2 h, then immersed in ethanol for 2 h to remove the surfactants 
incorporated in the material [158] and dried at RT.  
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Figure 4.2: Fabrication process for HR4-DOPA film on glass slides. The glass slides were 
22 mm in diameter. 
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 Measurement of surface roughness 4.2.3
Surface roughness of the glass slides and the HR4-DOPA film were analyzed using an 
atomic force microscope (AFM; MobileS, Nanosurf AG, Switzerland). The substrates were 
probed in tapping and noncontact mode with a single crystal silicon tip (PPP-NCLR-10; 
Nanosensors AG, Switzerland) with a resonant frequency of approximately 155 kHz. The 
properties of the single crystal silicon chip are described in Table 4.2.  
 
Figure 4.3: Resonance frequency of the cantilever with a single crystal silicon tip (PPP-NCLR-
10). 
 
Table 4.2: Properties of a single crystal silicon tip (PPP-NCLR-10). 
Type PPP-NCLR-10 
Product POINTPROBE-PLUS
®
 Silicon-SPM-Sensor 
Material N*-Silicon (Resistivity: 0.01–0.02 Ω·cm 
Cantilever dimension 
Thickness Length Width 
7.1 ± 1 µm 225 ± 10 µm 38 ± 7.5 µm 
Resonance Frequency 146 – 236 kHz 
 
Height and phase images (measured area, 1 × 1 μm2) of 3 different samples at 5 separate 
points were collected simultaneously (n = 15) and analyzed using Nanosurf MobileS software 
(version, 2.2.1.16). All roughness values, filtered by polynomial fit in this paper, referred to 
the root-mean square (RMS). The RMS of the surface was measured relative to the center 
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plane and was calculated by the following equation: 
𝑅𝑀 =   𝐿 𝐿𝑦  ∫ ∫ [𝑓(  𝑦)]    𝑦
𝐿𝑥
 
𝐿𝑦
 
  Equation (4.1) 
 
where 𝑓(  𝑦)  was the surface relative to the center plane and 𝐿  and 𝐿𝑦  were the 
dimensions of the surface. 
 Water contact angle goniometry of HR4-DOPA film 4.2.4
All sessile drop contact angle measurements were conducted at RT using a goniometer 
(DSA 10MK2, Krüss, Germany) equipped with a microliter syringe. The typical protocol 
involved using a constant drop volume (10 ml) of ultrapure water, which was gently 
deposited onto the surface and allowed to grow prior to slow needle retraction and image 
collection. Captured images were analyzed using Drop Shape Analysis (DSA1 V1.80, Krüss, 
Germany) to determine contact angles. All readings were performed immediately after 
sample preparation to minimize contamination. Average values and standard deviations (SDs) 
were obtained from 5 different measured values. 
 Results 4.3.
 Surface roughness 4.3.1
The surface of the glass slide as a substrate for HR4-DOPA film was measured because 
the thin HR4-DOPA film follows the surface roughness of the glass. The average ± SD 
surface roughness of the glass slides was 446.00 ± 128.06 pm from 5 different points in 3 
separate samples (see Table 4.3). 
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Table 4.3: Measured surface roughness (RMS) in a 1 × 1 μm2 area of the glass slide. 
Glass slides Sample 1 Sample 2 Sample 3 
Point 1 729.00 pm 387.04 pm 545.23 pm 
Point 2 770.59 pm 251.35 pm 452.73 pm 
Point 3 600.15 pm 348.83 pm 298.30 pm 
Point 4 346.69 pm 332.49 pm 538.78 pm 
Point 5 377.35 pm 352.67 pm 358.83 pm 
 
 
Figure 4.4: AFM images of pure white glass coverslips. The measured area was 1 × 1 μm2 in 
tapping and noncontact mode. The average (± SD) surface roughness was 446.00 ± 128.06 pm. 
 
The average (± SD) surface roughness of HR4-DOPA films coated on glass slides was 
789.35 ± 141.56 pm, as shown in Table 4.4. Surface roughnesses of HR4-DOPA remained 
below 1 nm despite being increased by 77.0% compared to the glass coverslip.  
Table 4.4: Measured surface roughness (RMS) in a 1 × 1 µm
2
 area of the HR4-DOPA film. 
HR4-DOPA Sample 1 Sample 2 Sample 3 
Point 1 795.71 pm 1295.1 pm 739.91 pm 
Point 2 842.61 pm 1027.5 pm 719.94 pm 
Point 3 835.96 pm 551.11 pm 588.45 pm 
Point 4 795.45 pm 713.69 pm 994.79 pm 
Point 5 690.87 pm 677.16 pm 568.01 pm 
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Figure 4.5: AFM images of the HR4-DOPA film on the glass coverslip.  
The measured area was 1 × 1 μm2 in tapping and noncontact mode. The average (± SD) surface 
roughness was 789.35 ± 141.56 pm. 
 
 Water contact angle of HR4-DOPA film 4.3.2
The water contact angle of HR4-DOPA film was examined in order to determine 
whether the film was applicable for cell adhesion in terms of wettability. Since values can 
decrease gradually as water droplets evaporate, all measurements were conducted 
immediately (i.e., < 10 s) after dropping the water droplet on the surface. The average (± SD) 
water contact angle was 62.08° ± 1.90° (see Figure 4.6). The value was similar to that of 
polydopamine [187] and demonstrated that HR4-DOPA has lower wettability than HR4 (49°) 
[158]. The wettability of HR4-DOPA was in the range of moderate wettability for cell 
adhesion: i.e., 40–70° [51, 88]. 
 
Figure 4.6: The water contact angle (sessile drop) of HR4-DOPA was 62.08° ± 1.90° at room 
temperature. The water volume was 10 ml. 
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 Long-term stability of HR4-DOPA  4.3.3
The stability of a silane coupling agent (MPTMS) in the different mesoporous inorganic-
organic resins of HR4 and HR4-DOPA was observed for two years. Figure 4.7 shows the 
different conditions for HR4 and HR4-DOPA, which contain catecholic salt and catecholic 
amine (dopamine), respectively, that were kept for two years at 8°C after synthesis. The 
formation of cross-linked silane aggregates – islands – was observed in HR4 (Figure 4.7, left) 
due to direct attachment by individual molecules to surface hydroxyl groups of MPTMS in 
HR4 [49]. However, HR4-DOPA exhibited a clear, stable state after long-term storage, 
suggesting that dopamine prevents MTPMS from forming cross-linked silane aggregates in 
HR4-DOPA. 
 
Figure 4.7: Comparison of the stability of MPTMS in HR4 and HR4-DOPA over time. Both 
resins were kept in vials at 8°C for two years after synthesis without being opened. The 
formation of cross-linked silane aggregates – islands – was observed in HR4 (left), while HR4-
DOPA remained clear and stable for a long period of time. 
 
 Discussion 4.4.
 Surface roughness of HR4-DOPA 4.4.1
Surface roughness on the nanometer-scale regulates cell adhesion behaviors and cell 
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phenotypes [96, 188, 189]. The optimal surface roughness ranged from 10–30 nm (RMS) for 
cell adhesion [96, 188]. HR4-DOPA films appeared smooth, even on the subnanometer scale, 
indicating that the effect of HR4-DOPA surface roughness on cell adhesion was insignificant. 
In future applications, surface treatment with HR4-DOPA can be used to create the optimal 
surface roughness for cell adhesion. 
 Long-term stability of HR4-DOPA  4.4.2
Water, ethanol, and acid are essential for the sol-gel process in synthesizing silica-based 
inorganic-organic hybrid materials as well as HR4-DOPA [190]. Moreover, inorganic and 
organic components were hybridized by silane coupling agents, which are unstable in 
aqueous environments [181, 190]. Hamming et al. [191] utilized a DOPA-initiator instead of 
a silane coupling agent for improving the stability and interfacial adhesion of inorganic-
polymer composites. Although a small amount of dopamine (1.03 mol%) was found in HR4-
DOPA, the long-term stability of the resin was indicated by its ability to stabilize a silane 
coupling agent in an aqueous environment over a 2-year period. However, a more detailed 
chemical analysis is required to explain the effects of the dopamine found in HR4-DOPA on 
the long-term stability of the resin. 
 Conclusion 4.5.
This study investigated the surface roughness and wettability of a dopaminergic 
mesoporous inorganic-organic hybrid resin (HR4-DOPA) to determine its capacity for cell 
adhesion. HR4-DOPA was also modified by dopamine instead of a catecholic salt in order to 
stabilize a silane coupling agent in previous mesoporous inorganic-organic hybrid resins. The 
average surface roughness of HR4-DOPA was 789.35 pm, indicating that this material is 
smooth and would exert insignificant effects on cell adhesion. Surface treatment with HR4-
DOPA can be used to create the optimal surface roughness for cell adhesion. The water 
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contact angle of HR4-DOPA was 62.08°, indicating a moderate wettability for cell adhesion. 
The stability of a silane coupling agent in HR4-DOPA was observed over a long-term storage 
period of 2 years, but a more detailed chemical analysis is required in order to explain the 
effects of the dopamine found in HR4-DOPA on the long-term stability of the resin. 
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 Biocompatibility of dopaminergic inorganic-Chapter 5. 
organic hybrid resin film 
 Introduction 5.1.
 Cell adhesion assay 5.1.1
The analysis of cell adhesion is an essential part of cell biology. Cell survival is 
dependent on proliferation, migration, and communication via cell-cell and cell-matrix 
interactions, and cellular adhesion is the first step in these processes [192]. Cell adhesion is 
dominated by the chemical or/and physical properties of the substrates [193, 194], and thus, 
cell adhesion assays are utilized for studying cell-substrate interactions as well as the 
biocompatibility of new biomaterials for microcellular applications [52, 195, 196]. 
Quantification of cell adhesion can be performed using several methods: by manually 
counting the number of adhered cells per unit area [193, 197], by colorimetric or fluorometric 
detection [198], or by measuring the depletion of a variety of extracellular matrix proteins in 
the medium [199]. 
 Cell adhesion 5.1.1.1
Cells continually communicate with their extracellular environment and respond to 
specific signals. A large number of receptors, channels, and cell adhesion molecules (CAMs) 
that mediate specific cellular interactions are embedded in the phospholipid bilayer of the cell 
membrane [200], as shown in Figure 5.1, and these play a significant role in cell adhesion.  
A transmembrane protein (TP), which is a specific CAM, is a protein that goes from one 
side of a membrane through to the other side. TPs include proteins such as integrins, 
cadherins, and selectins. They interact with their specific ligands, which are located either in 
the extracellular matrix (ECM) surrounding cells or are embedded in the cell membrane of 
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other cells and establish a close contact between them. Each of these adhesion molecules has 
a different function and recognizes different ligands. Cadherins are named for “calcium-
dependent adhesion” molecules and mediate calcium (Ca2+)-dependent homophilic cell-cell 
adhesion [201]. Selectins mediate the initial attachment of leukocytes to venular endothelial 
cells prior to their firm adhesion and diapedesis at sites of tissue injury and inflammation 
[202]. Integrins are heterodimers with variable α and β subunits that usually mediate cell-
matrix adhesions [203, 204], as shown in Figure 5.2.  
 
Figure 5.1: Structure of the cell membrane. The cell membrane is composed of a phospholipid 
bilayer, which is embedded with a large number of receptors, channels, and cell adhesion 
molecules. This depiction of the cell membrane was adapted from Wikipedia. 
(http://commons.wikimedia.org/wiki/File:Cell_membrane_detailed_diagram_3.svg#filelinks). 
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The extracellular domains of integrin receptors bind to ECM glycoproteins (e.g., 
fibronectin, collagen, or laminin), whereas the intracellular domains of integrin receptors 
interact with the actin cytoskeleton [203].  
Here, we will discuss two types of cell adhesion: focal adhesions and hemidesmosomes. 
Hemidesmosomes prefer keratin-associated adherence, while actin-associated adherence is 
observed in focal contacts. 
 Focal adhesion 5.1.1.1.1
Once the integrin is bound to fibronectin, the cell forms focal adhesions near the 
periphery. Focal adhesions are large and robust attachment sites containing a large number of 
proteins, and they serve to integrate the extracellular matrix with the actin cytoskeleton [205]. 
 
Figure 5.2: Integrin-mediated focal cell adhesion to the extracellular matrix (ECM) [204].  
(a) Suspended cells adhere to the surface of the ECM via integrins. Some of the nascent 
adhesion contacts grow and form mature focal adhesions.  
(b) Integrins function as a heterodimer composed of α- and β-chains.  
(c) The cytoplasmic portions of integrins recruit multiple cellular proteins and form cross-linked 
platforms to regulate both the actin cytoskeleton and signal transduction. 
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Focal adhesion proteins act as linkers between the integrin receptors and the cytoplasmic 
actin cytoskeleton [206]. In addition, integrins recruit several structural and signaling 
molecules such as the focal adhesion kinase (FAK). The accumulated FAK is phosphorylated 
and initiates signal transduction cascades such as tyrosine phosphorylation, creating docking 
sites for other signaling proteins [203, 205]. After building these focal adhesions, the cells 
start spreading. Therefore, the integrin-mediated cell adhesions provide dynamic bidirectional 
links between the ECM and the cytoskeleton [207].. 
 Hemidesmosomal adhesion 5.1.1.1.2
Hemidesmosomes are a type of specialized integrin-mediated adhesion. In contrast to 
desmosomes, which are cadherin-mediated cell-cell contacts, hemidesmosomes are cell-
matrix contacts that connect the basal lamina (i.e., a special form of the ECM) with epithelial 
cells (Figure 5.3) [208, 209]. The basal lamina is composed of the lamina lucida and the 
underlying lamina densa, both of which mainly consist of proteins such as collagen and 
laminin. The anchoring filaments (i.e., sub-basal lamina fibrous components) connect the 
hemidesmosomes with the lamina densa. Additionally, anchoring fibrils spread from the 
basement membrane along the dermal edge of the lamina densa. These anchoring fibrils 
either (1) loop back and reinsert into the lamina densa or (2) extend perpendicularly from the 
basement membrane and insert into the anchoring plaques of the hemidesmosomes, which are 
electron-dense condensations at the ends of anchoring fibrils, together with other associated 
constituents of the basal lamina [210, 211]. The intracellular domains of integrin receptors 
embedded in the membrane of the epithelial cells connect with the keratin filament network, 
while their extracellular domains connect with laminin-anchoring filaments of the basal 
lamina to establish hemidesmosomes [212]. This hemidesmosomal adhesion, consisting of 
the hemidesmosomal plaque, anchoring filaments, and fibrils, provides stable adherence of 
the epithelial cell to the basal lamina [213].  
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Figure 5.3: Schematic showing the major components of hemidesmosomes in epithelial cells 
[209].  
Basal keratinocytes adhere to the basement membrane by the interaction of cytoplasmic and 
transmembranous components of hemidesmosomes, such as BP230, BP180, and α6β4 integrin, 
with ligands such as laminin 5 located in the lamina lucida and lamina densa of the 
dermoepidermal basement membrane. 
 
 Cell spreading and migration 5.1.1.2
Integrin-mediated signaling events in focal adhesions contribute to stable cell spreading, 
migration, survival, proliferation, and differentiation [214], while hemidesmosomes cause 
stable anchorage of epithelial cells to maintain a migration direction during wound healing 
[215]. Figure 5.4 shows integrin-mediated cell spreading and migration. 
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Figure 5.4: Integrin-mediated cell spreading and migration.  
G-actin polymerizes to F-actin at the leading edge of the cell (pseudopod). Integrin-fibronectin 
binding allows linkers to bind integrins to F-actin. Clustering of integrin-fibronectin forms 
strong focal adhesion plaques. Contraction of actin (interacting with myosin) allows the cell to 
be pulled forward. The depiction was adapted from a web site of the University of Toronto. 
(http://www.erin.utoronto.ca/~w3bio315/lecture13.htm) 
 
 Cell viability assay 5.1.2
Cell viability assays are an essential tool for determining viable or dead cells in cell-
based studies to evaluate the efficacy of anticancer compounds in drug screening or the effect 
of new biomaterials on cells. Cell viability is assessed by directly counting the number of 
healthy cells or by measuring a chemical indicator of healthy cells in cell populations [216-
221]. The reagents widely used as chemical indicators are 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyl-2H-tetrazolium bromide (MTT), 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-
tetrazolium-5-carboxanilide (XTT), and 5-bromo-deoxyuridine (BrdU) [218]. The MTT 
assay is based on the metabolism of the yellow tetrazolium salt MTT by mitochondrial 
dehydrogenases of active cells into blue formazan crystals [219]. The XTT assay uses water-
soluble orange XTT crystals whose optical density (OD) can be measured directly by an 
enzyme-linked immunosorbent assay (ELISA) reader, without any preceding solubilization 
[220]. The BrdU assay is based on the incorporation of BrdU as a pyrimidine analogue in 
place of thymidine into the newly synthesized DNA of proliferating cells. BrdU is then 
detected by a monoclonal anti-BrdU-antibody [221]. 
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 Biocompatibility of dopaminergic inorganic-organic hybrid resin films 5.1.3
In this study, we analyzed the biocompatibility of dopaminergic inorganic-organic 
hybrid resin (HR4-DOPA) with respect to the growth and proliferation of HeLa cells. We 
used cell adhesion and cell viability assays to investigate the applicability of the HR4-DOPA 
film for an isolated single-cell array. The cell adhesion assay was performed by manually 
counting the adhered HeLa cells per unit area of 1 mm
2
 in the time-lapse format for 6 h. The 
HeLa cell adhesion on HR4-DOPA was compared with the adhesion on mesoporous 
inorganic-organic hybrid resin (HR4), ECM proteins (i.e., collagen IV and fibronectin), and 
glass. The viability of HeLa cells on HR4-DOPA was measured using the XTT assay after 2-
d incubation. 
 Materials and Methods 5.2.
 Culture of HeLa cells  5.2.1
HeLa cells (Deutsche Sammlung für Mikroorganismen und Zellkulturen GmbH 
[DSMZ], Germany) were cultivated in an incubator at 37°C and 5% CO2. In all the 
experiments, we used RPMI 1640 medium (PAN Biotech GmbH, Germany) supplemented 
with 10% FBS (Sigma-Aldrich) and 2% penicillin/streptomycin (Sigma-Aldrich). Confluent 
cultures of HeLa cells were passaged 1:3 (v/v) every 3 d, using a trypsin/EDTA solution 
(Sigma-Aldrich) for 5 min in an incubator at 37°C and 5% CO2. The cells were washed 3 
times with 400 μl PBS to remove trypsin after centrifugation for 3 min at 200 × g. HeLa cells 
were subsequently resuspended in growth medium to achieve a seeding density of 
1 × 10
6
 cells/80 cm
2
.. 
 Preparation of HR4-DOPA and HR4 film 5.2.2
HR4-DOPA was kindly provided by Prof. Dong-Pyo Kim from Chungnam National 
University, South Korea. HR4-DOPA is a derivative of HR4 and is prepared by replacing 
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catecholic salt with dopamine during chemical synthesis. We used HR4-DOPA and HR4, 
which were from the series of HR-DOPAs (HR1-4-DOPA) and HRs (HR1–4), respectively, 
because they contained the largest amount of the organic compound (PEG-DMA), which 
lessens the brittleness and improves the microfabrication process. HR4-DOPA and HR4 had 
a TEOS:TiCl4:MPTMS:PEG-DMA:dopamine (for HR4-DOPA) or catecholic salt (for HR4) 
molar ratio, respectively, of 1:0.1:0.88:0.416:0.05 [158]. 
Borosilicate glass coverslips (Fisher Scientific, Germany; diameter, 22 mm) were 
cleaned by acetone and subsequently washed with ethanol and deionized water. The slides 
were then dried on a hotplate at 150°C for 10 min. HR4-DOPA was spun on the glass slide at 
3000 rpm for 20 s by using a spin-coater (BLE Laboratory Equipment GmbH, Germany) 
after oxygen plasma treatment at 200 W and 30 mbar for 25 s (Diener Electronic GmbH, 
Germany). These films were cured on a hotplate at 50°C for 5 h and subjected to post-heat 
treatment at 100°C for 2 h, immersed in ethanol for 2 h to remove the surfactants 
incorporated in the material [158], and dried at room temperature (RT).  
 Cell adhesion assay  5.2.3
In preparation for the cell adhesion assay, the adhered HeLa cells were first detached 
using trypsin/EDTA. The HeLa cell suspension was then washed 3 times with 400 μl PBS 
and diluted in PBS to achieve a concentration of 5 × 10
5
 cells/ml. The HeLa cell 
concentration was measured 3 times for each trial by using a CASY cell counter (CASYton; 
Schärfe System GmbH, Germany). The HeLa cell adhesion assay on HR4-DOPA was 
compared with HR4, rat-tail collagen IV (Sigma-Aldrich), human fibronectin (Sigma-
Aldrich), and glass (Fisher Scientific, Germany). All the substrates had a diameter of 22 mm. 
The glass slides were sterilized by immersion in ethanol for 5 min and drying at RT. The 
prepared substrates were put into an untreated polystyrene (PS) 6-well plate (BD Biosciences) 
and positioned at the center of the well. Subsequently, 3.0 × 10
6
 HeLa cells in 3 ml medium 
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were seeded into each well. The samples were cultured at 37°C and 5% CO2 for 15 min, 
30 min, 45 min, 1 h, 3 h, or 6 h. After incubation, non-adherent cells were carefully rinsed 
with PBS 3 times (see Figure 5.5).  
 
Figure 5.5: Procedure for the HeLa cell adhesion assay. 
 
 
Figure 5.6: Observation points for the HeLa cell adhesion assay. The adhered HeLa cells were 
manually counted in 3 different view fields (0.48 mm
2
) from each sample using the grid 
function. The left/right observing point is 11 mm away from the center of the sample.  
 
Images from 3 different view fields (× 10 objectives; area, 0.48 mm
2
) were acquired 
from each sample by using a semi-confocal microscope (IX70, Olympus) mounted with a 
CCD camera (Olympus soft imaging systems, F-View), using the grid function of the cell 
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software package (Olympus). The average number of adhered cells was calculated per 
millimeter square of the image area. All the values indicate the average and the standard error 
of the mean (SEM). 
HeLa cell viability on HR4-DOPA was examined using an XTT cytotoxicity assay kit 
(Sigma-Aldrich), and the viability was compared with that on HR4. The HR4-DOPA- or 
HR4-coated substrates were put into an untreated PS 6-well plate. HeLa cells in 2 ml medium 
were seeded into each well at a cell concentration of 2.0 × 10
6
 cell/ml and were subsequently 
incubated for 48 h at 37°C and 5% CO2. After incubation, XTT reagent (400 μl) was added to 
each well, and the plate was incubated for 8 h. The XTT dye solution (200 μl) was transferred 
from each sample to a 96-well plate. The light absorbance of each sample was measured 3 
times by using an ELISA reader (Tecan Sunrise Plate Reader; Tecan Group Ltd., Switzerland) 
at a wavelength of 450 nm. The XTT reagent is colorless but is converted to a brightly 
colored molecule by the cell’s metabolism, and its light absorbance increases according to the 
cell viability. We used HeLa cells incubated in a well without any substrate as a control; any 
reduction in the light absorbance indicated reduction in cell viability. 
 Statistical analysis 5.2.4
All statistical computations were performed with the GraphPad Prism 5 software 
(GraphPad Software Inc., USA). We compared cell adhesion and cell viability on HR4-
DOPA with that on other substrates. One-way analysis of variance (ANOVA) with P ≤ 0.05 
was considered to be significant, and pairwise comparisons between the substrates were 
conducted using the Tukey-Kramer test with a significance level of 0.05. 
 Results 5.3.
 HeLa cell adhesion assay 5.3.1
HeLa cells were used to study the cell adhesion behaviors on the HR4-DOPA surface 
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because of their biological value for cancer treatment and their robust adherence to surfaces 
that are rendered hydrophilic through the use of microtechniques such as O2 plasma treatment 
or deposition of self-assembled monolayers (SAMs) [39-42, 143]. HeLa cell adhesion was 
monitored by counting the cells adhered on HR4-DOPA in 3 different view fields after 
incubation for 15 min, 30 min, 45 min, 1 h, 3 h, and 6 h. The maximum incubation time was 
6 h because HeLa cell populations exhibited insignificant growth for the first 6 h of 
incubation, with only a 9% increase in the number of cells. The cell morphological features at 
each time point are shown in Table 5.1. HeLa cells firmly adhered to HR4-DOPA and spread 
out on the surface. A larger number of adhered cells were observed as the incubation time 
increased. 
The HeLa cell adhesion behavior on HR4-DOPA was compared with that on HR4 to 
determine the effect of dopamine versus catecholic salt on cell adhesion. ECM proteins (i.e., 
collagen IV and fibronectin) and glass were used as controls for cell adhesion. Collagen IV 
and fibronectin are cell-adhesive ECM proteins and have been used to biologically modify 
surfaces in order to control cell functions such as adhesion, proliferation, and differentiation 
[222]. Glass was also used as a control because it has been shown to have a low cell adhesion 
strength and is commonly used to verify the improved cell adhesive characteristics of a new 
biomaterial [223]. The choice of control substrates was based on the cell adhesion assay of 
Yamamoto et al. [223]. Table 5.2 shows the morphological features of HeLa cells adhered on 
the controls after each time point. One of the 3 different view fields has been shown for each 
sample. 
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Table 5.1: Morphological features of the adhered HeLa cells on HR4-DOPA. The grid size is 
100 × 100 µm
2
.. 
HR4-DOPA Left point Center point Right point 
15 min 
   
30 min 
   
45 min 
   
1 h 
   
3 h 
   
6 h 
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Table 5.2: Morphological features of HeLa cell adhered on the control substrates. The grid size 
is 100 × 10 µm
2
. 
 HR4 Collagen IV Fibronectin Glass 
15 min 
    
30 min 
    
45 min 
    
1 h 
    
3 h 
    
6 h 
    
 
The average number (± SEM) of the HeLa cells adhering to the substrates is summarized 
in Table 5.3 and graphically shown in Figure 5.7. 
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Table 5.3: The number of HeLa cells per millimeter square adhering to the various substrates. 
The values indicate the mean ± SEM values from the 3 different view fields on the sample 
(n = 3). 
Time HR4-DOPA HR4 Collagen IV Fibronectin Glass 
15 min 5.56 ± 1.08 27.78 ± 4.48 15.97 ± 0.62 3.47 ± 0.31 0.69 ± 0.31 
30 min 15.97 ± 1.54 54.17 ± 4.63 27.08 ± 0.46 4.86 ± 0.31 2.08 ± 0.46 
45 min 20.19 ± 2.47 52.78 ± 6.17 53.47 ± 4.48 4.86 ± 0.77 2.78 ± 0.62 
1 h 46.53 ± 4.48 60.42 ± 6.02 77.08 ± 5.09 10.42 ± 1.85 8.33 ± 1.39 
3 h 61.81 ± 5.40 168.06 ± 14.04 216.67 ± 7.41 83.33 ± 2.78 44.44 ± 2.93 
6 h 71.53 ± 4.94 313.20 ± 9.57 275.00 ± 8.80 377.08 ± 26.39 395.14 ± 34.41 
 
 
Figure 5.7: The number of adhered HeLa cells at various incubation times on dopaminergic 
mesoporous inorganic-organic hybrid resin (HR4-DOPA), mesoporous inorganic-organic hybrid 
resin (HR4), ECM protein layers (collagen IV and fibronectin), and glass.  
The cells were incubated at a concentration of 1.0 × 10
6
 cells/ml in 3 ml RPMI 1640 medium 
with 10% FBS at 37°C. The values indicate the average number of the adhered HeLa cells per 
millimeter square, and the vertical bars indicate the standard error of the mean (SEM). The 
asterisks (*) indicates a significant (P value ≤ 0.05) difference between HR4-DOPA and the 
controls. The red asterisks show that cell adhesion on the indicated substrate is significantly 
higher than on HR4-DOPA, while the blue asterisks show that adhesion is significantly less than 
on HR4-DOPA. 
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HeLa cells began to adhere to all substrates even after a short period of incubation, and 
the population gradually increased over time. Comparison with the controls showed that both 
HR4 and collagen IV demonstrated a strong adhesion behavior at all time points, while the 
number of cells remained low for 1 h on fibronectin and for 3 h on glass, and then 
dramatically increased. 
As a reference, HeLa cell harvest density – the maximum number of adhering and 
spreading HeLa cells in a unit area – is approximately 625 cells/mm2, based on the spreading 
area of 1600 ± 500 µm
2
 of the cells when adhered to the substrate [146]. In cell adhesion 
assays, the HeLa cell concentration cannot exceed the harvesting density because over-
proliferated cells are eliminated by self-destruction mechanisms like apoptosis, during which 
cells develop abnormal phenotypes [151]. Among all the substrates tested, the maximum 
number of adherent HeLa cells was ~395 cells/mm
2
 (i.e., 60.7% of the harvest density) on the 
glass substrate after 6 h.  
On the HR4-DOPA film, the number of adhered HeLa cells increased until 1 h, after 
which the growth rates remained low. Therefore, the HeLa cells on HR4-DOPA were 
significantly lower in number than on HR4 after 3 h, collagen IV after 1 h, and all controls at 
6 h. HR4-DOPA and HR4 share the same chemical compositions, with dopamine in place of 
the catecholic salt in HR4; however, we found a significant difference between the number of 
cells adhered to HR4-DOPA and HR4 after 3 h of incubation (P ≤ 0.05). The number of cells 
adhered to HR4-DOPA was comparable to that for collagen IV at 45 min and fibronectin at 
1 h (P > 0.05). HR4-DOPA showed a better cell adhesion performance than glass until 3 h, 
but the result was only significant at 45 min and 1 h. In contrast, glass exhibited significantly 
higher cell adhesion than HR4-DOPA at 6 h. 
 HeLa cell viability assay 5.3.2
The viability of HeLa cells on HR4-DOPA was assessed using XTT in vitro toxicology 
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assays after disturbance-free incubation for 48 h and was compared to viability on HR4, 
whose biocompatibility had been previously proved by implanting an HR4-coated 
poly(ethylene terephthalate) (PET) disc in mice for 12 weeks [158]. Table 5.4 shows the light 
absorbance in the XTT assay of the samples. Average values and standard deviations (SDs) 
were obtained from 3 different measured values. The blank contained XTT reagent alone, 
without any cells in the well. The light absorbance of the control was 1.432, indicating 100% 
viability of the cells. The cell viability was 86.1% for HR4-DOPA and 134.3% for HR4, 
based on the control. In this experiment, HeLa cell viability was not negatively affected by 
HR4-DOPA. The difference between the light absorbance of HR4-DOPA and the control was 
not significant (P > 0.05), despite a lower cell viability on HR4-DOPA. However, the 
viability of HeLa cells on HR4 was significantly higher than that on the others (P ≤ 0.05).  
Table 5.4: Light absorbance of the XTT reagent for HeLa cell viability for HR4-DOPA and 
HR4. The blank contained XTT reagent alone, without any cells in the well. The positive 
control consisted of XTT reagent plus HeLa cells cultured in medium without substrate. 
Sample 
Light absorption 
(1) 
Light absorption 
(2) 
Light absorption 
(3) 
Mean ± SD 
Blank 0.204 0.142 0.229 0.192 ± 0.033 
HeLa, control 1.421 1.455 1.420 1.432 ± 0.015 
HeLa, HR4-DOPA 1.217 1.260 1.224 1.234 ± 0.018 
HeLa, HR4 1.660 1.689 2.420 1.923 ± 0.331 
 
 Discussion 5.4.
 HeLa cell adhesion assay 5.4.1
In the HeLa cell adhesion assay, HR4 exhibited a better cell-adhesive performance than 
HR4-DOPA over the entire time range from 15 min to 6 h, whether the differences were 
significant or insignificant. Therefore, we studied the adhesion of HeLa cells in terms of the 
wettability of the substrate and the effect of dopamine on the substrate. We also examined the 
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effect of cell culture conditions and cell treatment methods on cellular adhesion. 
 Effect of wettability on HeLa cell adhesion 5.4.1.1
The water contact angle, which is associated with wettability, of HR4-DOPA was 
62.08°± 1.90° (mean ± SD, n = 5), as described in Chapter 4. The wettability of HR4-DOPA 
is lower than that of HR4, which has a water contact angle of 49° [158], but it was in the 
range of moderate wettability for cell adhesion, i.e., 40–70° [51, 88]. However, the optimal 
water contact angle is ~50° for HeLa cell adhesion [51], which suggests that HR4-DOPA is 
inferior to HR4 for HeLa cell adhesion, at least with regard to wettability. 
 Effect of dopamine on HeLa cell adhesion 5.4.1.2
In Chapter 4, we discussed the use of dopamine rather than catecholic salt in cellular 
substrates to achieve long-term stability of silane-coupling agents in aqueous environments. 
Although the dopamine-based polymer exhibited cell-adhesive characteristics for even non-
adherent cells [186], HR4-DOPA demonstrated inferior adhesion of HeLa cells compared to 
that for HR4 and the controls used in this study. The disadvantage of using HR4-DOPA for 
cell adhesion might be caused by the dopamine in the medium. Moshkov et al. [224] verified 
that the dopamine in the cell culture medium highly regulated cell adhesion and viability in a 
dose-dependent manner. When the dopamine concentration in the medium was higher than 
10
–4
 M, there was a negative effect on cell adhesion due to changing the cytoplasmic globular 
actin of the cells as shown in Figure 5.8. The amount of dopamine in the medium, which 
may have been released from the HR4-DOPA film containing 1.03 mol% dopamine, should 
be investigated to better understand the negative effect of dopamine on cell adhesion. 
Changing the molar ratio of HR4-DOPA may improve the long-term stability of the substrate 
by controlling the concentration of dopamine in the cell culture medium (i.e., ≤ 10–5 M [224]). 
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Figure 5.8: Morphological features of BHK-21 cells after treatment with various concentrations 
of dopamine [224].  
(a) Dopamine affects the cells adhering to the substrate for 48 h: [A] control, [B] 10–5 M, [C] 
10–4 M, and [D] 10–3 M. Scale bars, 100 µm. 
(b) Dopamine affects the cells adhering to the substrate for 72 h: [A] control, [B] 10–5 M, and 
[C] 10–4 M. Scale bar, 100 µm. 
 
 Conditions of the cell culture medium 5.4.1.3
The adhesion behavior of the cells depends not only on the coated surfaces but also on 
the culture conditions [222]. The amount of serum in cell culture medium is one of the 
important parameters for regulating cellular behavior [88, 92, 163, 168, 172, 174-178, 180]. 
Serum (e.g., FBS or fetal calf serum [FCS]) is commonly used as a supplement to cell culture 
media at a concentration of 10% of the total volume and provides a broad spectrum of 
macromolecules, carrier proteins for lipoid substances and trace elements, attachment and 
spreading factors, low molecular weight nutrients and hormones, and growth factors [225]. 
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Moreover, ECM proteins in the serum – mainly fibronectin and vitronectin – are adsorbed in 
advance onto surfaces and these regulate cell adhesion, proliferation, and migration [88, 92, 
163, 168, 172, 174-178, 180]. 
 
Figure 5.9: Adsorption of fibronectin from serum solutions in relation with cell-spreading 
activity and cell adhesion [165]. In all the experiments, pairs of tissue culture dishes were 
treated with human serum at the concentrations indicated in the buffers shown, for 10 min at 
22°C. At the end of the incubations, the dishes were rinsed and fixed. 
(a) Fibronectin adsorption and cell-spreading activity with respect to serum concentration in 
media. The amount of plasma fibronectin adsorption was determined by the indirect 
antibody assay (left axis), and cell-spreading activity was determined by visually estimating 
the percentage of well-spread cells: 5–35% (1+), 40–60% (2+), 65–85% (3+), and 90–100% 
(4+) (right axis). The amount of adsorbed plasma fibronectin increased by 0.1% and later 
decreased as the serum concentration increased. 
(b) Cell adhesion with respect to serum concentration in media. The highest cell adhesion was 
seen in all media supplemented with 0.1% serum. 
The process of cell adhesion occurs in two main steps: (1) serum proteins such as 
fibronectin and vitronectin are adsorbed onto the surface, as shown in Figure 2.6 (b); and (2) 
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cells subsequently attach to the pre-adsorbed proteins by focal cell adhesion, as shown in 
Figure 5.2. However, the amount of serum in the medium plays a primary role in the pre-
adsorption rate of the cell-adhesive ECM proteins, thereby affecting cell adhesion [165]. The 
optimal amount of serum in medium is 0.1% for fibronectin adsorption, cell spreading, and 
cell adhesion, as shown in Figure 5.9. 
Table 5.5: Effect of the serum in the medium on the adhesion and proliferation of RIN-5F cells 
on various ECM proteins by comparing two different culture conditions: in serum-free medium 
(RPMI 1640) or in serum medium (RPMI 1640 with 10% FBS). The cells were cultured for 8 h 
at 37°C and 5% CO2. 
 Fibronectin Vitronectin Laminin 
Serum-free 
medium 
   
Serum  
medium 
   
 Collagen I Collagen II Collagen IV 
Serum-free 
medium 
   
Serum  
medium 
   
 
Moreover, the existence of serum in the medium also regulates cell spreading and cell 
adhesion, even on the cell-adhesive ECM proteins. Proteins generally utilized for surface 
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modification of biomaterials are fibronectin, vitronectin, laminin, collagen I, collagen II, and 
collagen IV [222], as shown in Table 5.5. The serum in the medium regulated cell adhesion 
and cell proliferation on fibronectin; the fibronectin-coated surface had some positive effects 
on cell spreading only in serum-free medium. In contrast, the effect of laminin, collagen I, 
collagen II, and collagen IV on cell adhesion and proliferation was independent of the 
existence/absence of serum.  
In conclusion, the serum in the culture medium regulates the adsorption of the cell-
adhesive ECM proteins (i.e., fibronectin and vitronectin) and cell behaviors (i.e., cell 
adhesion, spread, and proliferation), even on fibronectin. Therefore, a more detailed 
investigation of the concentration of FBS in the medium is required to explain the effects of 
FBS on the cell adhesion to HR4-DOPA. 
 Settling time of HeLa cells 5.4.1.4
For the cell adhesion assay, HeLa cells were seeded at a cell density of 
1.0 × 10
6
 cells/ml in a 6-well plate and cultivated in RPMI 1640 (3 ml) supplemented with 10% 
FBS at 37°C. The settling time of HeLa cells, that is, the time taken for the cells in 
suspension to completely settle onto the bottom of the plate and begin to adhere to the surface, 
was 316.7 s (i.e., ~5 min) under these culture conditions (see Table 3.14). Although the cell 
adhesion was postponed because of the settling time required, the cells still had sufficient 
time to adhere to the substrates, even for the minimum culture time of 15 min. 
 Cell fixation 5.4.1.5
While obtaining images in different view fields for a single sample, we noticed that the 
morphological features of the adhered HeLa cells in the other samples continuously changed. 
Therefore, only a few images (i.e., 3 per sample) could be acquired before this morphological 
change was noticed, due to the time required to load/unload the samples and position the 
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fields of view. We attempted to fix the cells by ethanol or paraformaldehyde at the end of the 
treatment time [226, 227] because this would give us enough time to obtain a larger number 
of images (≥ 100); however, this method was inappropriate for our experiment because the 
cells died after fixation [226]. 
 HeLa cell viability assay 5.4.2
The viability of HeLa cells was 86.1% on HR4-DOPA, and this value did not differ 
significantly on the control substrate. However, the minimum viability of HeLa cells on HR4-
DOPA cannot be disregarded because dopamine can deplete various cancer cells and might 
play a role as an anti-tumor agent in clinical treatment [228-230]. Additionally, dopamine is a 
catecholamine neurotransmitter in humans and an important molecule bridging the nervous 
and immune systems by controlling movement; endocrine regulation; and cardiovascular, 
renal, and gastrointestinal functions [231-234]. HR4-DOPA should be additionally tested 
using a normal mammalian cell line in order to confirm the viability for the cells. 
 Conclusion 5.5.
The biocompatibility of dopaminergic inorganic-organic hybrid resin (HR4-DOPA) for 
HeLa cells was investigated using cell adhesion and cell viability assays.  
The cell adhesion assay of HR4-DOPA was performed by manually counting the 
adhered HeLa cells per unit area in the time-lapse format for 6 h in RPMI 1640 supplemented 
with 10% FBS and compared with mesoporous inorganic-organic hybrid resin (HR4), ECM 
proteins (i.e., fibronectin, collagen IV), and glass. On the HR4-DOPA film, the number of 
adhered HeLa cells increased until 1 h, after which the growth rates remained low. Thus, 
HeLa cells adhering to HR4-DOPA were significantly less than those adhering to HR4 after 
3 h, collagen IV after 1 h, and all controls at 6 h. Both HR4-DOPA and HR4 share the same 
chemical compositions, except that HR4-DOPA contains dopamine in place of the catecholic 
 １１９ 
salt in HR4. The dopamine in HR4-DOPA led to poor cell adhesion performance at all time 
points; however, the differences between HR4-DOPA and HR4 were not significant until 
after 3 h of incubation (P ≤ 0.05). During the initial phase of cell adhesion, the adhesion for 
HR4-DOPA was comparable to that for collagen IV for 45 min and fibronectin for 1 h 
(P > 0.05). 
The water-contact angle of HR4-DOPA (62.08°) was in the moderate wettability range 
for cell adhesion (i.e., 40–70°), but the optimal value for HeLa cell adhesion was ~50°, which 
indicated that the HR4 film (water-contact angle, 49°) was more suited for HeLa cell 
adhesion than HR4-DOPA. Dopamine helped achieve long-term stability of a silane-coupling 
agent in HR4-DOPA, but the dopamine in the medium, perhaps released from HR4-DOPA, 
might weaken the HeLa cell adhesion. The FBS in the medium also regulates not only the 
amount of the cell-adhesive ECM protein adsorption but also cell adhesion and proliferation 
on even the pre-adsorbed proteins. Therefore, a proper FBS concentration is required for 
optimal conditions in the cell adhesion assay on the HR4-DOPA film. HeLa cells required the 
settling time of ~5 min for settling and adhering to the substrates, but the time was given to 
the cells enough time for adhesion, even for the minimum culture time of 15 min. 
The HeLa cell viability for HR4-DOPA was assessed using XTT assays after 2-d 
incubation, and viability was compared to that on HR4. The HeLa cell viability of HR4-
DOPA was 86.1% that for the control. While this cell viability is not significantly less, the 
minimum viability cannot be disregarded because dopamine might act as an antitumor agent. 
Both the cell adhesion and viability assay results sufficiently support the 
biocompatibility of HR4-DOPA and demonstrate its applicability for an isolated single-cell 
array as a function of cell-adhesive material.  
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 A Microwell Array Coated by Dopaminergic Chapter 6. 
Mesoporous Inorganic-organic Hybrid Resin 
Film 
 Introduction 6.1.
 Requirement of a microwell array for drug discovery 6.1.1
Cell models in conventional in vitro cell-based screening continue to provide misleading 
data that are not necessarily representative of in vivo responses due to the presence of slightly 
different cellular environments in in vitro assays [8, 18-21]. Uniform cellular environments 
are required during the early discovery process in order to increase the reliability of cellular 
response analyses and to benefit economically from the small-scale nature of such assays [8, 
19]. 
To allow highly accurate measurement of cellular responses to a drug, researchers have 
used microfabrication techniques to provide a uniform cellular environment and mimic in 
vivo functions [4, 8, 19, 27, 29, 30]. Moreover, microarrays of individual living cells may 
facilitate elucidation of the biological effects of a drug on a single cell by eliminating 
multiplexing and complicated cell-cell contact and communications interferences that conceal 
direct and accurate correlations between cells and stimuli, thereby providing large amounts of 
information regarding cellular chemistry at the molecular level [20, 24, 27]. By spatially 
arranging isolated single cells, a sufficient number of cells can be quantitatively analyzed to 
draw valid conclusions, rather than interpreting individual cell variation as noise due to cell 
population heterogeneity [23, 27, 28, 54, 55]. Since quantitative measurements of cellular 
responses rely on the number of cells exposed to external stimuli, small chip-to-chip 
variations in the arrayed isolated single cells may allow for more accurate quantification of 
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the effects of anticancer drugs on cancer cells [59].  
Single-cell microarrays are generally developed using planar cell adhesive patterns; 
however, conventional 2D cultures are often subject to loss of native cell morphology and 
functionality [34, 35]. Compared to 2D cultures, 3D in vitro cell models provide a more 
realistic cellular environment and permit the reproduction of in vivo cellular phenotypes, such 
as those related to metabolism and function, including morphogenesis, gene expression, and 
differentiation [36, 37]. Therefore, microwells containing single cells are required in order to 
preserve the native cell morphology and functionality in 3D in vitro cell models for drug 
discovery. 
 Limitations of the previous microwell arrays 6.1.2
Microwells to trap single cells are generally fabricated of poly(dimethylsiloxane) 
(PDMS) because this material enables numerous replications at both micro- and nanometer 
scales from micro- and nanofabricated molds with high precision [38, 112, 114, 117, 118]. 
However, the cytophobic properties of PDMS do not allow for cellular adhesion; this may 
adversely affect the natural behaviors of anchorage-dependent cells, which can survive only 
when they adhere to appropriate substrates, due to the absence of supporting cells, 
extracellular matrix, and growth factors [38]. Therefore, the ability of microwells to maintain 
the native 3D morphology of anchorage-dependent cells can only be achieved when the inner 
surface of the microwell is conducive for cell adhesion. 
Ochsner et al. [111] fabricated a cell-adhesive surface inside microwells of plasma-
treated PDMS adsorbed with cell-adhesive fibronectin. However, this methodology was 
problematic both because the PDMS surface should be immediately immersed in an aqueous 
solution (i.e., water, methanol, or trifluoroethanol) after plasma treatment to preserve its 
bioactive characteristics [62, 235], and because fibronectin can be easily degraded [236]. 
Additionally, Leong et al. [70] fabricated microwells coated with a cell-adhesive self-
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assembled monolayer (SAM); however, only the bottom of the microwells, not the walls, 
were coated with the SAM, creating an unpredictable native 3D cellular morphology in 
anchorage-dependent cells. Broderick et al. [71] fabricated 3D polyurethane-based microwell 
cell culture arrays; the inside surfaces of the wells were functionalized to promote cell 
adhesion, while the plateaus of wells were functionalized to resist cell adhesion. Although 
this method appeared promising, the process for selectively functionalizing the inner surfaces 
of the microwells and plateaus proved to be quite complicated. 
 Dopaminergic mesoporous inorganic-organic hybrid resin 6.1.3
A dopaminergic mesoporous inorganic-organic hybrid resin (HR4-DOPA) was modified 
from a mesoporous inorganic-organic resin (HR4) for long-term stability with the help of 
dopamine to preserve the fabricability of HR4 for micro- or nano-engineering [47, 237], as 
described in Chapter 4. Moreover, the biocompatibility of HR4-DOPA for HeLa cells was 
also demonstrated by cell adhesion and cell viability assays in Chapter 5. In this study, we 
used the biocompatible HR4-DOPA film to create an adhesive inner surface in microwells. 
 A microwell array coated by dopaminergic inorganic-organic hybrid resin film 6.1.4
In this study, we sought to fabricate a microwell array for single cell analysis that could 
preserve the native 3D morphology and functionality of HeLa cells by creating microwells 
with a cell-adhesive inner surface. We designed square microwells (size, 25 × 25 µm
2
) with 
various depths (e.g., 10, 25, and 40 µm). The PDMS substrate containing the microwell 
arrays was fabricated by soft lithography, and the inner surfaces of the microwells were 
functionalized to promote cell adhesion using microcontact printing. Finally, we optimized 
the technology (i.e., cell concentration and physical dimensions of the microwells) for HeLa 
cells by examining single-cell occupancy of the microwells after live-cell staining, allowing 
us to comment on whether this technology may be developed further as a mimic in vivo 
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microfluidic device for high-throughput single-cell-based assays. 
 Materials and methods 6.2.
 Fabrication of a replica-micromolding master for soft lithography 6.2.1
Silicon wafers (diameter, 100 mm; Si-mat, Kaufering, Germany) were used as a 
substrate for construction of a replica-molding master. The wafers were baked on a hot plate 
at 160°C for 20 min to remove moisture and treated with oxygen plasma at 200 W for 180 s 
(Pico, Diener electronic GmbH, Ebhausen, Germany).  
 
Figure 6.1: Fabrication process for the SU-8 micromolding master for soft-lithography. 
 
A negative SU-8 10 photoresist (PR; MicroChem Corp., Newton, MA, USA) was used 
to construct a 10- or 25-µm thick replica-molding master. SU-8 10 was spread at 500 rpm for 
10 s and then spun at 3000 or 1160 rpm for 30 s to yield feature heights of 10 or 25 µm, 
respectively. Immediately after spinning, each wafer was placed on a 65°C hot plate for 2 or 
3 min, according to the feature height. The temperature of the hot plate was then increased to 
95°C at 5°C/min, held at 95°C for 5 or 7 min, respectively, and lowered back to room 
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temperature. The wafers were then exposed to UV at 375 mJ/cm
2
 on a mask aligner (MA6, 
SUSS MicroTec AG, Garching, Germany) on a dark-field mask (Photo Data Ltd., Hitchin, 
UK), with high vacuum contact between the wafer and the mask, for 32 or 37.5 s, 
respectively. The wafers were placed on a 65°C hot plate for 1 min, and the temperature was 
raised to 95°C at 5°C/min, held at 95°C for 3 or 5 min, respectively, and cooled to room 
temperature (RT). Next, the substrates were immersed in SU-8 developer (mr-Dev 600, 
Micro Resist Technology GmbH, Berlin, Germany) for 3 or 5 min, respectively, to remove 
unexposed portions of the SU-8 10 PR. 
A negative SU-8 2050 PR (MicroChem Corp.) was used to create a 40-µm-thick replica-
molding master. SU-8 2050 was spread at 500 rpm for 10 s and then spun at 4000 rpm for 
30 s to yield feature heights of 40 µm. Immediately after spinning, each wafer was placed on 
a hot plate at 65°C for 3 min, and the temperature was raised to 95°C at 5°C/min, held at 
95°C for 7 min, and lowered back to RT. The wafers were then exposed to UV on the mask 
aligner on a dark-field mask, with high vacuum contact between the wafer and the mask, for 
25.9 s. The wafers were placed on the hot plate at 65°C for 2 min, and the temperature was 
raised to 95°C at 5°C/min, held at 95°C for 5 min, and cooled to RT. Next, the substrates 
were immersed in SU-8 developer (mr-dev 600; Micro Resist Technology GmbH, Germany) 
for 5 min to remove unexposed portions of the SU-8 2050 PR. 
Table 6.1: Fabrication specifications for construction of negative SU-8 photoresists with 
various thicknesses. 
PR (thickness) Spin-coat Soft bake UV exposure Post bake Development 
SU-8 10 
(10 µm) 
500 rpm, 3 s 
3000 rpm, 30 s 
65°C, 2 min 
95°C, 5 min 
375 mJ/cm
2
 
32 s 
65°C, 1 min 
95°C, 3 min 
3 min 
SU-8 10 
(25 µm) 
500 rpm, 3 s 
1160 rpm, 30 s 
65°C, 3 min 
95°C, 7 min 
375 mJ/cm
2
 
37.5 s 
65°C, 2 min 
95°C, 5 min 
5 min 
SU-8 2050 
(40 µm) 
500 rpm, 3 s 
3000 rpm, 30 s 
65°C, 3 min 
95°C, 7 min 
375 mJ/cm
2
 
25.9 s 
65°C, 2 min 
95°C, 5 min 
5 min 
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Images of the fabricated microstructures were obtained by scanning electron microscopy 
(JSM-6400F; JEOL GmbH, Germany) after deposition of a thin Pt film over the 
microstructure surface using a sputter coater (K675X; EMITech Inc., Fall River, MA, USA). 
 Fabrication of a microwell coated by dopaminergic mesoporous inorganic-6.2.2
organic hybrid resin 
The SU-8 microstructure masters were exposed to a trichloro (1H,1H,2H,2H-
perfluorooctyl) silane (CF3(CF2)5CH2CH2SiCl3; Sigma-Aldrich, St. Louis, MO, USA) vapor 
at 60 mbar for 3 h. This step rendered the exposed silicon surface highly inert, which 
facilitated the release of the PDMS mold (Sylgard 184; Dow Corning GmbH, Wiesbaden, 
Germany) after curing. Then, we used soft lithography methods to fabricate a microwell array 
of PDMS. Briefly, a PDMS oligomer was mixed with a cross-linker at a 10:1 volume ratio, 
degassed, and poured onto the master. PDMS was cured in a convection oven at 65°C for 3 h 
after a second degassing. The cured PDMS, shaped to the microwell array, was manually 
detached from the master. 
HR4-DOPA, diluted with 5 wt% ethanol, was spun on the microwell array-shaped 
PDMS substrate at 3000 rpm for 30 s after oxygen plasma treatment at 7 W for 30 s. The 
coated film was cured on a hotplate at 50°C for 5 h and subjected to postheat treatment at 
100°C for 2 h. To passivate the plateau of the microwell arrays with a cell-repellent PDMS 
layer, we used a microcontact printing method. The PDMS/cross-linker mixture was diluted 
to 10 wt% by tert-butyl alcohol (TBA; (CH3)3COH, Alfa Ä sar GmbH, Karlsruhe, Germany) 
prewarmed at 35°C, subjected to thorough manual mixing, and spun on a glass slide (size, 
22 × 40 mm
2
; Carl Roth GmbH, Karlsruhe, Germany) at 6000 rpm for 5 min. The HR4-
DOPA-coated PDMS microstructures were stamped upside down for 30 s on glass slide 
coated with the diluted PDMS layer and then immediately detached and cured on hot plate at 
65°C for 3 h. This fabrication process for the single-cell microwell array is shown in Figure 
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6.3. The HR4-DOPA-coated microwells were arrayed in a 500 × 500 µm
2
 area, obtained by 
cutting the boundaries of an 8-array area (2 × 2 mm
2
) with a sharp knife, immersed in ethanol 
for 2 h in order to eliminate the incorporated surfactants [158], and dried at RT.  
 
Figure 6.2: Fabrication process for the PDMS microwell array. 
 
The depths of the microwells were profiled using a noncontact laser 3D scanning 
profilometer (µscan explorer; Optoelektronische Messtechnik GmbH, Ismaning, Germany). 
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Figure 6.3: Fabrication process for the PDMS microwell array coated with cell-adhesive HR4-
DOPA on the inner surface of the microwells. 
 
 Culture of HeLa cells 6.2.3
HeLa cells (Deutsche Sammlung für Mikroorganismen und Zellkulturen GmbH 
[DSMZ], Braunschweig, Germany) were cultivated in an incubator at 37°C and 5% CO2. In 
all experiments, we used RPMI 1640 medium (PAN Biotech GmbH, Aidenbach, Germany) 
supplemented with 10% fetal bovine serum (FBS, Sigma-Aldrich) and 2% penicil-
lin/streptomycin (Sigma-Aldrich) without phenol red. Confluent cultures of HeLa cells were 
passaged every 3 days by treatment with a trypsin/EDTA solution (Sigma-Aldrich) for 5 min 
at 37°C with 5% CO2. Cells were centrifuged for 3 min at 200 × g and then washed 3 times 
with 400 μl PBS to remove residual trypsin. HeLa cells were subsequently resuspended in 
growth medium to achieve a seeding concentration of 1 × 10
6
 cells/80 cm
2
. 
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 HeLa cell occupancy of a microwell array 6.2.4
For the preparation of single-cell occupancy in the microwell array, adhered HeLa cells 
were first detached using trypsin/EDTA as described above. The HeLa cell suspension was 
then washed 3 times with 400 μl PBS and diluted in PBS to achieve a concentration of 
0.5 × 10
6
, 1.0 × 10
6
, or 2.0 × 10
6
 cells/ml. The HeLa cell concentration was measured 3 times 
for each trial using a CASY cell counter (CASYton, Schärfe System GmbH, Reutlingen, 
Germany). 
 
Figure 6.4: The HeLa cell occupancy experiment in the microwell array. 
 
Next, HeLa cell occupancies were assessed at the various microwell depths (i.e., 10, 25, 
and 40 µm). The microwell arrays were sterilized by immersion in ethanol for 5 min and then 
dried at RT. Each prepared array was placed into an untreated PS 6-well plate (BD 
Biosciences, San Jose, CA, USA) and positioned at the center of the well. Subsequently, 
HeLa cells in 3 ml medium were seeded into each well. All samples were cultured for 6 h at 
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37°C with 5% CO2. After incubation, nonadherent cells were carefully rinsed in PBS 3 times. 
In order to identify adhered live cells in the microwells, the cells were stained with 
10 µM 5(6)-carboxyfluorescein diacetate n-succinimidyl ester (CFSE; Molecular Probes, 
Invitrogen Detection Technologies, Karlsruhe, Germany) for 30 min at 37°C with 5% CO2. 
After staining, the cells were rinsed twice with PBS to remove excess CFSE that diffused out 
of the cells, and cell occupancy was analyzed by cell counting in 6 different microwell arrays 
using ImageJ software (version 1.45; http://rsbweb.nih.gov/ij/). 
 Results 6.3.
 Design of a microwell array 6.3.1
The physical dimensions of the microwells were designed to achieve high single-cell 
occupancy. Square microwells measured 25 × 25 µm
2
 in size, slightly larger (by 
approximately 10 µm) than the diameter of a HeLa cell (16.17 ± 2.4 µm) [38, 70, 80, 118-
120], as previously described in Chapters 2 and 3. The depths of the microwells (i.e., 10, 25, 
and 40 µm) were also investigated in order to fully characterize the physical dimensions of 
the microwells. 
The microwells were arranged in an array resembling a chess pattern in order to increase 
the microwell density per unit area since shorter distances and diffusion times for molecules 
and cells are more suitable for time-efficient, accurate analyses, especially in high-throughput 
applications [27, 55]. Moreover, cell number is critical for quantitative measurements; 
conventionally, 10,000 cells are used for single-cell analysis [54]; however, some single-cell 
analysis techniques have assessed as few as 1000 single cells to provide adequate sets of data 
[55]. Therefore, in our study, the total number of microwells on the 8 arrays was 1,600 (each 
array measured 500 × 500 µm
2
, with a total area of 2 × 2 mm
2
). In the array, 200 microwells 
were placed between passivated areas of the same size in order to facilitate easy calculation 
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of single-cell occupancy (see Figure 6.5). The passivation areas were positioned in such a 
way as to demonstrate the existence of the cell-adhesive HR4-DOPA film inside the 
microwells through comparison of two controls: one coated with the HR4-DOPA film on the 
entire surface and the other with an untreated PDMS surface. 
 
Figure 6.5: Microwell arrays in an area of 2 × 2 mm
2
. This area contained a total of 8 arrays, 
and each array (area, 500 × 500 µm
2
) contained 200 microwells (size, 25 × 25 µm
2
 each). 
 
 Fabrication of a microwell array 6.3.2
The PDMS substrate containing the microwell array was fabricated using soft 
lithography, and a cell-adhesive surface, coated with the HR4-DOPA film, was created using 
microcontact printing. 
 Fabrication of a replica-micromolding master 6.3.2.1
We used oxygen plasma treatment to clean the silicon wafers by ashing organic 
contamination and to increase the surface contact strength between SU-8 PRs and substrates. 
Hexamethyldisilazane (HMDS) and MCC primer 80/20 (MicroChem Corp.) are widely used 
in the MEMS processes to improve the adhesion of SU-8 PRs to oxides, i.e., glass or silicon 
dioxide (SiO2); however, as shown in Figure 6.6, the SU-8 microstructures were easily 
detached when the microstructured wafers were overdeveloped by SU-8 developer or when 
the developed structures were rinsed with isopropyl alcohol in this study. 
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Figure 6.6: Detached SU-8 microstructures on the MCC primer 80/20-coated silicon substrate 
after development. Red circles show the locations of SU-8 microstructure detachment, which 
occurred despite their size (100 × 100 µm
2
). 
 
The fabricated replica-micromolding master containing 25-µm-high SU8 microstruc-
tures is shown in Figure 6.7. The SU-8 films were spun and patterned on the oxygen plasma-
treated silicon wafer. 
 
Figure 6.7: Scanning electron microscope images of the fabricated replica-micromolding 
master containing the array of 25-µm-high SU-8 structures shaped in 25 × 25 µm
2
 squares. 
 
 Fabrication of a microwell array coated by dopaminergic inorganic-organic 6.3.2.2
hybrid resin (HR4-DOPA) film  
The PDMS substrate containing the microwell features had a thickness of approximately 
1.3 mm after coating the wafer (100 mm in diameter) with 10 ml PDMS in order to increase 
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the softness and allow easy removal of air bubbles within the microwell plateau during 
microcontact printing passivation by a thin cytophobic PDMS layer. HR4-DOPA was diluted 
and spun on the oxygen plasma-treated PDMS substrate. Oxygen plasma treatment of PDMS 
was assessed for production of a silicate layer and the ability to react with the HR4-DOPA 
layer using covalent siloxane coupling [47]. HR4-DOPA was diluted to 5 wt% with ethanol 
in order to reduce the thickness of the spin-coated HR4-DOPA film on the surface to the 
nanometer scale (i.e., approximately 2 nm) and to decrease changes to the inner dimensions 
of the microwells [158]. 
 
Figure 6.8: Pattern transfer failure of the liquid PDMS layer (thickness, 5 µm). 
(a) The pressure applied in microcontact printing caused the flow of the liquid PDMS layer into 
the microwells. 
(b) Photomicrographs of 25-µm-deep microwell arrays filled with PDMS in microcontact 
printing. 
 
The plateau of the microwell array was biologically passivated by the PDMS layer using 
the microcontact printing method. The liquid PDMS layer was sandwiched between the 
plateaus of the micromold and a flat substrate, and pressure was applied to the PMDS layer; 
the pressure applied caused the flow of the voluminous liquid PDMS layer (approximately 
 １３４ 
5 µm thick, which was the minimum achievable thickness for 100% PDMS when spun at 
6000 rpm for 5 min [238]) into the microwells (see Figure 6.8). Therefore, the thickness of 
the liquid PDMS layer should be reduced to permit high reproducibility of pattern transfer in 
microcontact printing. 
When PDMS is diluted with TBA at different concentrations, the thicknesses of the 
spin-coated layers change as a function of spin speed [238], as shown in Figure 6.9. 
Therefore, we diluted PDMS by 10% with TBA to obtain a thickness of less than 1 µm, 
thereby eliminating the formation of PDMS-filled microwells during microcontact printing. 
The melting point of TBA is 25°C, and thus, the TBA solution should be prewarmed at 35°C 
before use. 
Photomicrographs of the HR4-DOPA film coated on the inside surface of the microwells, 
including both laser surface and line plot profiles, are shown in Figure 6.10; these data 
indicated that 25-µm-deep microwells were formed from SU-8 10 PR spun at 1160 rpm. 
 
Figure 6.9: Thickness of the PDMS films at various concentrations of PDMS in tert-butyl 
alcohol (TBA) as a function of spin speed [238]. All substrates were spun for 5 min. 
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Figure 6.10: The fabricated microwell array coated with dopaminergic inorganic-organic 
hybrid resin (HR4-DOPA) on the inner surface of the microwells. The plateaus of the 
microwells were passivated by the cytophobic PDMS layer using microcontact printing. 
(a) Photomicrographs of the 25-µm-deep microwell arrays coated with HR4-DOPA on the inner 
surface of the microwells. 
(b) Laser surface and line plot profiles indicate that the microwell array is 25 µm deep. The 
sharp peak is noise from the boundary of the microwell and the plateau. 
 
 HeLa cell adhesion on the controls 6.3.3
In order to verify the fabrication processes, i.e., the deposition of HR4-DOPA film using 
spin coating and the passivation of microwell plateaus by the cytophobic PDMS layer using 
microcontact printing, we examined two controls. One was a positive control coated with 
HR4-DOPA film on the entire surface, while the other was a negative control having an 
untreated PDMS surface. Cell adhesion assays were conducted for both of the controls by 
seeding HeLa cells (cell density, 1.0 × 10
6
 cells/ml) and incubating for 3 h. For the positive 
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control, HeLa cells adhered to the plateaus coated with the HR4-DOPA film, as well as the 
inner microwells. In contrast, adhered HeLa cells were not observed on any surface in the 
negative control. 
 
Figure 6.11: HeLa cell adhesion on the control surfaces. HeLa cells were cultured for 3 h at an 
initial seeding concentration of 1.0 × 10
6
 cell/ml. The cells were stained green with 5(6)-
carboxyfluorescein diacetate n-succinimidyl ester (CFSE). All images depict overlapped 
fluorescent photomicrographs.  
(a) Photomicrographs of a positive control coated with HR4-DOPA on the entire PDMS surface 
after oxygen plasma treatment. [A] The image was taken at 3× magnification. [B] The image 
was taken at 10× magnification. 
(b) Photomicrograph of a negative control having an untreated PDMS surface. The image was 
taken at 3× magnification. 
 
 HeLa cell occupancy of a microwell array 6.3.4
To investigate the optimal cell density for preparation of the single-cell microwells, we 
used a narrow range of cell concentrations, testing 0.5 × 10
6
, 1.0 × 10
6
, and 2.0 × 10
6
 cells/ml. 
A previous study suggested that a cell concentration of 1.0  106 cells/ml was optimal for 
isolated single-cell arrays; however, 10-fold increments (i.e., 1 × 10
5
, 1 × 10
6
, and 
1 × 10
7
 cells/ml) were used, rather than our 2-fold increments in the current study [114].  
For all experiments, we used a cell incubation time of 6 h because these cell populations 
were shown to exhibit insignificant growth during the first 6 h of incubation, with only a 9% 
increase in the number of cells during this time, as described in Chapter 3. After this 
incubation, HeLa cell occupancies were investigated in terms of cell concentrations for each 
depth (i.e., 10, 25, and 40 µm). 
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Table 6.2: Microwell arrays (size, 25 × 25 µm
2
; depth, 10 µm) coated with the HR4-DOPA film 
for assaying HeLa cell occupancy of microwells. 
Fluorescent photomicrographs of HeLa cells in the arrayed microwells coated with the HR4-
DOPA layer after 6 h of culture at various initial cell concentrations (0.5 × 10
6
, 1.0 × 10
6
, or 
2.0 × 10
6
 cells/ml) in untreated polystyrene 6-well plates containing RPMI 1640 medium with 
10% FBS and 2% antibiotic solution at 37°C. The cells were stained green with 5(6)-
carboxyfluorescein diacetate n-succinimidyl ester (CFSE). The images in the top row depict 
overlapped fluorescent photomicrographs, while those in the bottom row depict fluorescent 
photomicrographs of HeLa cells. All images were taken at 3× magnification. 
0.5 × 10
6
 cells/ml 1.0 × 10
6
 cells/ml 2.0 × 10
6
 cells/ml 
   
   
 
Table 6.2 shows fluorescent photomicrographs of the HeLa cells adhering in the 10-µm-
deep microwells, and Table 6.3 indicates the average number of cells (± standard deviation 
[SD]) found in microwells from 6 arrays, which contained 200 microwells each (n = 6). For 
these measurements, occupancy was measured as single cell, 2 cells, 3 or more cells, or 
empty. Overall, the number of adhered HeLa cells was insufficient at all concentrations; 
174.8 ± 9.5 out of 200 microwells were empty at 0.5 × 10
6
 cells/ml, 185.7 ± 9.0 were empty 
at 1.0 × 10
6
 cells/ml, and 165.0 ± 15.0 were empty at 2.0 × 10
6
 cells/ml. Here, 
2.0 × 10
6
 cells/ml yielded the highest single-cell occupancy of the microwells, and 
microwells containing 2 HeLa cells (i.e., 1.8 ± 2.1 wells) were also observed. Therefore, 
2.0 × 10
6
 cells/ml was the optimal cell concentration for single-cell occupancy in the 10-µm-
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deep microwell array. 
Table 6.3: The number of microwells (depth, 10 µm) occupied by different numbers of HeLa 
cells at various cell concentrations. The microwells measured 25 × 25 µm
2
 in size and were 
coated with the HR4-DOPA film. The initial seeding cell concentrations were 0.5 × 10
6
, 
1.0 × 10
6
, and 2.0 × 10
6
 cells/ml. The values indicate means ± SDs.  
Cell concentration 
(cells/ml) 
1 cell 2 cells 3 or more cells Empty 
0.5 × 10
6
  91.7 ± 8.4 6.2 ± 3.5 0.0 ± 0.0 102.2 ± 6.7 
1.0 × 10
6
 134.8 ± 11.8 4.3 ± 2.1 0.0 ± 0.0 60.8 ± 9.8 
2.0 × 10
6
 96.0 ± 19.7 30.8 ± 9.5 5.8 ± 2.8 67.3 ± 8.9 
 
Table 6.4: Microwell arrays (size, 25 × 25 µm
2
; depth, 25 µm) coated with the HR4-DOPA film 
for assaying HeLa cell occupancy of microwells. 
Fluorescent photomicrographs of HeLa cells in the arrayed microwells coated with the HR4-
DOPA layer after 6 h of culture at various initial cell concentrations (0.5 × 10
6
, 1.0 × 10
6
, and 
2.0 × 10
6
 cells/ml) in untreated polystyrene 6-well plates containing RPMI 1640 medium with 
10% FBS and 2% antibiotic solution at 37°C. The cells were stained green with 5(6)-
carboxyfluorescein diacetate n-succinimidyl ester (CFSE). The images in the top row depict 
overlapped fluorescent photomicrographs, while those in the bottom row depict fluorescent 
photomicrographs of HeLa cells. All images were taken at 3× magnification. 
0.5 × 10
6
 cells/ml 1.0 × 10
6
 cells/ml 2.0 × 10
6
 cells/ml 
   
   
  
Table 6.4 shows fluorescent photomicrographs of HeLa cells positioned in the 25-µm-
deep microwells, and Table 6.5 indicates the average number of microwells occupied with 
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different numbers of HeLa cells (e.g., 0, 1, 2, or 3 or more cells) from 6 arrays, which 
contained 200 microwells each (n = 6). Among the tested cell concentrations, the 
1.0 × 10
6
 cells/ml concentration had the greatest number of singly occupied microwells 
(approximately 135) and the smallest number of empty microwells (approximately 61). 
Approximately 37 microwells contained 2 or more cells in the 2.0 × 10
6
 cell/ml array, which 
yielded a lower single-cell occupancy (96 microwells) than that of 1.0 × 10
6
 cell/ml. Thus, in 
the case of 25-µm-deep microwells, 1.0 × 10
6
 cells/ml was the optimal cell concentration for 
single-cell analysis. 
Table 6.5: The number of microwells (depth, 25 µm) occupied by different numbers of HeLa 
cells at various cell concentrations. The microwells measured 25 × 25 µm
2
 in size and were 
coated with the HR4-DOPA film. The initial seeding cell concentrations were 0.5 × 10
6
, 
1.0 × 10
6
, and 2.0 × 10
6
 cells/ml. The values indicate means ± SDs.   
Cell concentration 
(cells/ml) 
1 cell 2 cells 3 or more cells Empty 
0.5 × 10
6
  91.7 ± 8.4 6.2 ± 3.5 0.0 ± 0.0 102.2 ± 6.7 
1.0 × 10
6
 134.8 ± 11.8 4.3 ± 2.1 0.0 ± 0.0 60.8 ± 9.8 
2.0 × 10
6
 96.0 ± 19.7 30.8 ± 9.5 5.8 ± 2.8 67.3 ± 8.9 
 
Table 6.6 shows fluorescent photomicrographs of HeLa cells attached in the 40-µm-
deep microwells, and Table 6.7 indicates the average number of microwells occupied with 
different numbers of HeLa cells (e.g., 0, 1, 2, or 3 or more cells) from 6 arrays, containing 
200 microwells each (n = 6). At the 1.0 × 10
6
 cells/ml concentration, an average of 18.0 
microwells had 2 or more cells, while 41.0 microwells contained 2 or more cells at the 
2.0 × 10
6
 cells/ml concentration. Thus, for 40-µm-deep microwells, 1.0 × 10
6
 cells/ml was 
found to be the optimal cell concentration for cell occupancy. Moreover, an average of 96.8 
microwells were occupied by single cells at the 1.0 × 10
6
 cells/ml concentration, which was 
greatest number of singly occupied microwells, but was still less than that of 25-µm-deep 
microwells (134.8). Moreover, a cell concentration of 1.0 × 10
6
 cells/ml yielded the fewest 
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empty microwells (85.2), which also suggested less efficient cell occupancy in these 40-μm-
deep microwells than in the 25-µm-deep microwells (60.8). 
Table 6.6: Microwell arrays (size, 25 × 25 µm
2
; depth, 40 µm) coated with the HR4-DOPA film 
for assaying HeLa cell occupancy. 
Fluorescent photomicrographs of HeLa cells in the arrayed microwells coated with the HR4-
DOPA layer after 6 h of culture at various initial cell concentrations (0.5 × 10
6
, 1.0 × 10
6
, and 
2.0 × 10
6
 cells/ml) in untreated polystyrene 6-well plates containing RPMI 1640 medium with 
10% FBS and 2% antibiotic solution at 37°C. The cells were stained green with 5(6)-
carboxyfluorescein diacetate n-succinimidyl ester (CFSE). The images in the top row depict 
overlapped fluorescent photomicrographs, while those in the bottom row depict fluorescent 
photomicrographs of HeLa cells. All images were taken at 3× magnification. 
0.5 × 10
6
 cells/ml 1.0 × 10
6
 cells/ml 2.0 × 10
6
 cells/ml 
   
   
  
Table 6.7: The number of microwells (depth, 40 µm) occupied with different numbers of HeLa 
cells at various cell concentrations. The microwells measured 25 × 25 µm
2
 and were coated with 
the HR4-DOPA film. The initial seeding cell concentrations were 0.5 × 10
6
, 1.0 × 10
6
, and 
2.0 × 10
6
 cells/ml. The values indicate means ± SDs.  
Cell concentration 
(cells/ml) 
1 cell 2 cells 3 or more cells Empty 
0.5 × 10
6
  32.5 ± 3.5 3.3 ± 1.3 0.2 ± 0.3 164.0 ± 4.0 
1.0 × 10
6
 96.8 ± 5.9 16.5 ± 6.3 1.5 ± 1.3 85.2 ± 8.2 
2.0 × 10
6
 57.3 ± 8.4 30.2 ± 4.1 10.5 ± 4.0 102.0 ± 7.3 
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Next, we graphically compared cell occupancies of the cuboidal microwells for the 
tested microwell depths (i.e., 10, 25, and 40 µm) and cell concentrations (i.e., 0.5 × 10
6
, 
1.0 × 10
6
, or 2.0 × 10
6
 cells/ml), as depicted in Figure 6.12. Both of these conditions affected 
HeLa cell occupancy of the microwell array. Among the different cell concentrations tested 
in this study, the 1.0 × 10
6
 cells/ml concentration yielded the highest single-cell occupancy 
and lowest number of empty wells; additionally, the 2.0 × 10
6
 cells/ml concentration 
generally yielded the greatest number of multicell wells. The 25-µm-deep microwells 
exhibited the highest level of single-cell occupancy for all cell concentrations. Among the 9 
(3 × 3) different conditions, the highest single-cell occupancy (67.4%) was obtained at a 
HeLa cell concentration of 1.0 × 10
6
 cells/ml in 25-µm-deep microwells, which we 
considered to be the most optimal conditions for single-cell analysis. 
 
Figure 6.12: HeLa cell occupancy in 6 microwell arrays under two different experimental 
conditions: cell concentration and microwell depth. 
Each arrays comprised 200 microwells. Cell occupancy was assessed in microwells of various 
depths (i.e., 10, 25, or 40 µm) and at various cell concentrations (i.e., 0.5 × 10
6
, 1.0 × 10
6
, or 
2.0 × 10
6
 cells/ml). The horizontal bars indicate the average number of microwells occupied by 
different numbers of HeLa cells (i.e., 0, 1, 2, or 3 or more). The error bars indicate the SD.  
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 Discussion 6.4.
 Physical dimension of the microwell array 6.4.1
 Microwell size for HeLa cells 6.4.1.1
In a previous chapter 3, we investigated the percentage of HeLa cells smaller than the 
microwell size (diameter, ≤ 25 µm) from the cell size distribution, as measured by CASY cell 
counter (see Figure 3.4) using Image J software as a function of stack analysis. Viable HeLa 
cells ranged in size from 12 to 30 µm, and the percentage of HeLa cells measuring between 
12 and 25 µm was 93.6%. Therefore, we expected that most HeLa cells were able to be 
loaded into the microwells in this study.  
 Surface area of the microwells 6.4.1.2
The areal size of a cell-adhesive surface strongly regulates cell behaviors, such as cell 
growth, migration, proliferation, and viability. A surface area larger than 3000 µm
2
 was 
suggested to be optimal for long-term cell culture, providing cells with adequate space to 
spread, increasing cell growth, and minimizing apoptosis [45, 72]. The surface areas of the 
microwells (size, 25 × 25 µm) coated with the cell adhesive HR4-DOPA film differed for the 
various microwell depths, i.e., 1625 µm
2
 for the 10 µm depth, 3125 µm
2
 for the 25 µm depth, 
and 4625 µm
2
 for the 40 µm depth. Therefore, the microwells should be deeper than 25 µm in 
order to permit the maintenance of the native 3D cellular morphology and promote normal 
cell function during single cell analysis. 
 Volume of the microwells 6.4.1.3
Total volumes were 6250 µm
3
 for 10-µm-deep microwells, 15,625 µm
3
 for 25-µm-deep 
microwells, and 25,000 µm
3
 for 40-µm-deep microwells. The measured HeLa cell volume 
was 2385 µm
3
 (see Chapter 3); therefore, microwells of 10, 25, and 40 µm depths could 
theoretically contain 2.63, 6.55, and 10.48 HeLa cells, respectively. Thus, we were able to 
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observe the presence of multiple HeLa cells per microwell (see Figure 6.13). 
  
Figure 6.13: Microwells containing 2 or more HeLa cells at the seeding cell concentration of 
2.0 × 10
6
 cells/ml.  
(a) Fluorescent photomicrographs of HeLa cells in arrayed square microwells (depth, 25 µm) 
coated with HR4-DOPA. Photomicrographs were taken at 10× magnification [A] and 20× 
magnification [B]. 
(b) Fluorescent photomicrographs of HeLa cells in arrayed square microwells (depth, 40 µm) 
coated with HR4-DOPA. Photomicrographs were taken at 10× magnification [A] and 
20×magnification [B]. 
The microwell size of 25 × 25 µm
2
, which was about 10 µm larger than the size of a 
HeLa cell [38, 70, 80, 118-120], was optimal for single-cell arrays using HeLa cells; however, 
the square shape was unsuitable in terms of the volumetric analysis of the microwell. 
Therefore, in future studies, the microwell shape should be redesigned to meet the following 
criteria: (1) the surface area should be larger than 3000 µm
2
, and (2) the volume of each 
microwell should not exceed the volume of two target cells. 
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 Depth of the microwells 6.4.1.4
The 25-µm-deep microwells showed the highest single-cell occupancy of all tested cell 
concentrations, indicating that 25 µm was the ideal depth for the 25 × 25 µm
2
 microwells. 
These results were supported by previous studies demonstrating that the optimal ratio of size 
to depth was approximately 1 [38, 117]. Rettig and Folch [38] demonstrated that single-cell 
occupancy increased dramatically as the ratio of size to depth increased up to 1, after which 
single-cell occupancy decreased slightly; this tendency was also observed in our current study. 
 Number of microwells in the arrays 6.4.1.5
The highest single-cell occupancy obtained in this study was 134.8 ± 11.8 microwells 
per array; this occurred in the 25-µm-deep microwells at a concentration of 1.0 × 10
6
 cells/ml. 
From these data, we can expect to achieve single-cell occupancy with HeLa cells in 1072 
microwells from 8 microwell arrays in the 2 × 2 mm
2
 area. Thus, since the single-cell 
occupancy achieved in this study satisfied the requirement for adequate sets of data (i.e., 
1000 single cells) in advanced single-cell analysis techniques [55] and since the array-to-
array variation, i.e., the SD of the number of microwells containing single cells relative to the 
total number of microwells, was 5.9%, we can conclude that this microwell array had the 
capacity for use in quantitative analyses in advanced single-cell analysis techniques. 
Moreover, after the elimination of passivated areas, the density of microwells can be doubled 
and the technique becomes more suitable for high-throughput applications. 
 Cell conditions 6.4.2
 Cell concentration 6.4.2.1
A seeding cell concentration of 1.0  106 cells/ml is commonly used for static culture 
[70, 110, 114, 116, 117]. Liu et al. [114] showed the effect of cell concentration on single-
cell occupancy by varying cell concentrations from 1  105 to 1  107 cells/ml. At cell 
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densities of 1  106 and 1  105 cell/ml, single-cell occupancies of 90% and 84%, 
respectively, were achieved in Ramos cells. Higher cell seeding densities (exceeding 
1  106 cells/ml) did not have an obvious effect on cell occupancy. Thus, their results 
indicated that 1.0  106 cells/ml was the optimal concentration for isolated single-cell arrays. 
For this reason, we used 1.0 × 10
6
 cell/ml as the standard cell concentration, but 
performed a more detailed investigation of the effects of cell concentration on single-cell 
occupancy of the microwell array, using a narrower range of concentrations (from 0.5 × 10
6 
to 2.0 × 10
6
 cells/ml). Among these tested cell concentrations, the optimal HeLa cell 
concentration was 1.0  106 cells/ml, while 2.0  106 cells/ml exhibited adverse effects on 
single-cell occupancy, often yielding multiple cells per microwell. 
 Washing the non-adherent cells 6.4.2.2
Cell occupancy, i.e., the number of microwells occupied with any number of HeLa cells, 
was expected to be highest at 2.0 × 10
6
 cells/ml because a greater number of cells would have 
the chance to settle into the microwells. However, while this hypothesis was correct when we 
compared 0.5 × 10
6
 and 1.0 × 10
6
 cells/ml, cell occupancy at 2.0 × 10
6
 cells/ml (132.6 
microwells) was lower than that at 1.0 × 10
6
 cells/ml (139.2 microwells). 
This result may be due to the strong cell-cell interactions of HeLa cells, a cell line that is 
derived from epithelial cells, which are known to pack densely to form the epithelium, 
interacting and attaching to each other [157]. At 2.0 × 10
6
 cells/ml, HeLa cells attached to 
each other and formed cell aggregates, with balls of cells observed and single cells anchored 
on the microwell surface; this may have created tremendously increased shear stress through 
fluid flow during washing-off of nonadherent HeLa cells, a step included in our protocol. 
This strong shear stress may detach these balls of cells, even when the cells were adhered to 
the cell-adhesive HR4-DOPA surface on the microwells. 
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 Cell types 6.4.2.3
Interactions between cells placed in the microwell and the surface of the microwell are 
strongly dependent on the characteristics of the cells, whether adherent or nonadherent. Given 
the cell adhesive surface of the microwell, adherent cells firmly adhere to the microwell 
while nonadherent cells are mechanically trapped inside the microwell. Because of this, 
higher single-cell occupancy is expected for adherent cells than for nonadherent cells. 
However, single-cell occupancy of nonadherent cells is often higher than that of 
adherent cells [38, 114, 118]; for example, the single-cell occupancy of nonadherent Ramos 
cells reached at 90% [114], while adherent HeLa cells showed single-cell occupancy of 83.19% 
[118]. This difference in single-cell occupancy between adherent and nonadherent cells may 
be due to the different shapes of these cells. The morphological features of adherent versus 
nonadherent cells are compared in Figure 6.14.  
 
Figure 6.14: Different morphologies of adherent (anchorage-dependent) and nonadherent 
(anchorage-independent) cells.  
(a) Scanning electron microscope image of an adherent HeLa cell. HeLa cells have long, narrow 
cilia on their surfaces (http://www.smithsonianmag.com).  
(b) Scanning electron microscope image of a nonadherent Jurkat cell [239]. Jurkat cells have 
short, thick cilia on their surfaces. 
 
 １４７ 
Adherent cells have long and narrow cilia on their surfaces in order to interact with and 
attach to each other or survive by attaching to the surface [157], while nonadherent cells have 
short, thick cilia on their surfaces. The long cilia of adherent cells may interfere with cell 
loading into the microwells. Therefore, we can conclude that the achievement of 67.5% 
single-cell occupancy (the highest value we obtained) was an acceptable result for adherent 
HeLa cells in this experiment. 
 Conclusion 6.5.
In this study, we fabricated a microwell array for single-cell analysis that was expected 
to preserve the native 3D morphology and functionality of HeLa cells through construction of 
microwells with a cell-adhesive inner surface using soft lithography and microcontact 
printing. Microwells were shaped as squares (size, 25 × 25 µm
2
) according to the physical 
dimensions of HeLa cells (diameter, 16.17 ± 2.4 µm). We fabricated 8 arrays, with each array 
containing 200 microwells, in a 2 × 2 mm
2
 area. 
We also investigated the optimal conditions for achievement of single-cell occupancy 
with HeLa cells, defining optimal microwell depth (i.e., 10, 25, or 40 µm) and cell 
concentration (i.e., 0.5 × 10
6
, 1.0 × 10
6
, or 2.0 × 10
6
 cells/ml). Microwells deeper than 25 µm 
provided cell-adhesive surface areas larger than 3000 µm
2
, which has been suggested to 
improve long-term cell culture by helping cells adequately spread, increasing cell growth, and 
minimizing apoptosis. However, the volumes of all microwells was large enough to allow 
multiple HeLa cells to adhere (i.e., 2.63–10.48 cells), and a change in the shape of the 
microwell may be necessary in order to achieve less than 2 cells per microwell. 
HeLa cells are adherent cells that exhibit strong cell-cell interactions due to their long, 
narrow cilia. Therefore, the densest cell concentration (2.0 × 10
6
 cells/ml) did not yield the 
highest single-cell occupancy due to HeLa cell aggregation, which increased shear stress 
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during the washing process, and disturbance of the cilia. 
In various microwell depths and cell concentrations, the highest single-cell occupancy 
achieved in this study was 67.5% in 25-µm-deep microwells at 1.0 × 10
6
 cells/ml; these data 
indicated that we could achieve adequate data (i.e., 1072 singly occupied microwells) for 
advanced single-cell analysis techniques. Moreover, the presence of only 5.9% array-to-array 
variation demonstrated the suitability of this microwell array for accurate quantification in 
single-cell analyses. Therefore, a microwell size of 25 × 25 µm
2
, with a 25 µm depth, and a 
cell density of 1.0  106 cells/ml were optimal conditions for single-cell occupancy with 
HeLa cells and verified the applicability of this technique as a high-throughput single-cell-
based assay. 
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 Discussion Chapter 7. 
In this study, the microwell array was coated with a cell-adhesive dopaminergic 
mesoporous inorganic-organic hybrid resin (HR4-DOPA) film on the inner surface to control 
HeLa cell shape and maintain native cell morphology and functionality. In order to obtain the 
optimal biological conditions and physical dimensions of the microwells, various 
biological/physical parameters used in previous studies were reviewed.  
 Biological conditions used in the cellular experiments 7.1.
For assessing cell adhesion, viability, and single-cell occupancy of the microwell array 
for drug discovery, HeLa cells (cancerous cell line) were used at a density of 
1.0  106 cells/ml, and the medium used was RPMI 1640 medium supplemented with 10% 
FBS and 2% penicillin/streptomycin. 
 HeLa cells 7.1.1
In this study, we chose HeLa cells among the potential mammalian cell models for 
microengineering because of their biological relevance to cancer treatment and their ability to 
adhere to hydrophilic surfaces created by microtechniques [39-42, 143]; HR4-DOPA was 
used as cell- adhesive material because its water contact angle (wettability, 62°) is within the 
range for cell adhesion (40–70°). 
HeLa cells, derived from epithelial cells, pack densely to form the epithelium, interact 
with and attach to each other [157], and have long, narrow cilia on the plasma membrane. 
Moreover, the measured diameter of HeLa cells could not be used to accurately predict the 
volume, and vice versa, due to the spheroidal shape of normal HeLa cells undergoing mitosis. 
Therefore, these biological characteristics, morphological features, and physical dimensions 
of HeLa cells provided unexpected results such as inconstant settling velocity, prolonged 
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settling time, and less than 70% single cell occupancy. 
 Settling velocity of HeLa cells 7.1.1.1
The strong interactions between HeLa cells and their long cilia violate the assumptions 
of Stokes’ law for calculating the settling velocity of HeLa cells: (1) particles do not interfere 
with each other, and (2) particles have a smooth surface. The spheroidal shape (eccentricity, 
0.507) also violates the assumptions of Stokes’ law in which particles are spheres. These 
violations of the assumptions of Stokes’ law caused the inconstant settling velocity to 
function as a Boltzmann sigmoidal curve and prolonged settling time by 46.1% of the 
mathematically expected value. 
 Single-cell occupancy in the microwells 7.1.1.2
The biological characteristics of HeLa cells may interfere with cell loading into the 
microwells; the achievement of 67.5% single-cell occupancy (the highest value we obtained) 
was an acceptable result for adherent HeLa cells, although this value is less than that for 
nonadherent cells (≥ 90%) with short cilia [114]. HeLa cells attached to each other and 
formed cell aggregates, with balls of cells and single cells anchored to the microwell surface; 
this may have tremendously increased shear stress during washing to remove nonadherent 
cells. This strong shear stress may detach these balls of cells, even when the cells were 
adhered to the HR4-DOPA surface. 
 Cell concentration 7.1.1.3
We investigated the effect of cell concentration on single-cell occupancy in microwell 
arrays. Liu et al. [114] demonstrated that the concentration of 1.0  106 cells/ml was optimal 
for an isolated single-cell array by using cell concentrations varying from 1  105 to 1  107 
cells/ml (10-fold increments), but we performed a more detailed investigation of the effects 
of cell concentration on single-cell occupancy of the microwell array by using a narrower 
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range of concentrations (from 0.5 × 10
6 
to 2.0 × 10
6
 cells/ml; 2-fold increments). However, 
we also obtained the highest single cell occupancy for the microwell array at a HeLa cell 
density of 1.0  106 cells/ml. 
 FBS concentration in the medium 7.1.2
Serum, e.g., fetal bovine serum (FBS) or fetal calf serum (FCS), is a common 
supplement in cell culture media and is used at a concentration of 10% of the total volume 
[225]; we also used RPMI 1640 medium supplemented with 10% FBS in all the experiments. 
However, the amount of serum in the medium plays a primary role in pre-adsorption of cell-
adhesive ECM proteins, thereby regulating cellular behavior [88, 92, 163, 165, 168, 172, 174-
178, 180]. The optimal amount of serum in medium is 0.1% for fibronectin adsorption, cell 
spreading, and cell adhesion [165]. Therefore, a more detailed investigation of FBS 
concentration is required to explain the effects of FBS on cell adhesion to HR4-DOPA. 
 Dopaminergic mesoporous inorganic-organic hybrid resin 7.2.
We used the HR4-DOPA film, modified from a previous mesoporous inorganic-organic 
hybrid resin (HR4) [47, 158], as a cell-adhesive surface with long-term stability in aqueous 
environments and good adhesive characteristics. HR4-DOPA demonstrated the ability of 
dopamine to stabilize a silane-coupling agent, which is unstable and aggregated in an aqueous 
environment, over a 2-year period. 
 HeLa cell adhesion on HR4-DOPA 7.2.1
In the HeLa cell adhesion assay, HR-DOPA exhibited worse adhesive performance than 
HR4 over 6 h; the differences were not significant at some time points despite the long-term 
stability of HR4-DOPA. The results may be caused by the fact both that the optimal water 
contact angle for HeLa cells is ~50° and that dopamine concentrations greater than 10
–4
 M 
have a negative effect on cell adhesion due to changes in cytoplasmic globular actin [224]. 
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HR4-DOPA (water contact angle, 62°) is inferior to HR4 (water contact angle, 49°) for HeLa 
cell adhesion, although it is in the range of moderate wettability, i.e., 40–70° [51, 88, 158]. 
Moreover, the disadvantage of HR4-DOPA may be due to dopamine in the medium, released 
from the HR4-DOPA film, which contains 1.03 mol% dopamine. 
 HeLa cell viability of HR4-DOPA 7.2.2
HeLa cell viability was 86.1% on HR4-DOPA and did not differ significantly from the 
control, which consisted of XTT reagent plus HeLa cells cultured in substrate-free medium. 
However, the minimum viability of HeLa cells on HR4-DOPA cannot be disregarded 
because dopamine can deplete various cancer cells and might serve as an anti-tumor agent in 
clinical treatment [228-230]. HR4-DOPA should be tested using a normal mammalian cell 
line in order to confirm cell viability. 
 Physical dimensions of the microwell array 7.3.
 Physical dimensions of the microwell 7.3.1
The physical dimensions of the HR4-DOPA film-coated microwells were designed to 
achieve high single-cell occupancy. The dimensions of the square microwells were 
25 × 25 µm
2
, that is, slightly larger than the diameter of HeLa cells (16.17 ± 2.4 µm) [38, 70, 
80, 118-120]. The highest single cell occupancy was provided by microwells with a depth of 
25 µm, supported by the fact that the optimal size: depth ratio was ~1 in previous studies [38, 
117]. The cell-adhesive surface of the cuboidal microwells (25 × 25 × 25 µm
3
) was 3125 µm
2
, 
which is larger than the minimum area suggested for long-term cell culture in order to ensure 
adequate spreading; adequate spreading is important for increasing cell growth and thereby 
minimizing apoptosis [45, 72].  
However, microwells of 10, 25, and 40 µm depths could theoretically contain 2.63, 6.55, 
and 10.48 HeLa cells, respectively. Thus, we were able to observe the presence of multiple 
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HeLa cells per microwell. In future studies, the microwell shape should be redesigned to meet 
the following criteria: (1) the surface area should be larger than 3000 µm
2
 and (2) the volume 
of each microwell should not exceed the volume of 2 target cells. 
 Physical dimensions of the microwell array for single-cell occupancy 7.3.2
After testing various microwell depths and cell concentrations, the highest single-cell 
occupancy achieved in this study was 67.5% (i.e., 1072 singly occupied microwells) in 25-
µm-deep microwells at 1.0 × 10
6
 cells/ml; these data indicated that we could achieve 
adequate throughput: 1000 single cells for advanced single-cell analysis techniques [55]. 
Moreover, the 5.9% array-to-array variation demonstrated the ability of this microwell array 
to be used for accurate quantification. Therefore, a microwell size of 25 × 25 µm
2
, with a 25-
µm depth and a density of 1.0  106 cells/ml were optimal for single-cell occupancy with 
HeLa cells and verified the feasibility of this technique for high-throughput single-cell-based 
assays. 
 System integration 7.4.
 Microfluidic biochip 7.4.1
Microfluidic biochips are designed for immobilizing single cells, mimicking the in vivo 
microenvironment, and application to high-throughput drug screening with cellular analysis. 
The microwell array is essential to maintain the native morphology and functionality of 
experimental cells and provide results that predict in vivo responses during drug discovery. 
 Cell-based biosensors 7.4.2
Cell-based biosensors are portable sensing devices that contain living cells and detect 
physiological changes that are induced in biological components (i.e., enzyme, antibody, 
animal or plant cell, oligonucleotide, lipid, and microorganisms) by exposure to 
environmental stimuli (i.e., toxicants, pathogens, or other chemical/biological agents), and 
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assess these changes in real-time by using physical transducers (i.e., an electrode, an optical 
fiber, or a vibrating quartz) [240-243]. 
The single-cell microwell array for 3D cell culture can increase the feasibility of cell-
based biosensors for high-throughput screening of bioprocess-produced antibodies and 
candidate drug screening, including target identification, ligand fishing, assay development, 
lead selection, and manufacturing quality control [240-243], and provides remarkable real-
time information regarding cellular chemistry at the molecular level [20, 27]. 
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 Conclusion Chapter 8. 
In this study, we fabricated a microwell array for isolated single-cell analysis that 
maintains native cell morphology and functionality for 3D in vitro models for high-
throughput drug discovery using HeLa cells and dopaminergic mesoporous inorganic-organic 
hybrid resin (HR4-DOPA). HeLa cells are widely used for their biological relevance to 
cancer and their ability to adhere to hydrophilic surfaces created by microtechniques; HR4-
DOPA stabilizes a silane-coupling agent through its dopamine modification. 
The physical properties of HeLa cells were investigated for potential application in 
microbiochips. HeLa cell populations exhibited only a 9% increase in the number of cells in 
the first 6 h of incubation. We could assess cell adhesion on HR4-DOPA in the absence of 
apoptosis due to overproliferation; single-cell occupancy in the microwells inhibited cell 
growth in the wells. This may explain their spheroidal shape during cell division. These 
measurements were used to theoretically analyze and measure the settling velocity and time. 
Stokes law was used to calculate the theoretical Stokes velocity of the HeLa cells, and 
experiments to investigate settling velocity were performed in a PS cuvette (internal 
dimensions, 10 × 10 × 20 mm
3
) at 23°C. This timed study showed that the settling velocity 
developed slowly during the initial phase and decreased exponentially during the final phase, 
leading to a Boltzmann sigmoid-shaped curve, and prolonged the settling time by 46.1% from 
the theoretical time. Although the assumptions of Stokes’ law were violated by several 
conditions, that is, the presence of cilia, the non-perfect spherical shape of the HeLa cells, 
and cell-cell interactions, the measured Stokes velocity exhibited only an 11.1% deviation as 
compared to the theoretical velocity. 
The applicability of the dopaminergic mesoporous inorganic-organic hybrid resin (HR4-
DOPA) for the construction of cell-adhesive microwells was proven by the stability of a 
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silane-coupling agent over long-term storage (2 years); the average surface roughness of 
789.35 pm, indicating that the material is smooth and should have little effect on cell 
adhesion; and the water contact angle of 62.08°, indicating moderate wettability for cell 
adhesion (i.e., 40–70°). The biocompatibility of HR4-DOPA with HeLa cells was assessed by 
cell adhesion and viability assays. In the cell adhesion assay, the number of adhered HeLa 
cells on the HR4-DOPA film initially increased within the first hour, after which growth rates 
remained low. Thus, significantly fewer HeLa cells adhered to HR4-DOPA than to HR4 after 
3 h, collagen IV after 1 h, and all controls at 6 h. The dopamine in HR4-DOPA led to poor 
cell adhesion at all time points; however, the differences between HR4-DOPA and HR4 were 
not significant until after 3 h of incubation. During the initial phase of adhesion, HR4-DOPA 
was comparable to collagen IV for 45 min and fibronectin for 1 h. The optimal water contact 
angle for HeLa cell adhesion was ~50°, suggesting the HR4 film (49°) was better suited for 
HeLa cell adhesion than HR4-DOPA (62.08°). Dopamine helped achieve long-term stability 
of a silane-coupling agent in HR4-DOPA, but the dopamine in the medium, perhaps released 
from HR4-DOPA, might weaken cell adhesion. The HeLa cell viability was 86.1% that of the 
control because dopamine might act as an antitumor agent. 
We fabricated a microwell array comprising 8 arrays – each containing 200 microwells 
in a 2 × 2-mm
2
 area – for single-cell analysis that was expected to preserve the native 3D 
morphology and functionality of HeLa cells through construction of microwells with an 
adhesive inner surface using soft lithography and microcontact printing. Microwells were 
shaped as squares according to the diameter of HeLa cells. After testing various microwell 
depths and cell concentrations, the highest single-cell occupancy achieved in this study was 
67.5% in 25-µm-deep microwells at 1.0 × 10
6
 cells/ml. This provided sufficient cell-adhesive 
surface area for long-term cell culture (≥ 3000 µm2) enabling adequate spread, increasing cell 
growth, and minimizing apoptosis. The presence of 1072 singly occupied microwells and 
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only 5.9% array-to-array variation indicated that we could achieve adequate throughput for 
accurate quantification in advanced single-cell analysis techniques.  
We determined that microwells coated with HR4-DOPA are feasible for use in a high-
throughput single-cell-based assay for drug discovery. Given that the microwell arrays are 
integrated in a microfluidic biochip, they can mimic the in vivo microenvironment; we can 
thus predict in vivo responses through high-throughput, isolated single-cellular analysis. 
Additionally, the single-cell array of microwells for 3D cell culture can increase the 
feasibility of cell-based biosensors for high-throughput screening of bioprocess-produced 
antibodies and candidate drug screening including target identification, ligand fishing, assay 
development, lead selection, and manufacturing quality control, and provide remarkable real-
time information regarding cellular chemistry at the molecular level. 
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 Future Work Chapter 9. 
 Integration of cell-based biosensors in microwells 9.1.
Cell-based biosensors are portable sensing devices that contain living cells and detect 
physiological changes of biological components (i.e., enzyme, antibody, animal or plant cell, 
oligonucleotide, lipid, or microorganisms) induced by exposure to environmental stimuli (i.e., 
toxicants, pathogens, or other chemical/biological agents) in real time by using physical 
transducers (i.e., electrode, optical fiber, or vibrating quartz) [240-243]. 
The development of 3D cell culture technologies increases the feasibility of cell-based 
biosensors for high-throughput screening of bioprocess-produced antibodies and for 
candidate drug screening including target identification, ligand fishing, assay development, 
lead selection, and manufacturing quality control [240-243]. 
In this study, microwell arrays demonstrated significant biological functions as they 
maintained native 3D morphologies and cellular functions of anchorage-dependent cells. 
Therefore, given that the microwells for individual single cells array are integrated with cell-
based biosensors, they can provide remarkable real-time information regarding cellular 
chemistry at the molecular level [20, 27].  
 Mimic in vivo microenvironments 9.2.
A potential application for this research is a bio-cell processor for drug discovery, 
integrated with novel platforms such as microfluidic chips and biochips. Microfluidic chips 
are designed to introduce nutrient cell media and drugs via microvalves and mixers. Biochips 
are designed to immobilize single cells for mimicking the in vivo microenvironment and for 
application to high-throughput drug screening. A single-cell array is essential to the bio-cell 
processor for maintaining the native morphology and functionality of experimental cells and 
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providing results that better predict in vivo responses during drug discovery. 
We planned to construct the biochip (see Figure 9.1) for high-throughput drug screening 
with microcomponents: (1) a micro cell-incubation chamber for individual cells to mimic in 
vivo environments, (2) 2 inlet ports for cell loading with vertical sheath flow to shorten 
settling time and for injecting anti-cancer drugs, and (3) an outlet port for waste (dead or non-
adherent target cells) or to transport biological components (i.e., enzyme, antibody, animal or 
plant cell, oligonucleotide, lipid, or microorganisms) to biosensors. 
  
Figure 9.1: Microbiochip for mimicking in vivo microenvironments in a bio-cell processor for 
application to high-throughput drug screening with cellular analysis. 
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Abbreviations  
AFM atomic force microscopy  
AP alkaline phosphatase  
APTES amino-silane  
BPAECs bovine pulmonary artery endothelial cells  
BPEI branched polyethyleneimine  
BrdU 5-bromo-deoxyuridine  
CAMs cell adhesion molecules  
CDC the Centers for Disease Control and Prevention 
CFSE 5(6)-carboxyfluorescein diacetate n-succinimidyl ester  
CR cell retainers  
CVD cardiovascular disease  
DEP dielectrophoresis  
DETA 3-trimethoxysilyl propyl-diethylenetriamine  
E. coli  escherichia coli 
ECM extracellular matrix  
ELISA enzyme-linked immunosorbent assay  
EP electrophoresis  
FAK focal adhesion kinase  
FBS Fetal bovine serum 
FCS fetal calf serum  
FDA Food and Drug Administration 
Fn fibronectin  
GFP green fluorescent protein  
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HDT 1-hexadecanethiol 
HEMA 2-hydroxyethylmethacrylate  
hFOBs human fetal osteoblastic cells  
HMDS hexamethyldisilazane 
HR mesoporous inorganic-organic hybrid resin  
HR-DOPA dopaminergic mesoporous inorganic-organic hybrid resin  
IND investigational new drug 
ITO indium tin oxide  
LPP line plot profile  
MA microwell array 
MEMS microelectromechanical systems  
MFG large-scale manufacturing 
MMAAPA (10-mercaptomethyl-9-anthyl)(4-aldehydephenyl)acetylene  
MPTMS 3-(methacryloyloxy) propyltrimethoxysilane  
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide  
NCEs new chemical entities  
NDA new drug application  
ORLD optimized rapid lifetime determination  
OTS octadecyltrichlorosilane  
PBS phosphate buffered saline  
p-DEP positive dielectrophoretic  
PDMS poly(dimethylsiloxane) 
PEG poly(ethylene glycol) 
PEG-DMA poly(ethylene glycol)-dimethacrylate  
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PET poly(ethylene terephthalate) 
PGLA poly(glycolic-co-lactic)acid  
PR photoresist  
PS polystyrene  
PVDMA poly(2-vinyl-4,40-dimethylazlactone)  
PW picoliter well  
RMS root-mean square  
RT room temperature  
SAMs self-assembled monolayers  
SD standard deviation 
SEM standard error of the mean  
SPP surface plot profile  
TBA tert-butyl alcohol  
TEOS tetraethylorthosilicate 
TP transmembrane protein  
Vn vitronectin  
XPS X-ray photoelectron spectroscopy  
XTT 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-
carboxanilide 
μCS microcapillary system  
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